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1 
1 Summary 
 
 
This thesis deals with catalytic asymmetric synthesis of α- and β-amino acids using metal-free 
catalysts. For the synthesis of α-amino acids, existing methods were revisited using new type of 
catalysts whereas a new method was developed for the synthesis of β-amino acids, which involved 
the kinetic resolution (KR) of oxazinones. 
A series of bifunctional organocatalysts (Scheme 1.1) were synthesized using trans-1,2-diamino-
cyclohexane as the central chiral unit. 
 
 R1 R2 R3 X  R1 R2 R3 X
 
1 
 
Me 
 
Me 
 
3,5-(CF3)2C6H3 
 
S
 
7 
 
Me 
 
Me 
 
2,4,6-(CH3)3C6H2 
 
O  
2 Me Me 3,5-(CF3)2C6H3 O 8 Me Me 3-pyridyl S
3 Et Et 3,5-(CF3)2C6H3 O 9 Me Me c-hex S
4 -(CH2)4- 3,5-(CF3)2C6H3 O 10 Me Me 1-adamantyl S
5 Me Bn 3,5-(CF3)2C6H3 O 12 Me Me (R)-PhCH(CH3) O
 
 
 
NR1R2
N
H
N
H
X
R3
 
6 Me Me 3,5-(NO2)2C6H3 O 13 Me Me (S)-PhCH(CH3) O
 
 
 
N
H NMe2
N
H
OH
N
H
N
O
Me2N
3
 
 
N
H NMe2
N
H
S
Me2N  
 
 
 11 14  
 
 
R1 
 
R2 
 
n  
 
15 
 
Me 
 
Me 
 
0   
16 Et Et 0  
17 i-Bu i-Bu 0  
18 Me Bn 0  
20 H Bn 0  
 
 
 
  NMe2
N
H
N
H
S
N
O
R2
R1
t-Bu
n
21 Me Bn 1  
 
NMe2
N
H
N
H
S
N
O
t-BuMe
Ph
 
19 
Scheme 1.1 Library of bifunctional organocatalysts. 
Summary 
 
 2 
This library of catalysts was screened in the ring opening of the tert-leucine derived azlactone 
rac-22a with allyl alcohol 23 (Scheme 1.2). The best results in terms of enantioselectivity were 
obtained with catalyst 18 containing a second element of chirality. 
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Scheme 1.2 Alcoholytic DKR of the tert-leucine derived azlactone rac-22a. 
 
The best catalyst 18 was applied for the DKR of a broad range of azlactones 22a-h derived both 
from natural and non-natural α-amino acids (Scheme 1.3). 
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Scheme 1.3 Substrate scope for the DKR of azlactones with 18. 
 
Using 5 mol % of 18, the (R)-N-benzoyl α-amino acid allyl esters 24a-h were obtained in high 
yields (up to 94 %) and with excellent enantioselectivities (up to 95 % ee) in most cases. The level 
of enantioselectivity produced by catalyst 18 is the highest ever achieved in the chemically 
catalyzed DKR of azlactones. 
Kinetic and NMR-studies were also carried out to shed light on the mechanism of this DKR 
process. The involvement of one catalyst molecule in the catalytic cycle and the type of 
substrate-catalyst interaction were evidenced from these studies. 
 
The catalyst 18 was then applied for the kinetic resolution (KR) of oxazinones 25 (Scheme 1.4), the 
β-amino acid counterparts of the azlactones 22. A series of oxazinones 25a-f derived from 
β-substituted β-amino acids with aromatic and aliphatic substituents were subjected to ring opening 
with allyl alcohol 23 (Scheme 1.4). 
 
Summary 
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Scheme 1.4 Substrate scope for the KR of oxazinones with 18. 
 
All oxazinones were resolved with high degrees of enantioselectivity. In the presence of 5 mol % of 
catalyst 18, the oxazinones (R)-25a-f were generally recovered with excellent enantiomeric 
excesses (>97 % ee) whereas the esters (S)-26a-f were still produced with 80-90 % ee. This is the 
first example of catalytic alcoholytic ring opening of oxazinones by kinetic resolution. 
 
Besides the DKR process described above, another method, namely the hydrocyanation of 
aldimines 27 (Scheme 1.5) was adopted for the asymmetric synthesis of α-amino acids. 
 
R H
N Ph HCN 
Catalyst* R ∗ CN
HN Ph
27  28 
Scheme 1.5 Asymmetric hydrocyanation of aldimines. 
 
The catalysts employed for this reaction were the chiral oxazaborolidines 29 and their protonated 
counterparts, oxazaborolidinium cations 30 (Scheme 1.6). 
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         29a/30a: Ar = Ph, R = Me 
         29b/30b: Ar = Ph, R = Ph 
         29c/30c: Ar = m-Xyl, R = o-Tol 
Scheme 1.6 Oxazaborolidines and oxazaborolidinium cations. 
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Screening of the catalysts 29a-c as well as 30a-c for the hydrocyanation of the benzaldehyde 
derived imine 27a (R = Ph, Scheme 1.5) proved 29a and 30a to be the most practical catalysts 
(among those in Scheme 1.6) for this reaction. 
A series of imines 27a-f derived from aromatic aldehydes and pivalaldehyde were subjected to 
hydrocyanation in the presence of 29a or 30a (Scheme 1.7). 
 
R CN
HN Ph
 
10 mol % 30a 
 
HCN, toluene, –70 °C 
2-3 h 
R H
N Ph
 
20 mol % 29a 
 
HCN, toluene, –25 °C 
24 h 
R CN
HN Ph
 
(R)-28a-f  27a-f  (S)-28a-f 
R = Ph, o-BrC6H4, m-BrC6H4, 2-naphthyl, p-OMeC6H4, t-Bu 
Scheme 1.7 Substrate scope for the asymmetric hydrocyanation of imines with 29a or 30a. 
 
Although the enantioselectivities of the product α-amino nitriles 28a-f were only moderate in both 
cases (up to 71 % ee in the case of 29a and up to 42 % ee in the case of 30a), products with 
opposite sense of stereoinduction were obtained upon protonation of the catalyst. This is the first 
successful application of neutral and cationic oxazaborolidine for the asymmetric hydrocyanation of 
imines. Moreover, to the best of my knowledge, this is the first example of a protonation-induced 
switch of the sense of stereoinduction. 
 
In addition to the synthesis of enantioenriched α- and β-amino acids, a new modular tridentate 
ligand system 31 (Scheme 1.8) was developed and three ligands 31a-c were synthesized following 
an ex-chiral pool approach. 
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31  
       31c: R = Br 
Scheme 1.8 The new tridentate ligand system 31 and ligands synthesized. 
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To demonstrate the potential of this new ligand system, an aluminium complex 32 (proposed 
structure) of the ligand 31a was prepared and applied for hydrocyanation of benzaldehyde 33 
(Scheme 1.9). 
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HCN, toluene 
–40 °C 
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33  34 32 
Scheme 1.9 Asymmetric hydrocyanation of benzaldehyde catalyzed by the proposed aluminium complex 32. 
 
The cyanohydrin 34 was obtained only in moderate enantiomeric purity of 50 % ee. Nevertheless, 
this reaction showed the potential of this modular ligand system. 
 
 
 
 
 
 
 
 
 
6 
2 Introduction 
 
 
“If a definitive history of twentieth century science is ever written, one of the highlights may well be 
a chapter on the chemical synthesis of complex molecules, especially the total synthesis of naturally 
occurring substances.” – E. J. Corey.[1]  
 
Many naturally occurring substances are optically active due to the tendency of living organisms to 
produce only a single enantiomer of a given molecule. The asymmetry of these molecules arises 
from the inherent chirality of the enzymes that are responsible for their production. Besides 
innumerable natural products, there are thousands of synthetic compounds whose physical and 
chemical properties are characteristic of the spatial orientation of the atoms and groups within the 
molecule.[2] Although the apparent physical differences between two enantiomers may seem small, 
the spatial orientation of a single functional group/residue drastically affects the properties of the 
compounds. This has strong implications for the human body. The difference in our olfactory 
response to either one of the enantiomers can be illustrated by the classic example of the 
enantiomeric forms of the terpene carvone: (R)-(–)-carvone 35 has the odor of spearmint, whereas 
(S)-(+)-carvone ent-35 smells like caraway (Scheme 2.1).[3] 
 
CH3
O
H
H3C
O
H
(R)-(–)-Carvone 
35 
 (S)-(+)-Carvone 
ent-35 
Scheme 2.1 The enantiomers of the natural compound carvone. 
 
Similarly, different stereoisomers of a given biomolecule can exhibit dramatically different 
biological activities. This difference is demonstrated by the tragic administration of the drug 
thalidomide 36 (Scheme 2.2) to pregnant women in the 1960s.[4] Although, the (R)-thalidomide 36 
has desirable sedative properties, its (S)-enantiomer ent-36 is teratogenic.[5] This fact along with the 
in vivo racemization of the (R)-enantiomer[6] resulted in a high incidence of fetal deaths, neonatal 
deaths, and congenital malformations. 
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(R)-(+)-Thalidomide, 36  (S)-(–)-Thalidomide, ent-36 
Scheme 2.2 The enantiomers of the drug thalidomide 36 and ent-36. 
 
These examples are among literally hundreds of cases where biological systems, whether in plant, 
animal, or insect domain, react differently to the enantiomeric forms of a certain molecule. It is thus 
highly desirable, if not mandatory, to prepare molecules in enantiomerically pure form for 
meaningful studies of their chemical and biological properties. Besides the ex-chiral pool 
synthesis[7] from the nature’s collection of chiral compounds, there are two general methods for 
obtaining enantiomerically homogeneous compounds: they may either be synthesized in racemic 
form and resolved by mechanical or chemical means into their optical antipodes, or the synthesis 
may be performed in an enantioselective  manner so as to produce chirally enriched compounds. 
The separation of enantiomers was achieved for the first time by mechanical resolution in 1848 
when Louis Pasteur separated the crystals of the two optical isomers of sodium ammonium tartrate. 
Although this method itself is not generally applicable, the idea of selective crystallization of one 
enantiomer by diastereomeric salt formation is still quite popular for the large scale preparation of 
enantiomerically pure acids or amines. Other methods of resolution involve the formation of 
covalent bonds between the racemic substrate and an enantiomerically pure compound. The 
resulting diastereomeric products can be separated, in most cases, by chromatographic techniques 
and the desired enantiomer can be regenerated from the appropriate diastereomer by chemical 
manipulations. The separation of enantiomers has also been achieved up to gram scale by more 
sophisticated chiral chromatographic techniques. In addition to several limitations associated with 
each of the above methods, they suffer from lack of elegance. 
Furthermore, the number of stereoisomers increases by a factor of 2n with the introduction of 
additional chiral centers. Consequently, in the cases of molecules with more than two chiral centers, 
the separation of one enantiomer from the mixture by resolution techniques is impractical, if not 
impossible to achieve. The solution to this problem is asymmetric synthesis. 
Within the domain of asymmetric synthesis, catalysis holds a special appeal for both the practitioner 
and the user alike. The ability to produce large quantities of desired, enantiomerically pure 
compounds from simple building blocks and relatively small quantities of enantioenriched catalysts 
has tremendous practical implications.[8] Until quite recently, the field of asymmetric catalysis was 
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dominated mainly by two types of catalysts – transition metal complexes and enzymes. For the 
synthetic chemists, it is very important to have reagents and catalysts with predictable behavior 
when planning new syntheses. The transition metal catalysts not only effect a wide range of 
transformations with useful level of enantioselectivity, but often do so with high predictability.[7] 
The contribution of transition-metal catalysis in organic chemistry is evidenced by the fact that in 
2001 the Nobel Prize in Chemistry was awarded to K. Barry Sharpless “for his work on chirally 
catalyzed oxidation reactions”, and to William R. Knowles and Ryoji Noyori “for their work on 
chirally catalyzed hydrogenation reactions”. With a few important exceptions (such as certain 
lipases), such generality is highly unusual with enzymes.[9] The past few years have witnessed a 
significant new movement in organic synthesis: the use of small, purely organic compounds as 
catalysts for an ever-widening range of asymmetric transformations.[10-13] The term organocatalysis 
has been aptly coined for this new approach, which is an alternative to the use of traditional 
metal-ligand complexes and biocatalytic enzymes that have previously been developed. Despite the 
rather recent introduction of this kind of catalysts to synthetic organic chemistry, organocatalytic 
reactions look back on a venerable history.[12] In fact, in the early days of asymmetric catalysis, 
some of the very first asymmetric catalysts were purely organic molecules.[11] As early as in 1912, 
Bredig et al. reported a modestly enantioselective alkaloid-catalyzed cyanohydrin synthesis.[14] The 
real breakthrough in the area of organocatalysis came in 1970s when Hajos et al. and Wiechert et al. 
reported a highly catalytic enantioselective intramolecular aldol reaction using the simple amino 
 
O O
O O
O
OH
O
O
n nn
L-Proline H+
n = 1   93% ee
n = 2   71% ee  
Scheme 2.3 The Hajos-Parrish-Eder-Sauer-Wiechert reaction. 
 
acid L-proline as the catalyst (Scheme 2.3).[15] Recently, List et al. promoted this reaction and used 
L-proline for intermolecular aldol reaction of ketones to various aldehydes.[13, 16]  
The growing interest in the field of asymmetric organocatalysis is evidenced by the increasing 
number of publications appearing everyday besides an already published book[12] and several 
reviews.[10, 11, 13] 
 
9 
3 Background 
 
3.1 Asymmetric Organocatalysis 
 
Organocatalysis is the process of acceleration of a chemical reaction with an organic compound that 
does not contain a metal atom in its active center.[10, 12, 13] This type of catalysis is complementary 
with the metal-complex mediated, and also, with biocatalytic transformations. Preparative 
advantages of organocatalysts are notable: they are readily available from simple chiral feedstocks. 
Usually the organocatalytic reactions can be performed under an aerobic atmosphere, with wet 
solvents and in most cases protection of functional groups is not required.[12] 
An important class of organocatalysts that were known even before the term organocatalysis was 
introduced is the phase transfer catalyst.[17] Even asymmetric version of the phase-transfer 
catalysts[12] has been quite popular ever since their introduction in 1976.[18] The field of asymmetric 
organocatalysis, during the first few years after it acquired the name, was dominated by covalent 
catalysis involving enamine or iminium ion intermediates (Scheme 3.1). Although L-proline 37 was 
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N
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R2
N
-H+
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R2
N
N
H
-H2O R1
R2
O
Iminium
catalysis
Enamine
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ElNu
+H+
 
Scheme 3.1 Activation of a carbonyl group by the formation of iminium ion or enamine intermediates. 
 
initially used for this type of catalysis, several proline derivatives and other chiral secondary amines 
were eventually developed (Scheme 3.2).[12] The enamine and iminium ion catalysis were applied 
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Scheme 3.2 L-Proline 37 and some other secondary amine organocatalysts. 
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for a wide range of asymmetric transformations and even for the synthesis of carbohydrates[19] and 
other complex natural products.[20] Very recently MacMillan and co-workers introduced a cascade 
enamine-iminium ion catalysis concept,[21] which clearly demonstrates the potential of this type of 
covalent catalysis. 
If the covalent catalysis via enamine and iminium ion intermediates is one of the most widely 
studied areas of asymmetric organocatalysis, the least studied area must be the chiral proton 
catalysis.[22] This strategy was reported a year ago by Johnston and co-workers.[23] In this approach, 
a chiral catalyst is generated by coordinating a proton, which stems from the strong Brønsted acid 
TfOH, to a chiral C2-symmetric diamine. The resulting salt 38 is an excellent catalyst for the 
asymmetric aza-Henry reaction and affords the corresponding products in good yields with up to 
95 % ee (Scheme 3.3).[23] 
 
 
 
H
N
Boc
NO2
R2
R1
+
 
 
10 mol % 38 
– 20 °C 
 
 
HN
Boc
R1
R2
NO2
NN
NN
HH
H
+
OTf
_
  50-69 % 
59-95 % ee 
38 
Scheme 3.3 Johnston’s chiral proton catalyst 38 in asymmetric aza-Henry reaction.[23] 
 
Another and even more promising chiral proton catalyst, a chiral phosphoric acid 39 (Scheme 3.4) 
was developed in the same year by Terada et al. for asymmetric Mannich reaction,[24] 
 
Ar
Ar
O
O
P
O
OH
39 
Scheme 3.4 The chiral proton catalyst 39 of Terada.[24-26] 
 
aza-Friedel-Crafts alkylation of furan[25] and direct alkylation of α-diazoester.[26] Quite recently 
Rueping and co-workers applied this catalyst for the enantioselective transfer hydrogenation of 
ketimines.[27] 
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An intermediate concept between the covalent enamine/iminium ion catalysis and chiral proton 
catalysis is the activation of substrates by hydrogen bonding.[28, 29] Hydrogen bonding activation by 
diols were first demonstrated by Hine[30] and Kelly[31] for the activation of epoxides and carbonyls, 
respectively; whereas Etter and co-workers[32] discovered the potential of ureas to form cocrystals 
with a variety of H-bond acceptors, including carbonyl compounds. This property of urea was 
explored by Curran[33] and Schreiner[34] for promoting chemical transformations using urea or 
thiourea as the catalysts. 
An important contribution in the arena of chiral diol-catalyzed asymmetric transformation was 
made by Rawal and co-workers.[35] They developed a highly enantioselective hetero-Diels-Alder 
(HDA) reaction catalyzed by a TADDOL derivative 40 (Scheme 3.5). In the presence of 10 mol % 
of 40, the HDA products were obtained in good yields and with excellent enantioselectivities. 
 
 
1. 10 mol % 40 
Toluene, –78 °C 
 
 
NMe2
TBSO
+
PhH
O
 
2. AcCl, DCM/Toluene 
15 min 
 
 
O
O Ph
O
O
Me
Me OH
OH
Ar Ar
Ar Ar
Ar = 1-naphthyl
  70 %, 98 % ee 40 
Scheme 3.5 Asymmetric hetero-Diels-Alder reaction from Rawal et al.[35] 
 
The most remarkable advances in the domain of urea and thiourea catalysts were made by the 
Jacobsen group.[36-42] They identified and optimized a series of (thio)urea-containing catalysts (e.g. 
41, Scheme 3.6) for a wide range of nucelophilic addition to imines. These catalysts represent the 
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H N
HO
t-Bu OCOt-Bu
N
H
S
N
O
Me
t-BuMe
41 
Scheme 3.6 An example of Jacobsen’s thiourea-containing catalysts. 
 
most enantioselective double-hydrogen-bonding catalysts discovered so far. A representative 
example of the application of these catalysts is the enantioselective hydrophosphonylation of imines 
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(Scheme 3.7).[42] In the presence of 10 mol % of 41, α-amino phosphonates were obtained in high 
yields and excellent enantioselectivities in most cases. 
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Scheme 3.7 Enantioselective hydrophosphonylation of imines from Jacobsen et al.[42] 
 
3.2 Bifunctional asymmetric catalysis 
 
Despite tremendous progress in the field of asymmetric catalysis,[7, 43] the development of new 
enantioselective catalysts continues to be an important topic in the field of organic chemistry. At the 
same time there has been ongoing interest for the discovery of new catalyst concepts. From the 
catalyst design to the synthesis of complex molecular architecture, the chemists have always been 
inspired by nature. Nature is an uncontested master for promoting chemical transformations in most 
efficient, selective and atom-economical fashion. The selectivities (in every sense) achieved by 
nature’s catalyst, namely the enzymes, can barely be matched by their synthetic counterparts. The 
efficiencies and more importantly selectivities achieved by the enzymes in most, if not all, cases can 
be attributed to the synergistic cooperation between different functionalities at the active site 
(Scheme 3.8). On the other hand, most of the synthetic asymmetric catalysts rely on the activation 
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Scheme 3.8 Proposed multifunctional mode of action at the active site of class-II aldolase. 
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of only one of the substrates in an intermolecular reaction. Chemists were also inspired by nature’s 
approach of controlling reactivity and a new catalytic concept evolved: the so called multifunctional 
catalysis. A relevant and even more popular version of multifunctional catalysis is bifunctional 
catalysis, particularly in the domain of asymmetric catalysis.[44] Bifunctional catalysts can 
drastically improve the efficiency of asymmetric processes with respect to enantioselectivity and/or 
conversion rate owing to the attachment of both electrophilic as well as nucleophilic substrates to 
the chiral catalyst in the transition-state (Scheme 3.9). Such a coordination of both substrates within 
an asymmetric space would lead to a stronger stereodiscrimination and should result in a highly 
enantioselective process. The main concern for such two-center catalysts is the choice of suitable 
 
Lewis acid
Brønsted base
or Lewis base
substrate 2
substrate 1
chiral
backbone
 
Scheme 3.9 General concept of bifunctional asymmetric catalysis. 
 
Lewis acid and Lewis base/Brønsted base partners. In addition, the prevention of internal 
coordination between the acid-base pair is one of the main challenges for such systems. The latter 
issue is often overcome by integrating the two functionalities in an appropriate chiral environment.  
Important contributions in the field of bifunctional asymmetric catalysis have been made by Corey 
et al. in oxazaborolidine catalyzed asymmetric reduction of ketones (Scheme 3.10a) [45] and by 
Noyori et al. in the Zn-complex catalyzed asymmetric aldehyde alkylation reaction (Scheme 
3.10b).[46] These catalysts, however, utilize heteroatoms directly conjugated to the Lewis acid as a 
Lewis base (Scheme 3.10). 
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Scheme 3.10 Concepts of Lewis acid-Lewis base bifunctional asymmetric catalyst from (a) Corey and (b) Noyori. 
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The Shibasaki group recently reported a chiral Lewis acid-Lewis base bifunctional catalyst for the 
asymmetric cyanosilylation of aldehydes. Lewis acidic aluminium and Lewis basic phosphine oxide 
are elegantly embedded in the chiral 1,1′-binaphthyl backbone to form this highly efficient 
bifunctional catalyst 42 (Scheme 3.11a).[47] The internal complexation of phosphine oxide with 
aluminium is avoided by applying a linker of appropriate length between the two functionalities. In 
addition to the phosphine oxide already present in the catalyst, a substoichiometric phosphine oxide 
was used as an additive. In the working model proposed by the authors for the catalytic cycle, this 
external phosphine oxide would produce a trigonal bipyramidal aluminium complex by 
coordinating to the aluminium (Scheme 3.11b). This geometry would allow the aldehyde to position 
itself at the apical site close to the internal phosphine oxide. TMSCN could then be activated by 
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Scheme 3.11 (a) Shibasaki’s bifunctional catalyst and (b) its proposed dual activation in the cyanosilylation of 
aldehydes.[47] 
 
interacting with the internal phosphine oxide for the transfer of cyanide to the aldehyde to afford the 
cyanohydrin with the observed stereochemistry (S).[47] 
Building on the work of Shibasaki and co-workers, Nájera, Saá and co-workers designed a very 
similar bifunctional catalyst in which the Lewis basic phosphine oxide moiety was replaced by a 
Brønsted basic tertiary amine.[48] This catalyst was applied for the same reaction and similar level of 
enantioselectivity was achieved. 
In the field of organocatalysis, significant developments have also been made with respect to the 
design and discovery of new asymmetric bifunctional catalysts.[12] Corey and Grogan reported a 
C2-symmetric chiral bicyclic guanidine 43 (Scheme 3.12) for the asymmetric hydrocyanation of 
N-benzhydryl imines (for details, see page 31).[49] The authors proposed a bifunctional mode of 
action for this catalyst (Scheme 3.12). Protonation of the catalyst 43 with HCN generates a 
guanidinium cyanide complex which can serve as the hydrogen bond donor to the aldimine forming 
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Scheme 3.12 Corey’s chiral bicyclic guanidine 43 and its proposed bifunctional mode of action.[49] 
 
the termolecular pretransition-state assembly. The attack by cyanide ion within the ion pair on the 
hydrogen-bond-activated aldimines affords the hydrocyanation product.[49] 
An excellent example of diol based asymmetric bifunctional catalyst was demonstrated by Sasai 
and co-workers for the enantioselective aza-Morita-Baylis-Hillman reaction (Scheme 3.13).[50] In  
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Scheme 3.13 Diol-based bifunctional catalyst 44 for the enantioselective aza-Morita-Baylis-Hillman reaction.[50] 
 
this catalyst 44, a quasi-Lewis acidic diol and a Brønsted basic 3-aminopyridine-derivative were 
integrated on a chiral binaphthyl backbone. The authors showed that a combination of 3-DMAP and 
(S)-BINOL afford the racemic product only in low yield. This illustrates the importance of having 
two functionalities in the same molecule. 
Takemoto et al. developed a thiourea-based bifunctional organocatalyst for the enantioselective 
Michael addition of malonates to nitroolefins (Scheme 3.14).[51-53] This catalyst 1 is an elegant 
combination of the quasi-Lewis acidic thiourea and a Brønsted basic tertiary amine. These two 
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Scheme 3.14 Asymmetric Michael addition of malonates to nitoolefins by 1.[51] 
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functionalities are combined in a single chiral environment to generate this highly efficient catalyst 
that promotes the Michael addition to afford the products with high enantioselectivities.[51] The 
authors also investigated the mechanism of this reaction and proposed a bifunctional mode of 
activation of both the substrates by the catalyst 1 (Scheme 3.15). 
 
NMe2
NN
S
H H
N
OO
Ph
O
OH
EtO
OEt
CF3
F3C
 
Scheme 3.15 Transition state model for the Michael addition of malonates to nitroolefins by 1.[53] 
 
After the report of Takemoto et al.,[51] several groups applied[54-56] the catalyst 1 and developed[56-58] 
a number of (thio)urea-tertiary amine bifunctional organocatalysts (Scheme 3.16) for a wide array 
of asymmetric transformations with good results in most cases. 
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Scheme 3.16 Examples of Takemoto-type bifunctional organocatalysts [Ar = 3,5-(CF3)2C6H3]. 
 
3.3 Kinetic and dynamic kinetic resolution 
 
The goal of asymmetric synthesis is to prepare stereochemically-enriched compounds in the most 
efficient and practical manner possible. At the same time, it is important to accomplish the synthesis 
in a way to achieve highest “atom economy”.[59] Driven by the demand to enhance the economic 
balance of chemical processes, there has been an increased interest in the transformation of 
racemates into a single stereoisomeric product without the occurrence of an undesired isomer. 
Despite numerous efforts to transform an unwanted isomer into the desired final product, for 
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example by re-racemization or via independent enantio-convergent synthesis, processes based on 
the separate use of two enantiomers are far from being economically optimal and certainly lack 
elegance. Even today, the resolution of racemates is still one of the major methods for the 
production of enantiopure compounds on an industrial scale.[8, 60] Although numerous methods exist 
which are highly efficient in terms of enantio-discrimination, the maximum theoretical yield of 
50 % for each enantiomer sets a low ceiling on the productivity of such processes. In order to 
overcome this limitation, considerable effort has been devoted to create processes which afford the 
product with the same high enantiomeric purity, but in significantly improved chemical yield. A 
number of strategies have been developed during the past few years to allow the conversion of both 
enantiomers from a racemate into a single stereoisomer in a concurrent and non-sequential 
fashion.[61] One of these strategies, the so-called kinetic resolution (KR) is based on the difference 
of reaction rates (kR, kS) of substrate enantiomers (SR, SS) during the transformation to product 
enantiomers PR and PS by a chiral catalyst via diastereomeric transition state (Scheme 3.17).[62] Due 
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Scheme 3.17 Principles of kinetic and dynamic kinetic resolution. 
 
to the fact that two enantiomeric species react simultaneously at different rates (in preferably 
irreversible manner), the relative concentrations of SR/SS and PR/PS change as the reaction proceeds 
and, as a consequence, the enantiomeric composition of S and P becomes a function of the 
conversion. Recovery of the formed product PR and the unreacted substrate enantiomer SS in 
non-racemic form constitutes a kinetic resolution. The efficiency of KR is often expressed by the 
selectivity factor s or krel: s = kR/kS. Although the maximum theoretical yield based on racemic 
starting material is only 50 %, the most attractive aspect of KR from the point of view of 
preparative synthesis is that unreacted substrate can be recovered in high ee, simply by carrying the 
reaction to high enough conversion, even if s (or krel) is not very high.  
A significant breakthrough to overcome the 50 % yield barrier in KR was achieved by the 
development of dynamic kinetic resolution (DKR). The latter combines the resolution step with an 
in situ racemization of the substrate enantiomers SR and SS via an achiral or prochiral 
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intermediate/transition state (Scheme 3.17). As a consequence, as the faster reacting enantiomer 
(SR) is depleted during the enantioselective reaction, the equilibrium of SR/SS is constantly 
re-adjusted by racemization of the slow reacting counterpart SS. To indicate the non-static character 
of this process, the term “dynamic kinetic resolution” has been coined. It is conceivable that the 
kinetic balance of the two concurring reactions is of crucial importance for the success of a DKR. 
As a rule of thumb, the racemization of the substrate should occur at an equal or higher rate than the 
catalytic asymmetric reaction (see Scheme 3.17). 
 
3.4 The routes to enantiomerically pure α-amino acids 
 
α-Amino-carboxylic-acids, commonly known as α-amino acids, are one of the five major classes of 
natural products that exhibit diverse biological functions. They are fundamental constituents of 
proteins and act as mediators for nitrogen metabolism, providing the raw materials for the 
production of many primary and secondary metabolites. Historically, the amino acids have been 
subdivided into the 20 proteinogenic and the non-proteinogenic representatives. Besides their 
numerous applications for natural processes, enantiomerically pure α-amino acids are extremely 
valuable chemicals in their own right. Both proteinogenic and non-proteinogenic α-amino acids find 
wide application for the synthesis of a wealth of enantiomerically pure pharmaceuticals (Scheme 
3.18).[63] In this context, the structure of the extremely potent antibiotic vancomycin 45 
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is particularly noteworthy because of the presence of a wide array of nonnatural α-amino acids. 
Alongside the non-natural α-amino acids, there is a growing interest for natural or non-natural 
D-amino acids. D-Amino acids are significant as components of antibiotics, pharmaceuticals, or 
pesticides that are often more active and also more stable compared to their L-containing 
analogs.[63] D-Amino acid-containing pharmaceuticals for example, are more stable than L-analogs 
against decomposition in liver, kidney and bloodstream. Furthermore, α-amino acids are extensively 
used as chiral starting materials, auxiliaries, organocatalysts and also ligands for transition-metal 
catalysts in modern organic synthesis.[64, 65] The ever-increasing interest for various α-amino acids 
has prompted the development of new methodologies and strategies for their asymmetric synthesis. 
There are two general approaches for obtaining enantiomerically pure α-amino acids (as to the 
preparation of any enantiomerically pure compounds): (i) synthesis in racemic form, followed by 
separation of the product enantiomers, and (ii) asymmetric synthesis, preferably by catalytic 
methods.  
 
3.4.1 Resolution of racemic α-amino acids 
3.4.1.1 Dynamic kinetic resolution of hydantoins 
 
The compound imidazolidine-2,4-dione or hydantoin was discovered by von Baeyer in 1861 by 
reduction or hydrogenation of allantoin, a cyclic amide naturally occurring in many plants.[66] A 
wide spectrum of various 5-mono and 5,5′-disubstituted hydantoin derivatives of industrial and 
pharmaceutical interest is described in the literature.[9] Among them, 5-monosubstituted hydantoins 
may be regarded as cyclic ureides of α-amino acids. They are important precursors, in the industrial 
production of optically pure α-amino acids (Scheme 3.19). Various enzymes, so called 
hydantoinases, facilitate the hydrolysis of the hydantoin ring system as an initial reaction step. The 
hydantoinases generally have different substrate specificities and in general are selective in 
hydrolyzing D- or L-hydantoins to the corresponding D- or L-N-carbamoyl amino acids (or 
hydantoic acid). The hydantoins are often applied in combination with the highly stereoselective 
enzyme N-carbamoyl amino acid amidohydrolases (mostly known as N-carbamoylases), which 
catalyze the further hydrolysis of the hydantoic acids to the free aminoacids in an irreversible 
reaction. 5-Monosubstituted hydantoins racemize through keto-enol tautomerism above pH 8, 
owing to their acidic hydrogen in 5-position. However, the rate constant of racemization strongly 
depends on the residue in 5-position (τ1/2: phenylhydantoin 0.3 h, benzylhydantoin 5 h and  
 
Background 
 
 20 
N N
O
O
HH
R
N N
O
O
HH
RCO2HR
N
O
NH2H
CO2HR
N
O
NH2H
CO2HR
NH2
CO2HR
NH2
pH >8
and/or
racemase
D-hydantoinaseL-hydantoinase
L-hydantoin D-hydantoinL-N-carbamoylα-amino acid
D-N-carbamoyl
α-amino acid
L-carbamoylase D-carbamoylase
H2O
CO2, NH3CO2, NH3 L-amino acid D-amino acid
D-specificL-specific
H2O
 
Scheme 3.19 The “hydantoinase-process” for the production of D- and L-amino acids. 
 
isopropylhydantoin 56 h).[63] Thus, in some cases, a third enzyme called hydantoin-racemase is 
involved. Together, these three enzymes accomplish the total conversion of racemic 
5-monosubstituted hydantoin derivatives into the corresponding enantiomerically pure D- or 
L-α-amino acids. This cascade of reactions, whether located in whole cells or carried out using 
isolated enzymes is called the “hydantoinase-process” (Scheme 3.19).[9] 
 
3.4.1.2 Dynamic kinetic resolution of azlactones 
 
Oxazol-5(4H)-ones, commonly known as azlactones (A or ent-A in Scheme 3.20), constitute a 
readily available class of highly versatile intermediates for the synthesis of α-amino acids and 
peptides, for they undergo facile ring opening with various nucleophiles to produce α-amino acid  
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derivatives. They are easily prepared from glycine azlactone (R2 = H in Scheme 3.20) by the 
Erlenmeyer azlactone synthesis or from α-amino acids by N-acylation followed by 
cyclodehydration in the presence of a condensation agent (e.g. acetic anhydride).[67] Owing to the 
relatively high acidity of the C-4 proton (pKa ~ 8.9)[68] and aromatic character of the intermediate 
enol form (B in Scheme 3.20), azlactones racemize under very mild conditions, even in the absence 
of external base.[69] These properties of azlactones made them excellent substrates for 
enantioselective ring-opening under the condition of a dynamic kinetic resolution (see Scheme 3.17 
on page 17). The alcoholytic ring opening of azlactones leads to N-acyl α-amino acid esters (such as 
C or ent-C; Scheme 3.20), the N,C-doubly protected α-amino acid derivative.  
Proteases[70] and lipases[71] have been used for the rather efficient enzymatic DKR of azlactones. 
But only a few examples of chemically catalyzed DKR of azlactones appear to exist. As reported by 
Seebach et al., arylalanine-derived azlactones (R2 = CH2Ar in Scheme 3.20) could be resolved using 
titanium-taddolates 48 (Scheme 3.21) in good yields with moderate ee.[72] In this approach, 48 was 
used in stoichiometric quantities, or at 0.7 eq. loading in the presence of 0.5 eq. of Al(Oi-Pr)3. 
Enantiomeric excesses up to 72 % was obtained with 74 % yield of the product ester within 5 to 10 
days. 
Hua and co-workers used the cyclic dipeptide cyclo-[(S)-His-(S)-Phe] 49 (Scheme 3.21) as an 
organocatalyst for the alcoholic DKR of the phenylalanine-derived azlactone (R2 = CH2Ar in 
Scheme 3.20).[73] However, the enantiomeric excess achieved in this case was only up to 39 % with 
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Scheme 3.21 Non-enzymatic reagents and catalysts for the dynamic kinetic resolution of azlactones. 
 
a conversion of ca. 30 % after 15 days. All these methods described above suffer either from narrow 
substrate scope or very long reaction times (ranging from days to weeks), or both.  
Fu et al. showed that the DKR of azlactones can also be effected by alcoholysis in the presence of 
the planar-chiral DMAP-derivative 50 (Scheme 3.21) as catalyst.[74] For example, using 5 mol % of 
50 and methanol as the nucleophile, enantiomeric excesses of 44-61 % were achieved in the DKR 
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of a number of azlactones. In the case of the alanine-derived azlactone (R2 = CH3 in Scheme 3.20), 
78 % ee were observed with 2-propanol as the nucleophile (R3 = i-Pr in Scheme 3.20), albeit at the 
expense of a relatively low reaction rate.[74] 
 
3.4.2 Enantioselective synthesis of α-amino acids 
 
Several different (catalytic) asymmetric approaches to α-amino acids are reported in the 
literature.[75, 76] Most of them, if not all, involve enantioselective carbon-carbon, carbon-nitrogen 
and carbon-hydrogen bond formation as the key step (path a-d; Scheme 3.22).  
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Scheme 3.22 Catalytic asymmetric route to α-amino acids. 
 
3.4.2.1 Asymmetric hydrogenation of α,β-didehydroamino acid derivatives 
 
Asymmetric hydrogenation of α,β-didehydroamino acid derivatives has emerged as one of the most 
practicable and cost effective routes to a diverse array of both D- and L-natural and unnatural 
α-amino acids.[77] The historical importance of this reaction lies in the fact that the desire to develop 
practical routes to enantiomerically pure α-amino acid derivatives provided the initial inspiration for 
the advent of catalytic asymmetric hydrogenation reactions more than 30 years ago. The original 
objective was to identify a catalyst that would allow the enantioselective addition of hydrogen 
across the C=C double bond of an α-enamide substrate 51 (Scheme 3.23). The inaugural studies 
culminated in Monsanto’s commercial production of L-DOPA.[78] Shortly before the beginning of 
this study, Wilkinson established the feasibility of homogeneous hydrogenation of alkenes with 
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Scheme 3.23 Asymmetric hydrogenation of α,β-didehydroamino acid derivatives. 
 
RhCl(PPh3)3 as the catalyst precursor.[79] The most obvious approach was to replace PPh3 with 
chiral phosphine ligands. Although the initial studies were based on using chiral monophosphine 
(with the chiral centre on the phosphorous atom) as the ligand,[80] soon the importance of chelating 
diphosphines was realized.[81] Some of these chiral bis(phosphines) ligands are shown in Scheme 
3.24. Like several phosphine ligands, a wide range of catalysts also have been examined for this 
process. In general, the most efficacious catalysts for α-enamide hydrogenations have been those 
derived from rhodium complexes bearing chiral C2-symmetric diphosphine ligands. In particular, 
cationic rhodium complexes of the type [(diene)Rh(diphosphine)]+X– (diene = 1,5-cyclooctadiene 
or norbornadiene, diphoshphine = chiral diphosphine , X = non-coordinating anions like BF4, SbF4, 
OTf, etc.) have proven to be the most efficient and highly enantioselective catalyst precursors 
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Scheme 3.24 Selected examples of chiral bis(phosphines) ligands used for Rh-catalyzed asymmetric hydrogenation. 
 
discovered to date for α-enamide hydrogenations. An important fact about this reaction is that high 
enantioselectivities have been restricted primarily to Z-α-enamide substrates. The E-α-enamide 
isomer often is reduced with significantly lower enantioselectivity, and occasionally with opposite 
sense of stereoinduction. Although DiPAMP 53 appeared to be the most frequently used ligand and 
also performs satisfactorily in most cases, more recent studies showed that BPE (55) and 
particularly DuPHOS (54) are superior to all the other ligands for rhodium catalyzed asymmetric 
hydrogenation of enamides. Rhodium catalysts derived from the Me-DuPHOS (54, R = Me) and 
Et-DuPHOS (54, R = Et) ligands have been shown to be uniquely capable of providing high 
enantioselectivities in the hydrogenation of α-enamides 51 (Scheme 3.23 on page 23) bearing a 
wide array of both β-aryl and β-alkyl substituents. For example, N-acetyl-α-enamides 51 (R = CH3, 
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Scheme 3.23) bearing an unprecendented range of β-substituents may be hydrogenated with the 
cationic (R,R)-Et-DuPHOS-Rh catalyst to furnish unnatural D-α-amino acid derivatives with 
enantioselectivities routinely >98 % ee.[82] These cationic DuPHOS-Rh catalysts are extremely 
efficient; substrate-to-catalyst ratios as high as 50000:1 have been demonstrated in α-enamide 
hydrogenations. In many cases both E- and Z-α-enamide isomers may be hydrogenated with high 
enantioselectivity, and both geometric isomers afford products of the same absolute configuration. 
The potential of these catalysts to hydrogenate both E- and Z-isomers provides the possibility to 
extend the substrate scope to the β,β-disubstituted α-enamides 56 (Scheme 3.25). In fact, the 
DuPHOS-Rh and BPE-Rh catalysts are singular in their ability to hydrogenate β,β-disubstituted 
α-enamides with high enantioselectivity: they allow the production of an expansive array of novel 
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Scheme 3.25 Asymmetric hydrogenation of β,β-disubstituted α-enamides. 
 
β-branched α-amino acid derivatives 57 with enantioselectivities >96 % ee (Scheme 3.25).[83] Also, 
with two different β-substituents, two contiguous stereogenic centers are created simultaneously 
upon hydrogenation.  
Recent studies have also revealed that hydrogenation of α-enamides possessing more easily 
removed N-protecting groups, such as N-Cbz or N-Boc can be accomplished by DuPHOS-Rh 
catalysts. Enantioselectivities comparable to N-acetyl-α-enamides have been achieved with a wide 
range of N-Cbz and N-Boc α-enamides.[82, 84] 
 
3.4.2.2 Asymmetric alkylation of glycine derivatives 
 
The use of benzophenone imines of glycine esters 58 as substrates in enantioselective 
organocatalytic alkylation has emerged as an excellent method for the preparation of a wide range 
of optically active α-amino acids with high enantioselectivity (Scheme 3.26).[85] The application of 
chiral phase-transfer catalysts (PTC) to the asymmetric alkylation of glycine imine tert-butyl ester 
58 (R = t-Bu in Scheme 3.26) was first reported by the group of O’Donnell in 1989.[86] In the 
presence of 10 mol % of the cinchona-alkaloid-derived PTC 60 (Scheme 3.27), the desired products 
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Scheme 3.26 Alkylation of glycine derivative for the preparation of α-amino acids. 
 
of type 59 (R = t-Bu; Scheme 3.26) were obtained in good chemical yields (up to 82 %) and 
enantioselectivities up to 66 % ee.[86]  Few years later, the same group made a remarkable 
improvement in the enantioselectivity by using modified alkaloid catalyst with an O-allyl 
substituent.[87] Applying the new O-allylated PTC 61 (Scheme 3.27) in the alkylation reaction led to 
enantioselectivities up to 81 % ee.[87] A further major enhancement in the enantioselectivity with a 
“jump” of ee values to the range >90 % was achieved simultaneously in 1997 by the Lygo[88] and 
Corey[89] group. They replaced the N-benzyl group of the O’Donnell catalyst with a 
9-anthracenylmethyl group. The resulting PTCs 62 (Scheme 3.27) with either free or allylated OH 
group revealed their high catalytic potential with excellent enantioselectivities of up to 99.5 % ee 
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Scheme 3.27 Selected phase transfer catalysts for the asymmetric alkylation of glycine derivatives. 
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with both activated and non-activated alkyl halides as alkylating agents.[88, 89] Towards the end of 
the last century, Maruoka and co-workers developed a completely new type of robust and 
structurally rigid, C2-symmetric, 1,1′-binaphthyl-derived chiral spiro ammonium salts for 
asymmetric alkylation of glycine imine tert-butyl ester 58.[90, 91] In presence of only 0.2–1.0 mol % 
of the PTC 63 (Scheme 3.27), high yields of up to 98 % and excellent enantioselectivities, often 
99 %, were obtained for the product 59 within very short reaction times (0.5 to 10 h).[90] Despite 
these tremendous advantages along with their modular structure for substrate-specific optimization, 
these catalysts suffer from the serious drawback for large scale applications due to their rather long 
synthetic route and expensive starting materials (they are not derived from the chiral pool). 
Shibasaki et al. reported a tartrate-derived two-centered C2-symmetric phase-transfer catalyst 64 
(Scheme 3.27) for the alkylation of 58 (R = t-Bu in Scheme 3.26) with active alkyl halides.[92] 
Using 10 mol % of this catalyst under optimum reaction conditions, high yields (up to 92 %) and 
enantioselectivities (up to 93 %) were obtained for a broad range of substrates.[92] The Nagasawa 
group introduced a chiral C2-symmetric pentacyclic guanidinium cation 65 (Scheme 3.27) for the 
asymmetric alkylation of 58 (R = t-Bu in Scheme 3.26) with activated alkyl halides.[93] Applying 
30 mol % of 65 as the catalyst, alkylated products were formed with moderate to good yields 
(61-85 %) and good enantioselectivities (76-90 %).[93]  
Although this methodology is quite useful for the asymmetric synthesis of a wide range of aliphatic 
α-amino acids, it is not possible to synthesize aromatic α-amino acids by this technique.  
 
3.4.2.3 Asymmetric hydrocyanation of imines 
 
The addition of hydrogen cyanide to the in situ generated imines, the Strecker reaction, constitutes 
the oldest and most direct method for the synthesis of α-amino acids (Scheme 3.28a).[94] The 
versatility of this method stems from its simplicity and economical viability for the production of  
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α-amino acids both on lab scale as well as on technical scale. When using amines instead of 
ammonia, the pre-formation of imines, followed by hydrocyanation instead of the original one-pot 
synthesis represents a popular and widely used alternative route (Scheme 3.28b). The biggest 
advantage of this method is that, in principle, any α-amino acid can be synthesized via this route. 
Despite these practical advantages, this method suffers from the obvious limitation that the products 
obtained in this reaction are racemic. Consequently, an enantioselective version of the process, 
which could lead to the practical production of a wide range of α-amino acids, has been of great 
interest. 
Significant progress has been made in the development of stereoselective versions of this reaction 
using imines bearing covalently attached chiral auxiliaries. This method entails substitution of 
ammonia with optically active amines, thereby providing some asymmetric induction, resulting in 
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Scheme 3.29 Harada’s asymmetric synthesis of L-alanine by using a chiral auxiliary.[95] 
 
diastereoselective addition of HCN to the imine. Particularly noteworthy in this field is the 
pioneering work of Harada in 1963: (–)-α-methylbenzylamine was used as the chiral auxiliary for 
the synthesis of L-alanine in 95 % ee (Scheme 3.29).[95] Although the auxiliary-based methods 
afford quite high enantioselectivities, the cost of using stoichiometric amounts of unrecoverable 
chiral auxiliaries prevents the adoption of these methods for the large-scale synthesis of α-amino 
acids. Practical substitutes for the chiral auxiliaries are chiral catalysts.[96, 97] 
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The progress of catalytic asymmetric hydrocyanation of imines took place mainly during the last 
decade.[96, 97] Most of the catalytic asymmetric syntheses of α-amino acids by this route are based on 
the use of preformed imines 66 and the subsequent nucleophilic addition of HCN or TMSCN in the 
presence of a chiral catalyst (Scheme 3.30). The enantioselective catalysts for the imine cyanation 
can be broadly divided into two major classes: catalysts containing Lewis acidic metal ion in their 
active site[96, 97] and metal-free catalysts or organocatalysts.[12, 96, 97] 
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Scheme 3.31 Chiral metal catalysts for the asymmetric hydrocyanation of imines. 
 
In recent years, several groups contributed to the development of successful metal catalysts for the 
catalytic asymmetric Strecker reaction. As a result, a number of chiral Lewis acid catalysts 
containing various metals (e.g. aluminium, titanium, zirconium, lanthanoid etc.) have emerged 
during the last few years (Scheme 3.31). It is noteworthy that each catalyst requires the use of a 
specific N-substituent (R1 in Scheme 3.30) for obtaining good results. Thus, the preferred type of 
N-substituent depends on the type of applied catalyst.[97]  
Jacobsen et al. reported the first example of a metal-catalyzed enantioselective addition of 
hydrogen cyanide to imines 66 (R1 = allyl, Scheme 3.30) using a chiral Al(III)-salen complex 68 
(Scheme 3.31).[98] A variety of N-allylimines was evaluated in the reaction catalyzed by 5 mol % of 
68 at –70 °C over 15 h to give product 67, which were isolated as trifluoroacetamides (R1 = allyl, 
R2 = CF3CO; Scheme 3.30) in good yields (69-99 %) and moderate to excellent enantioselectivities 
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(37-95 % ee). Substituted arylimines 67 (R = Ar, Scheme 3.30) were the best substrates (79-95 % 
ee), while alkyl-substituted imines afforded products with considerably lower ee values (37-57 % 
ee).[98]  
A year later, Snapper, Hoveyda and co-workers employed the Ti-complex 69 (Scheme 3.31) of a 
modular Schiff base ligand for the enantioselective Strecker reaction of aromatic 
N-benzhydrylimines 66 (R1 = CHPh2, Scheme 3.30) to give the addition product 67 (R1 = CHPh2, 
R2 = H).[99, 100] Good to excellent enantioselectivities (85 to >99 % ee) were obtained in the 
presence of 5-10 mol % of 69 at 4 °C using TMSCN as the cyanide source. It was found that 
catalyst turnover was facilitated significantly in the presence of i-PrOH as an additive. Albeit most 
of the substrates studied are arylimines, the authors showed that alkyl imines can also be used and 
the products with same level of enantioselectivity as aryl substrate were achieved.[99] The 
aminonitriles 67 (R1 = CHPh2, R2 = H, Scheme 3.30) are stable and can be readily converted to the 
corresponding amino acids with 6N HCl by concomitant cyanide hydrolysis and amine 
deprotection.[99]  
The Shibasaki group disclosed a general asymmetric Strecker-type reaction that was controlled by 
bifunctional Lewis acid–Lewis base catalyst 42 (Scheme 3.31).[101] A variety of aromatic, aliphatic, 
heterocyclic, and α,β-unsaturated N-fluorenylimines underwent catalytic asymmetric 
trimethylsilylcyanation with 9 mol % of the binaphthol catalyst 42 at –40 °C to give α-aminonitriles 
in good to excellent yields (80-97 %) and enantioselectivities (72-95 % ee). The α-aminonitriles 
could then be converted into α-amino acids in several steps.The addition of phenol was found to 
have a beneficial effect on the reaction rates. The origin of high selectivity is believed to be 
attributed to the simultaneous activation of imines and TMSCN by the Lewis acidic Al(III) and the 
Lewis basic oxygen atom of the phosphane oxide, respectively.[101] 
Kobayashi et al. developed the chiral zirconium binuclear catalyst 70 (Scheme 3.31) for the 
asymmetric synthesis of α-aminonitriles from aldimines with tributyltin cyanide (Bu3SnCN).[102] An 
o-hydroxyphenyl group as an N-substituent (R1, Scheme 3.30) was found to be beneficial for high 
asymmetric induction. Various aromatic, aliphatic, and heterocyclic aldimines were employed as 
substrate in this reaction; high levels of enantioselectivities (up to 91 % ee) were observed with 
these substrates. The most attractive aspect of Kobayashi catalyst 70 is that the catalytic 
asymmetric Strecker amino acid synthesis starting from achiral aldehydes, amines (R2 = H, CH3) 
and hydrogen cyanide has been achieved with this catalyst (Scheme 3.32).[102] It is interesting to 
note that 150 years after the discovery of the Strecker reaction, a truly efficient three-component 
asymmetric version has been accomplished. While the use of tributyltin cyanide is suitable for 
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laboratory-scale experiments, industrial applications are expected for a more benign 
three-component catalytic asymmetric Strecker process using hydrogen cyanide.  
The Vallée group reported the addition of TMSCN to aromatic and aliphatic aldehyde-derived 
N-benzyl aldimines 66 (R = alkyl/aryl, R1 = PhCH2; Scheme 3.30 on page 27) using 
heterobimetallic scandium complex 71 (Scheme 3.31).[103] In the presence of 10 mol % of 71, high 
yields of 80 % and enantioselectivities of 91 % ee were obtained with N-benzyl benzaldimine after 
only 3 h reaction time. 
In addition to these metal-catalyzed asymmetric cyanations, several versions of this process based 
on the use of organocatalysts have been developed so far.[12, 97] Interestingly, completely different 
types of organic molecules were found to possess the ability to catalyze this reaction (Scheme 3.30 
on page 27).  
In 1998 Jacobsen and co-workers identified a new type of organocatalyst via parallel library 
synthesis and screening of resin-bound derivatives.[36] This highly modular Schiff base-(thio)urea 
organocatalyst (Scheme 3.33) was optimized through iterative structural modification of various 
components.[37, 39, 40] As low as 1 mol% of the optimum catalyst 41 was found to effect asymmetric 
hydrocyanation of a wide range of aromatic, aliphatic N-allyl (also N-benzyl) aldimines and cyclic 
imines with excellent yields (up to 99 %) and enantioselectivities (up to >99 % ee) of the product 
72 (Scheme 3.33).[37] The key elements responsible for the high enantioselectivity were the  
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presence of bulky tert-butyl substituents at both the amino acid position and at the 3-position of the 
salicylimine moiety. The authors also demonstrated the practical potential of the resin-bound 
catalyst for the hydrocyanation of pivalaldimine (R = t-Bu). The resin-bound catalyst allowed 
purification of the product by simple filtration and solvent removal, and the catalyst could be reused 
indefinitely without loss of either activity or enantioselectivity.[37] They also investigated the 
mechanism of this hydrocyanation reaction. It is believed that the imine was activated by the 
reversible binding of its Z-isomer to the catalyst through bifurcated hydrogen bonding from the 
thiourea NHs and addition of HCN takes place over the diaminocyclohexane portion of the 
catalyst.[39]  
The Corey group reported a C2-symmetric bicyclic guanidine as a bifunctional catalyst for the 
addition of HCN to achiral N-benzhydryl imines (Scheme 3.34).[49] In the presence of 10 mol% of 
43, aromatic and aliphatic N-benzhydryl imines undergoes hydrocyanation to afford 
N-benzhydryl-α-amino nitriles with high yields (88-99 %) and high enantioselectivities (up to 86 % 
ee). It turned out that the choice of the N-substituent is of importance. In contrast to the high 
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Scheme 3.34 Corey’s asymmetric hydrocyanation of imines with the chiral guanidine catalyst. 
 
enantioselectivities achieved with imines bearing N-benzhydryl substituent, remarkably lower ees 
(0-25 % ee) were observed with other N-substituents like N-benzyl or N-(9-fluorenyl). It is 
noteworthy that when aliphatic imines were used, the product was obtained with opposite 
selectivity (S-enantiomer major) compared to the aromatic imines (R-enantiomer major). The effect 
has been mechanistically explained by the Corey group.[49] The hydrogen atom (attached to the 
nitrogen of the guanidine) is essential for catalytic activity. From the viewpoint of practical 
application, this catalyst system is interesting because the catalyst 43 can be recovered for reuse in 
80-90 % yield by extraction with oxalic acid.  
Whereas these two organocatalysts activate the substrate imines via hydrogen bonding from the 
NHs, organic molecules without any NH bond, appear to be able to catalyze the cyanation of 
imines. Feng and Jiang found that in the presence of chiral N-oxides 73 (Scheme 3.35), the reaction 
of several types of aldimines and TMSCN furnished the desired α-amino nitrile in yields of 
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Scheme 3.35 Feng’s asymmetric cyanosilylation mediated by chiral N-oxides. 
 
up to 95 %, and with enantioselectivities in the range of 37-73 % ee.[104] However, stoichiometric 
amount of the chiral N-oxide 73 is required. Besides the use of a stoichiometric amount of N-oxide 
and medium enantioselectivities, another drawback is the use of TMSCN as the cyanide source 
from both atom-economical and industrial considerations.  
Recently, Corey et al. reported another type of catalyst, namely a chiral ammonium salt 74 (Scheme 
3.36) that possesses an activating site and a binding pocket for N-allyl aldimines as substrate.[105] In 
the presence of 10 mol % of 74, hydrocyanation occurs smoothly with a series of N-allyl aromatic 
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Scheme 3.36 Corey’s asymmetric hydrocyanation of imines with chiral ammonium salt. 
 
aldimines at –70 °C to give the corresponding (S)-α-amino nitrile in excellent yields (86-98 %) and 
good to excellent enantioselectivities (79 to >99 % ee). Like in the case of C2-symmetric guanidine 
catalyst 43 (Scheme 3.34), here also the choice of the N-substituent is important as the N-benzyl or 
N-benzhydryl aldimines afforded products with lower ees.[105] Dichloromethane was the preferred 
solvent over toluene, presumably due to the ability of toluene to compete with the aldimine 
substrate for the U-shaped binding pocket. An interesting aspect of this process is that the catalyst 
74 can be recovered with ca. 90 % efficiency by chromatographic purification. The main 
disadvantage of this method is the limited substrate scope, i.e. only aromatic aldimines can be used 
as the substrates. 
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3.4.2.4 Miscellaneous examples of α-amino acid synthesis 
 
Johannsen[106] and Jørgensen[107] group independently applied the combination of CuPF6 and 
(R)-tol-BINAP in the addition reaction of imino esters 75 to electron-rich aromatic compounds 
(Scheme 3.37). The reaction led to protected optically active α-aryl α-amino acid esters 76 
generally in good to high yields, high regioselectivities and enantioselectivities (up to 98 % ee). The 
limitation with this addition reaction is, however, the restriction to electron-rich aromatic 
compounds. 
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Scheme 3.37 The catalytic asymmetric arylation of α-imino esters.[106, 107] 
 
List and co-workers established a practical synthesis of α-amino acids via a proline-catalyzed 
α-amination of aldehydes with dibenzyl diazodicarboxylate I (Scheme 3.38).[108] A simple oxidation 
of the aldehyde intermediates II gave the chiral non-racemic α-hydrazino carboxylic acids III. 
Reductive N–N bond cleavage and simultaneous protecting group removal provides unprotected 
α-amino acids IV with moderate yields and high ees.[108] 
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3.5 The Routes to enantiomerically pure β-amino acids 
 
In contrast to proteinogenic α-amino acids which are constituents of all enzymes which control the 
metabolism in living organisms and are thus an essential prerequisite for life, most β-amino acids 
only occur as constituents of distinct natural products, such as peptides, cyclopeptides, 
depsipeptides, glycopeptides, alkakoids, or terpenoids.[109] Apparently, bacteria, cyanobacteria, 
fungi, and plants often incorporate β-amino acids into secondary metabolites that serve as tools to 
secure their survival in competition with other organisms. Therefore, these compounds are 
frequently characterized by potent biological and physiological activities that are often crucially 
based on their β-amino acid substructures. As a consequence, enantiomerically pure β-amino acids 
are of considerable importance because they are crucial components of medicinally useful 
molecules such as the anti-cancer natural product taxol 77 or the potent anti-tumor depsipeptide 
cryptophycin 78 (Scheme 3.39).[110] 
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Scheme 3.39 β-Amino acid containing pharmaceuticals. 
 
Moreover, the incorporation of β-amino acids into peptides instead of α-amino acids increases their 
stability against degradation by mammalian peptidases.[111] This enhanced stability is caused by a 
lack of enzymes which allow cleavage of peptidic bonds between α-amino acids and β-amino 
acids.[112] Therefore, β-amino acids are an important tool in the development of peptide-like drugs 
capable of withstanding hydrolytic degradation for prolonged period of time.[111] Furthermore, 
β-amino acids are synthetic precursors of β-lactams, which are potentially biologically active and of 
current interest.[113] 
The simplest β-amino acid is β-aminopropionic acid which is also called β-alanine. Although this is 
not a proteinogenic amino acid, it is an essential component of many relevant, biologically active 
compounds, such as vitamin B3/pantothenic acid (Scheme 3.40).  
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Scheme 3.40 The simplest β-amino acid and vitamin B3. 
 
There are three general types of open-chain chiral β-amino acids, depending on whether the 
substituents are at the carbon next to the carboxyl group (α-substituted), the carbon next to the 
amino group (β-substituted), or at both positions (α,β-disubstituted) (Scheme 3.41). 
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Scheme 3.41 The classification of β-amino acids. 
 
There is no single “best” approach towards enantiomerically pure β-amino acids. Each method itself 
possesses its own advantages and limitations. Nevertheless, likewise α-amino acids (see section 3.4 
on page 18), there are two general ways for obtaining enantiomerically pure β-amino acids[76, 110, 114, 
115]: (i) resolution of racemic mixture, and (ii) asymmetric synthesis. 
 
3.5.1 Resolution of racemic β-amino acids 
3.5.1.1 Classical resolution of β-amino acids 
 
A traditional method to resolve a carboxylic acid is to transform its racemic mixture into 
diastereomeric salts via complexation with a chiral base. Ephedrine is among the most commonly 
used chiral bases in this process, as it is readily available and inexpensive. Upon treatment of 
racemic N-protected β-amino acids with (–)-ephedrine two diastereomeric salts will be produced 
(Scheme 3.42) which can then be separated by fractional crystallization. After separation, the 
resulting diastereomerically pure salt can be easily converted back to the free acids while the chiral 
base can be recovered and reused. However, multistep fractional recrystallization is often required, 
and therefore the sequence is long and tedious. Following this methodology, a few β-substituted 
β-amino acids and carbocyclic β-amino acids were resolved in enantiopure form.[116] 
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Scheme 3.42 Resolution of β-amino acids using a chiral base. 
 
Alternatively, racemic amines can be transformed into diastereomeric salts with a chiral acid. 
β-Amino esters were resolved through diastereomeric salt formation between the amino group and a 
chiral acid, such as tartaric acid, mandelic acid or camphorsulfonic acid.[117] 
 
3.5.1.2 Enzymatic resolution of β-amino acids 
 
Despite the prominent role of the enzymatic resolution of racemates in the production of α-amino 
acids, far fewer results on its application for the preparation of enantiopure β-amino acids appear to 
exist. Indeed, a disadvantage of the enzymatic method is often the narrow tolerance of the substrate; 
thus the different position of the chiral center, usually α to the carbonyl group, can be a reason why 
the more popular methods for the enzymatic separation of α-amino acid derivatives fail when 
applied to the β-amino acid derivatives. 
Most of the resolution methods reported[118] so far involve either the selective acylation of the 
amine group of the racemic β-amino acids with some acylating agents (Scheme 3.43a), selective 
hydrolytic de-acylation of racemic N-acyl β-amino acids (Scheme 3.43b), or selective hydrolysis of 
the ester (Scheme 3.43c) under the condition of kinetic resolution in the presence of enzymes. 
Several different enzymes are employed for these purposes but only few of them, namely various 
lipases (e.g. CAL-A, CAL-B), acylases (penicillin G acylase or PGA) or amidases are found to 
effect the acylation or hydrolysis reactions with high selectivities. Although in some cases the 
enantioselectivities obtained are as high as >99 % ee and the enzymatic approach is the method of 
choice to prepare enantiomers of the corresponding β-amino acids, the major disadvantage of these 
biocatalytic procedures is the limit of 50 % theoretical yield for the resolution process. Moreover, 
these enzymes are highly substrate specific and thus restrict their application to differently 
substituted β-amino acids. 
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Scheme 3.43 Strategies for the enzymatic resolution of β-amino acids. 
 
3.5.2 Enantioselective synthesis of β-amino acids 
 
Enantioselective synthesis of β-amino acids can be broadly classified into three categories: (i) the 
chiral pool approach, (ii) the auxiliary-based approach, which can be more appropriately called 
diastereoselective synthesis and (ii) the catalytic asymmetric synthesis. 
 
3.5.2.1 The chiral pool approach 
 
α-Amino acids are ideal chiral pool compounds for the preparation of β-amino acids. This is due not 
only to the fact that a plethora of methods for their synthesis is available[75] but also to the 
stereogenic center present in these compounds that, on utilization of suitable methods, is retained 
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without significant racemization in the homologated β-amino acids.[110] Direct homologation of 
α-amino acids to prepare β-amino acids following the Arndt-Eistert procedure has found many 
applications in small molecule as well as natural product synthesis.[115] In this approach (Scheme 
3.44), the N-protected α-amino acids I were converted to the mixed anhydrides using 
Et3N/ClCO2Et, followed by addition of diazomethane to afford the diazoketones II with good yield 
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Scheme 3.44 Arndt-Eistert homologation of α-amino acids for the synthesis of β-substituted β-amino acid derivatives. 
 
and in enantiomerically pure form. Wolff rearrangement of diazoketones to the β-substituted 
β-amino acid derivatives (here ester III) was most conveniently achieved with catalytic amounts of 
silver cations, although photochemical or thermal conditions can be employed similarly.[110]  
Photo induced Wolff rearrangement was applied in the homologation to α,β-disubstituted β-amino 
acid derivatives.[119] In this approach (Scheme 3.45), the diazoketones II was converted to the 
α-alkyl diazoketones IV with alkyl halides. Photo-Wolff rearrangement of IV generates 
α,β-disubstituted β-amino acid derivatives V in good yield (up to 77 %) favoring the anti products. 
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Scheme 3.45 Homologation strategy for the synthesis of α,β-disubstituted β amino acid derivatives.[119] 
 
While the Arndt-Eistert protocol works very well for the preparation of enantiomerically pure 
β-substituted as well as α,β-disubstituted β-amino acid derivatives, it is not suitable for large scale 
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synthesis due to the high cost of the silver catalyst and difficult handling of the hazardous reagent 
CH2N2. Longobardo and co-workers have reported a new way to synthesize β-amino acids via 
reduction of N-protected α-amino acids, followed by conversion of the corresponding β-amino 
alcohols to β-amino iodides and then to β-amino cyanides (Scheme 3.46).[120]  
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Scheme 3.46 Alternative homologation strategy for the synthesis of β-substituted β-amino acid derivatives.[120] 
 
The key step of this transformation was to generate the iodide in high yields and without 
racemization using polystyryl diphenylphosphine-iodide (PDPI) complex.[120] 
Besides the homologation approaches described above, there are other strategies known for the 
synthesis of enantiopure β-amino acids using asparagine and aspartic acid as chiral pool 
compounds.[115] 
 
3.5.2.2 The auxiliary-based approach 
 
Analogous to the α-amino acids (section 3.4.2.3, page 26), enantioselective synthesis of β-amino 
acids has also been achieved by addition to imines containing a chiral auxiliary. The chiral imines 
used in this case were tert-butylsulfinyl imines 79, derived from chiral tert-butylsulfinamide 80 
(Scheme 3.47).[121] Addition of Ti(Oi-Pr)3 ester enolates to tert-butylsulfinyl imines 79 provides 
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Scheme 3.47 Synthesis of N-tert-butylsulfinyl protected β-amino esters.[122, 123] 
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N-tert-butylsulfinyl protected β-substituted, α,β-disubstituted, α,β,β- and α,α,β-trisubstituted, and 
α,α,β,β-tetrasubstituted β-amino acid derivatives in high yields and with high diastereoselectivities 
(Scheme 3.47).[122, 123] 
The N-tert-butylsulfinyl protecting group is cleaved using HCl in MeOH to afford β-amino esters 
(Scheme 3.48).[123] For β-substituted amino esters, the methyl ester is saponified using LiOH in 
MeOH and H2O without any deprotection of the N-sulfinyl-protected amine (Scheme 3.48).[123] 
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Scheme 3.48 Chemoselective cleavage of protecting groups of N-sulfinyl-protected β-amino esters.[124] 
 
Like any auxiliary-based synthesis, this approach also suffers from the limitation of the 
consumption of stoichiometric amounts of unrecoverable chiral auxiliaries. However, in this 
particular case this drawback is at least partially counterbalanced by easy accessibility of the chiral 
auxiliary 80.[124] 
 
3.5.2.3 The catalytic asymmetric synthesis 
 
As with α-amino acids, all catalytic asymmetric syntheses of β-amino acids involve C–H, C–C or 
C–N bond formation as the key step.[110] 
Enantioselective hydrogenation of prochiral β-(acylamino)acrylates 81 under the influence of a 
chiral catalyst offer one of the most efficient routes for the large scale preparation of enantiopure 
β-substituted β-amino acids (Scheme 3.49).[125] A large number of catalysts based on Ru or mainly 
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Scheme 3.49 Asymmetric hydrogenation of β-(acylamino)acrylates 81. 
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Rh and chiral phosphine ligands were applied for this reaction with varying results.[125] Like for the 
hydrogenation route to the α-amino acids, here also a major concern was the double bond 
configuration of the substrates as the enantioselectivities of the products obtained vary with E- or 
Z-configuration of the double bond depending on the catalyst employed. There is no single choice 
of catalyst that is suitable for every substrate, though Rh-complexes were found to be superior 
compared to the Ru-complexes.[125] 
As for the α-amino acids, Rh-complex of Me-DuPHOS (54, R = Me, Scheme 3.50) of type 
[(diene)Rh(diphosphine)]OTf was also found to be quite efficient for the hydrogenation of  
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Scheme 3.50 Chiral phoshphine ligands for Rh-catalyzed asymmetric hydrogenation of β-(acylamino)acrylates. 
 
E-β-(acylamino)acrylates with aliphatic substituents, afforded β-alkyl substituted β-amino acid 
derivatives with up to >99 % ee.[126] On the other hand, for the synthesis of β-aryl substituted 
β-amino acid derivatives, Rh-complex of Et-Ferrotane (83, R = Et, Scheme 3.50) of type 
[Rh-Et-Ferrotane(CH3OH)2]BF4 turned out to be highly effective.[127] A range of 
E-β-aryl-substituted β-(acylamino)acrylates containing both electron-donating as well as 
electron-withdrawing substituents were hydrogenated in the presence of 1 mol % of the 
Et-Ferrotane-Rh complex to generate the desired products with enantioselectivities between 98 and 
>99 % ee. 
Although the field of asymmetric hydrogenation has been dominated by bidentate phosphine 
ligands, high enantioselectivities could also be achieved using monodentate phosphine ligands. 
Feringa et al. recently reported the use of monodentate phosphoramidite (S,R)-84 (Scheme 3.50) 
for the asymmetric hydrogenation of Z-β-substituted β-(acylamino)acrylates.[128] Fairly high 
enantioselectivities (92-94 % ee) were obtained for alkyl and some aryl substituted 
β-(acylamino)acrylates. 
Enantioselective C–C bond formation reaction was applied by several groups for the synthesis of 
β-amino acids.[76, 110] Most of these approaches involve asymmetric Mannich-type reactions as the 
C–C bond formation step. Kobayashi and co-workers reported the first example of catalytic 
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enantioselective Mannich-type reactions of aldimines 85 with silyl enolates 86 using a 
Zr(IV)-based chiral Lewis acid catalyst 87 (Scheme 3.51).[129] This reaction afforded optically 
active β-amino acid derivatives 88 in high yields (70-100 %) and enantioselectivities (83-98 % ee). 
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Scheme 3.51 Kobayashi’s catalytic asymmetric Mannich-type reaction for the synthesis of β-amino acid derivatives.[129] 
 
The key elements responsible for the high yields, selectivities, and the catalyst turnover were the 
presence of N-substituted hydroxyphenyl moiety at the aldimine groups and the 
electron-withdrawing groups at the 6,6′-positions of the catalyst 87. Both syn- and anti-products 
were obtained depending on the O-substitutents (R1) of the silyl enolates 86 with selectivities up to 
98:2.[130] In the reactions with aliphatic aldimines, high enantioselectivities were obtained using 
imine 85 prepared from the aldehydes and 2-amino-3-methylphenol (R′ = 3-Me).[129] This method 
is only suitable for the synthesis of α,β-disubstituted β-amino acid derivatives. 
In 2002 Jacobsen et al. reported a highly efficient organocatalytic route to N-Boc protected 
β-substituted β-amino acids via the Mannich-type reaction using the thiourea catalyst 89 (Scheme 
3.52).[41] Aldimines derived from aromatic aldehydes gave products in high yields and with high 
enantiomeric excesses. This method is particularly suited for the highly enantioselective synthesis 
of thienyl-, furyl-, pyridyl- and quinolinyl-substituted β-amino acid derivatives. 
In addition to the two methods described above there are several other, particularly 
organocatalytic[131] methods for the synthesis of β-amino acids via enantioselective Mannich-type 
reactions. 
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Scheme 3.52 Jacobsen’s organocatalytic asymmetric Mannich-type reaction for β-amino acid synthesis.[41] 
 
Jacobsen group also developed a method for the synthesis of α-substituted β-amino acid derivatives 
via Al(III)(salen)Cl 68 catalyzed conjugate addition of cyanide to the α,β-unsaturated imides 90 
(Scheme 3.53).[132] The hydrocyanation adducts 91 were obtain in high yields and with very high 
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Scheme 3.53 Enantioselective conjugate addition of cyanide to α,β-unsaturated imide.[132] 
 
enantioselectivities. Conversion of 91 to the corresponding acid followed by Curtius rearrangement 
yielded Boc-protected cyanoamid which was subsequently hydrolyzed to afford Boc-protected 
α-substituted β-amino acid in excellent yield with only a very small degree of racemization 
(Scheme 3.54).[132] One limitation of this method is that this is applicable for the synthesis of 
β-amino acids with only aliphatic α-substituents. 
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Scheme 3.54 Conversion of into 91 α-substituted β-amino acid.[132] 
 
Catalytic enantioselective conjugate addition of an ammonia equivalent to α,β-unsaturated 
carboxylic acid derivatives represents another attractive and versatile method for the synthesis of 
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enantiopure β-amino acids.[110] Myers and Jacobsen have developed an Al(III)(salen)Me complex 
92 catalyzed addition of hydrazoic acid (HN3) to a range of α,β-unsaturated imides 90 (Scheme 
3.55).[133] In the presence of 5 mol % of 92, the imides 90 were converted to the azide adducts 93  
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Scheme 3.55 Enantioselective conjugate addition of hydrazoic acid to α,β-unsaturated imide.[133] 
 
in high yields (93-99 %) and with excellent enantioselectivities (95-97 % ee). Products 93 can be 
converted to the desired β-substituted β-amino acids in two simple steps; reduction of azide in the 
presence of Boc2O afforded an intermediate carbamate which can be hydrolyzed using NaOH to 
afford the Boc-protected amino acid in high yield.[133] However, this method is restricted only to the 
aliphatic substituents; only moderate ee was obtained for substrate with aromatic substituent. 
Miller and co-workers also reported an organocatalytic conjugate addition of azide to imides using 
a peptide based catalyst to produce β-amino acid derivatives with up to 92 % ee.[134] 
Besides azide, amines have also been used as the ammonia equivalent for conjugate addition to the 
α,β-unsaturated acid derivatives. The Sibi group developed a magnesium-based chiral Lewis acid 
catalyzed addition of O-benzylhydroxylamine to 3,5-dimethylpyrazole-derived enoate 94 (Scheme 
3.56).[135] In the presence of 30 mol % of MgBr2 and the bisoxazoline 95, β-amino acid derivatives 
96 were obtained in good yields and with high enantioselectivities. 
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Scheme 3.56 Sibi’s enantioselective conjugate addition of BnONH2.[135] 
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4 Concept 
 
4.1 Synthesis of new bifunctional organocatalysts for the 
DKR of azlactones and KR of oxazinones 
 
The goal of this work was to develop metal-free catalysts for the dynamic kinetic resolution (DKR) 
of azlactones A and kinetic resolution (KR) of oxazinones C (Scheme 4.1). The alcoholytic ring 
opening of azlactones A (or ent-A) in the presence of an suitable chiral catalyst would generate 
N-acyl-α-amino acid esters B (see section 3.4.1.2 on page 20), an N,C-doubly protected α-amino 
acid derivative (Scheme 4.1a). Formal insertion of a methylene group between the carbonyl group 
and the α-C-atom of the azlactone shifts the nitrogen atom to the β-position. The resulting 
compounds are known as 4,5-dihydro-1,3-oxazin-6-ones C which, in contrast to azlactones, are 
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Scheme 4.1 General concept for (a) the DKR of azlactones and (b) KR of oxazinones. 
 
configurationally stable. The alcoholytic ring opening of these oxazinones in the presence of an 
appropriate chiral catalyst would lead to kinetic resolution: one enantiomer of the oxazinones (e.g. 
ent-C) would be converted to the corresponding N-acyl-β-amino acid ester D whereas the other 
(e.g. C) would remain unaffected. 
From the work of Jacobsen[39] and Takemoto,[53] it was known that urea and thiourea can activate 
imines or nitroolefins towards nucleophilic attack by bifurcated hydrogen bonding from both NHs 
Concept 
 
 46 
of the (thio)urea moiety. The activation of carbonyls in the similar way was also demonstrated by 
Curran[33] and Schreiner.[28, 34] The idea behind this work was to exploit this ability of quasi-Lewis 
acidic urea and thiourea for the activation of azlactones and oxazinones towards nucleophilic 
(alcohol) attack. Alcohols can also be activated by coordinating to a Brønsted base such as tertiary 
amines. It was reasoned that pre-organization of these two functionalities (urea or thiourea and  
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Scheme 4.2 The catalyst concept (I) and the bifunctional mode of activation for the DKR of azlactones (II) and the KR 
of oxazinones (III). 
 
the tertiary amine) within a single molecule with an appropriate chiral environment would be 
efficient to activate the substrate (azlactone in case of DKR; oxazinone in case of KR) and the 
alcohol simultaneously (Scheme 4.2). Stereodiscrimination was also expected due to the presence 
of these supramolecular aggregates (II and III) in a chiral environment. 
An excellent example of this bifunctional (thio)urea-tertiary amine type organocatalyst is the 
catalyst 1 (Scheme 4.3) recently reported by Takemoto et al.[51-53, 55, 136] This catalyst is a 
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Scheme 4.3 Possible mode of variation and retrosynthesis of the bifunctional organocatalyst 1. 
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combination of the quasi-Lewis acidic thiourea and a Brønsted basic tertiary amine. Both the 
functionalities are elegantly incorporated in chiral trans-1,2-diaminocyclohexane moiety. The 
biggest advantage of this catalyst is its highly modular structure and the ease with which the 
modifications can be made. Also, the non-C2-symmetric structure of the catalyst is beneficial for 
diversification as changing any part of the structure would lead to a new compound. The (thio)urea 
group may be introduced in one step from the amine by reacting with iso(thio)cyanate, whereas the 
substituents on the tertiary nitrogen may be incorporated either by (SN2) alkylation with alkyl 
halides or by reductive alkylation, employing aldehydes in the presence of a reducing agent. Again, 
these two functionalities can be introduced in different orders (path A and B, Scheme 4.3). The 
selective mono-(thio)urea formation from the diamine followed by alkylation (path A) provides a 
shorter route to the catalyst (as the monoprotection of the diamine is not needed prior to alkylation 
as in path B). However, the scope of this pathway is rather limited because the alkyl groups on 
nitrogen can only be introduced by reductive alkylation; the SN2 alkylation may also lead to 
alkylation at the (thio)urea nitrogens. Path B is more general and may also be used for other 
diamines besides 1,2-diamines. A second element of chirality may also be introduced on the 
(thio)urea (with chiral R1). 
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4.2 Oxazaborolidine catalyzed asymmetric hydrocyanation 
of imines 
 
A second aim of this work was to develop a new (preferably metal-free) catalytic concept for the 
asymmetric hydrocyanation of imines, in particular aldimines. The hydrocyanation of aldimines E 
catalyzed by appropriate chiral catalysts would generate enantiomerically enriched α-amino nitriles 
F, important precursor for the synthesis of α-amino acids G (Scheme 4.4). Despite the myriad of  
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Scheme 4.4 Asymmetric hydrocyanation of imines. 
 
catalysts that already exist for the asymmetric imine hydrocyanation (see section 3.4.2.3, page 26), 
there is barely a single choice of method that is applicable to every imine.  
Chiral oxazaborolidines 29 (Scheme 4.6) are an important class of compounds that are known for 
catalyzing the highly enantioselective reduction of prochiral ketones (Scheme 4.5).[45] The most 
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Scheme 4.5 Enantioselective reduction of ketone with oxazaborolidine 29a. 
 
interesting aspect of these catalysts is the extraordinary predictability of the product configuration. 
The Corey group investigated the mechanism of this widely popular methodology in detail[45] and 
proposed a bifunctional mode of activation for both the carbonyl compound and the reducing agent 
borane (Scheme 4.6a). In this pre-transition state assembly, the coordination of the electrophilic 
BH3 to the nitrogen atom of 29 serves to activate BH3 as a hydride donor and also to increase the 
Lewis acidity of the endocyclic boron atom. The strongly Lewis acidic boron atom then readily 
binds to the carbonyl oxygen at the more sterically accessible electron lone pair 
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Scheme 4.6 Chiral oxazaborolidine 29 and the proposed pre-transition state assembly for (a) the reduction of ketones 
and (b) the hydrocyanation of imines. 
 
and activates the carbonyl carbon towards hydride attack. A similar bifunctional mode of activation 
was envisaged for the HCN addition to imines: the nucleophilicity of HCN would be enhanced by 
binding to the oxazaborolidine nitrogen whereas the coordination of the imine nitrogen to the boron 
atom would increase the electrophilicity of imine carbon for cyanide attack (Scheme 4.6b). The 
face-selective cyanide attack via a six-membered transition state was expected to form the desired 
α-amino nitrile with high enantiomeric purity. 
Recently Corey et al. also showed that protonation of oxazaborolidine 29 generates a potent 
cationic Lewis acid. This oxazaborolidinium cation 30 (Scheme 4.7) can be used as very active 
catalyst for highly enantioselective Diels-Alder and other cycloaddition reactions (both intra- and 
intermolecular),[137-139] and particularly for the cyanosilylation of aldehydes and ketones.[140, 141] A 
mechanistic model has been proposed for the cyanosilylation reactions (Scheme 4.7).[140] 
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Scheme 4.7 Chiral oxazaborolidinium cations 30 and the proposed transition state for the cyanosilylation reactions.[140] 
 
A similar mode of action was expected for the hydrocyanation of imines and therefore 
oxazaborolidinium cations 30 may also be used as catalysts for this reaction. 
A major advantage of using 29 or 30 is their modular structure: both aryl groups and substituent on 
the boron atom can be easily modified. A structural optimization can be carried out to find the best 
catalyst. Some oxazaborolidines (e.g. Ar = Ph, R = Me) are even commercially available. Others 
can be prepared easily in a one step procedure by cyclodehydration of α,α-diaryl prolinols 97 and 
Concept 
 
 50 
boronic acids 98. Diaryl prolinols 97 can in turn be synthesized from the readily available and 
inexpensive chiral pool compound L-proline 37 (Scheme 4.8). 
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Scheme 4.8 Retrosynthetic analysis of oxazaborolidines 29. 
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4.3 Development of a new ligand system for the metal-
catalyzed asymmetric transformations 
 
The third goal of this work was to develop an easy-to-synthesize and modular chiral ligand system 
that can coordinate to a Lewis acidic metal ion with the resulting complex being able to catalyze 
asymmetric transformations efficiently. Since the beginning of metal-complex catalyzed 
asymmetric transformations, numerous chiral ligands have been developed.[7, 65] One of the most 
widely applicable chiral ligands for Lewis acidic metal ions is the salen ligands 99 (Scheme 
4.9).[142] Chiral metal(salen) complexes have been applied for a wide array of different asymmetric  
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Scheme 4.9 Chiral salen ligands 99. 
 
transformations.[143] The popularity of these ligands is due to their easy accessibility, modular 
structure and because of the high levels of enantioselectivity often achieved with the metal 
complexes. These advantages of the salen ligands promoted the metal(salen) complexes to the level 
of privileged catalysts.[144] 
It was envisaged that disruption of the C2-symmetry of salen ligands would enhance their 
modularity to a great extent. A tridentate ligand system 31 containing an achiral salicylaldehyde 
derivative and an element of chirality would be of high stability and modularity (Scheme 4.10). 
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Scheme 4.10 Retrosynthetic analysis of the tridentate ligand system 31. 
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Besides modularity (through R1, R2 and Ar), the biggest advantage of this ligand system is the ease 
of synthesis. Such ligands may be synthesized in a single-step from α,α-diaryl prolinols 97 and 
salicylaldehyde derivatives 100 by C–N bond formation via reductive amination (Scheme 4.10). 
Several salicylaldehyde derivatives are commercially available or can be prepared from phenol. On 
the other hand, the α,α-diaryl prolinols 97 are ex-chiral pool compounds (see Scheme 4.8, page 50) 
and some of them are commercially available. 
A similar but C2-symmetric ligand system containing two such elements of chirality (Scheme 4.11) 
has been developed by Trost et al. for metal catalyzed asymmetric transformations.[145]  
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Scheme 4.11 Trost’s C2-symmetric ligand system for metal catalyzed asymmetric transformations. 
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5 Results 
 
5.1 Synthesis of bifunctional organocatalysts 
5.1.1 Synthesis of the parent catalysts 
 
The thiourea-tertiary amine catalyst 1 and its urea analog 2 can be synthesized in one step from the 
amine 101 (Scheme 5.1). 
 
NMe2
N
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H
X
CF3
F3C
  
NH2
NMe2  
1, X = S 
2, X = O 
 101 
Scheme 5.1 The parent catalysts 1 and 2, and their immediate precursor 101. 
 
The main challenge was to synthesize the unsymmetrically substituted amine 101. This was 
accomplished by a monoprotection → dimethylation → deprotection sequence from the 
commercially available enantiomerically pure trans-1,2-diaminocyclohexane 102.  
The monoprotection of the diamine 102 as phthalimide was carried out following the literature 
procedure by Gawronski et al.[146] Condensation of 102 with phthalic anhydride 103 in the 
presence of anhydrous p-toluene sulfonic acid afforded the salt 104, which can easily be 
deprotonated to generate the free monoprotected amine 105 (Scheme 5.2). The monoprotected 
diamine 105 was obtained in high yield (>90 %) over the two steps. 
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Scheme 5.2 Monoprotection of the diamine 102 as phthalimide.[146] 
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The dimethylation of the monoprotected diamine 105 was then achieved by reductive methylation 
which can be performed under two different conditions (Scheme 5.3).[146, 147] Under 
conditions 1,[146] the amine was refluxed with formaldehyde and formic acid whereas in 
conditions 2,[147] the reaction was carried out at room temperature using sodium cyanoborohydride 
(NaBH3CN) as the hydride source. The latter method was found to be superior over the first one in 
terms of reaction condition, yield and the purity of the product obtained. 
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Scheme 5.3 Dimethylation of the monoprotected diamine 105.[146, 147] 
 
Deprotection of the phthalimide group of 106 was accomplished with hydrazine monohydrate using 
a modified literature procedure (Scheme 5.4).[146] The immediate precursor of the target catalysts 
101 was obtained in good yield. 
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Scheme 5.4 Deprotection of the phthalimide group of 106.[146] 
 
With the unsymmetrically substituted amine 101 in hand, the desired thiourea-tertiary amine 
catalysts 1 and its urea analog 2 were synthesized by condensation with the commercially available 
3,5-bis(trifluoromethyl)phenyl isothiocyanate 107 and the corresponding isocyanate 108, 
respectively (Scheme 5.5). Both the thiourea 1 and urea 2 were obtained in good yields. 
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Scheme 5.5 Synthesis of the catalysts 1 and 2. 
 
The urea-derivative 2 was crystallized from chloroform to obtain crystals suitable for X-ray 
diffraction. The X-ray structure was determined (Figure 5.1). 
 
 
Figure 5.1 X-ray structure of 1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}urea 2. 
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5.1.2 Variation of the tertiary amine part of the catalyst 
 
To replace the methyl groups at the tertiary amine of the parent catalyst with ethyl residues, the 
monoprotected diamine 105 was diethylated by refluxing with ethyl iodide to obtain the diethyl 
derivative 109 in almost quantitative yield (Scheme 5.6). 
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Scheme 5.6 Diethylation of the monoprotected diamine 105 with ethyl iodide. 
 
Similarly, when 1,4-diiodobutane 110 was used as the alkylating agent, the pyrrolidine derivative 
111 was obtained in almost quantitative yield (Scheme 5.7). 
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Scheme 5.7 Synthesis of the pyrrolidine derivative 111. 
 
Whereas in the two above cases two identical substituents were introduced on nitrogen via SN2 
alkylation, the reductive alkylation protocol was followed to introduce different substituents. Thus, 
to prepare the methyl-benzyl-derivative 112, phthalimide protected diamine 105 was first reacted 
with benzaldehyde 33 to obtain the imine 113 in very high yield. The imine 113, without any 
further purification, was then applied as the substrate for the reductive methylation reaction with 
NaBH3CN to obtain the desired heterodialkyl substituted product 112 in pure form and excellent 
yield (Scheme 5.8). 
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Scheme 5.8 Synthesis of the methyl-benzyl substituted amine 112. 
 
The phthalimide groups of these dialkyl-substituted compounds were cleaved under the same 
conditions as for 106 with hydrazine monohydrate in ethanolic solution to obtain the free amines 
114-116 (Scheme 5.9). 
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Scheme 5.9 Hydrazinolytic cleavage of the phthalimide groups of 109, 111 and 112. 
 
These free amines 114-116 were then reacted with 3,5-bis(trifluoromethyl)phenyl isocyanate 108 
to obtain the corresponding urea catalysts 3-5, respectively in moderate to good yields (Scheme 
5.10). 
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Scheme 5.10 Synthesis of the urea catalysts. 
 
The urea derivative of the N,N-heterodialkyl amine 5 was crystallized from ethanol to obtain X-ray 
diffraction quality crystals (Figure 5.2). The crystal structure contains one ethanol molecule in the 
unit cell. 
 
 
Figure 5.2 X-ray structure of 1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-(N-benzyl-N-
methylamino)cyclohexyl}urea 5. 
 
5.1.3 Variation of the (thio)urea substituents of the catalyst 
 
After varying the substituents on the tertiary amine, the next site for diversification was the 
substituent on the (thio)urea nitrogen. For this study, the substituent on the (thio)urea nitrogen was 
varied, keeping the tertiary amine part fixed to N,N-dimethyl derivative.  
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5.1.3.1 Synthesis of catalysts containing aromatic substituents 
 
First, the 3,5-bis(trifluoromethyl)phenyl group of the catalyst 2 was replaced with another electron 
withdrawing aromatic group, 3,5-dinitrophenyl, to yield a new bifunctional catalyst 6. It was 
synthesized in good yield in a single-step procedure from the N,N-dimethyl amine 101 by reaction 
with commercially available 3,5-dinitrophenyl isocyanate 117 (Scheme 5.11). 
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Scheme 5.11 Synthesis of the 3,5-dinitrophenyl substituted urea 6. 
 
The urea-derivative 6 was crystallized from a methanol-water mixture to obtain X-ray diffraction 
quality crystals (Figure 5.3). The crystal structure contains one water molecule in the unit cell.  
 
Figure 5.3 X-ray structure of 1-(3,5-dinitrophenyl)-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}urea 6. 
 
Electron rich aromatic groups were also introduced on the urea nitrogen atom of the catalyst. The 
amine 101 was reacted with mesitylisocyanate 118 to obtain the urea-derivative 7 in moderate 
yield (Scheme 5.12). 
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Scheme 5.12 Synthesis of the mesityl substituted urea 7. 
 
Crystallization from ethanol afforded X-ray diffraction quality crystals of this urea-derivative 7 
(Figure 5.4). 
 
 
 
Figure 5.4 X-ray structure of 1-{(1R,2R)-2-(dimethylamino)cyclohexyl}-3-mesitylurea 7. 
 
Similarly, reaction of 101 with 3-pyridyl isothiocyanate 119 afforded the electron-rich aromatic 
heterocycle substituted thiourea 8 in 71 % yield (Scheme 5.13). This thiourea derivative contains, in 
addition to the tertiary amine, a second Brønsted basic functionality.  
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Scheme 5.13 Synthesis of 3-pyridyl substituted thiourea 8. 
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5.1.3.2 Synthesis of catalysts containing aliphatic substituents 
 
The aromatic moiety of the parent catalysts 1 and 2 was then replaced by aliphatic substituents. The 
cyclohexyl substituted bifunctional organocatalyst 9 was prepared by reacting the amine 101 with 
commercially available cyclohexyl isothiocyanate 120 in moderate yield (Scheme 5.14). 
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Scheme 5.14 Synthesis of the cyclohexyl substituted thiourea catalyst 9. 
 
To increase the steric bulk at this part of the molecule, the cyclohexyl group was exchanged with a 
bulkier 1-adamantyl group. This thiourea 10 was synthesized from 1-adamantyl isothiocyanate 121 
in 78 % yield (Scheme 5.15). 
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Scheme 5.15 Synthesis of the 1-adamantyl substituted thiourea 9. 
 
To check the effect of double bifunctionality in a single molecule, a catalyst containing two 
quasi-Lewis acidic urea moieties as well as two Brønsted basic tertiary amines was designed. A 
linear 1,6-hexyl chain was used as the spacer between two bifunctional units. The new compound 
11 was synthesized in one step from 1,6-diisocyanatohexane 122 in good yield (Scheme 5.16). 
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Scheme 5.16 Synthesis of the catalyst 11 with double bifunctionality. 
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5.1.3.3 Synthesis of catalysts containing a second element of chirality 
 
A series of bifunctional organocatalysts containing an additional element of chirality besides the 
chiral diamine (second-generation catalysts) were synthesized either from the commercially 
available isocyantes, or from the isothiocyantes derived from the readily available starting 
materials. First, the commercially available enantiomers of 1-phenylethyl isocyanate 123 and 
ent-123 were used as the second source of chirality (Table 5.1). The diastereomeric urea catalysts 
12 and 13 were obtained in rather good yields. 
 
        Table 5.1 Synthesis of bifunctional catalysts containing additional chiral centers. 
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Both of these compounds were crystallized from chloroform to obtain crystals suitable for X-ray 
diffraction. The X-ray structures of these two bifunctional organocatalysts (12 and 13) were 
determined (Figure 5.5).  
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Figure 5.5 X-ray structure of the diastereomeric catalysts 12 (top) and 13 (bottom). 
 
A C2-symmetric thiourea-tertiary amine catalyst 14 containing two N,N-dimethyl-
1,2-diaminocyclohexane 101 moieties was also synthesized. First, 101 was converted into the 
corresponding isothiocyanate 124 with thiophosgene. This isothiocyanate 124, without any further 
purification, was condensed with a second molecule of 101 to obtain the desired C2-symmetric 
catalyst 14 in acceptable 60 % yield over the two steps (Scheme 5.17). 
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Scheme 5.17 Synthesis of the C2-symmetric catalyst 14. 
 
A number of chiral isocyanates and isothiocyanates are commercially available which can be 
reacted with the amine 101 to obtain various bifunctional catalysts containing a second element of 
chirality. However, it was envisaged that an iso(thio)cyanate of modular nature would be very 
useful for diversification of the catalysts structure. Like the amine, the iso(thio)cyanate can also be 
modified easily at any desired part to find the best catalyst structure. The Jacobsen group developed 
a series (thio)urea-catalysts which were synthesized from α-amino acid derived 
iso(thio)cyanates.[36] These iso(thio)cyanates have two sites for modification (Scheme 5.18). There 
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Scheme 5.18 α-Amino acid derived iso(thio)cyanates. 
 
are 19 natural and numerous non-natural α-amino acids available for structural variation (different 
R1) and the same holds for the primary and secondary amines (different R2 and R3). Steric bulk at 
the chiral center can be tuned by using different amino acids. For the present purpose, L- and 
D-tert-leucine (R1 = t-Bu) and L-neopentylglycine (R1 = t-BuCH2) were used as the α-amino acid 
component. 
The point of departure for the synthesis was the Boc-protection of the α-amino acids with 
Boc-anhydride 125 (Scheme 5.19), which was carried out following a literature procedure.[148] Pure 
Boc-protected α-amino acids were obtained in excellent yields in most cases. 
 
 
 
Results 
 
 65
 
NH2
HO
O
t-Bu
n
 
 
 
+ 
 
O
O
OO
O
 
Na2CO3, MeOH/H2O 
 
RT 
 
N
H
HO
O
t-Bu
n
Boc
 
   126, n = 0 
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   127, n =1 
 125  128, n = 0, 91 % 
ent-128, n = 0, 98 % 
129, n = 1, 92 % 
Scheme 5.19 Boc-protection of α-amino acids. 
 
These N-Boc-α-amino acids were then coupled with various primary and secondary amines using 
O-benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU) as the coupling 
reagent following a literature procedure (Scheme 5.20).[39] The amides 130-135 were obtained 
contaminated with tetramethyl urea in very good to excellent yields and were used in the following 
step without any further purification. 
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HBTU, i-Pr2NEt 
 
DCM, RT 
 
N
H
N
O
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 128, n = 0 
ent-128, n = 0 
129, n = 1 
 130, n = 0, R1 = R2 = Me, >99 % 
131, n = 0, R1 = R2 = Et, 85 % 
132, n = 0, R1 = R2 = i-Bu, >99 % 
133, n = 0, R1 = Me, R2 = Bn, 91 % 
ent-133, n = 0, R1 = Me, R2 = Bn, >99 % 
134, n = 0, R1 = H, R2 = Bn, >99 % 
135, n = 1, R1 = Me, R2 = Bn, >99 % 
Scheme 5.20 Coupling of N-Boc-α-amino acids with amines. 
 
The Boc-group of these amides 130-135 was then deprotected with trifluoroacetic acid (TFA) 
following a standard literature procedure[39] to afford the free primary amines 136-141 in 
quantitative yields in most cases (Scheme 5.21). 
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130, n = 0, R1 = R2 = Me 
131, n = 0, R1 = R2 = Et 
132, n = 0, R1 = R2 = i-Bu 
133, n = 0, R1 = Me, R2 = Bn 
ent-133, n = 0, R1 = Me, R2 = Bn 
134, n = 0, R1 = H, R2 = Bn 
135, n = 1, R1 = Me, R2 = Bn 
 136, n = 0, R1 = R2 = Me, 77 % 
137, n = 0, R1 = R2 = Et, 99 % 
138, n = 0, R1 = R2 = i-Bu, >99 % 
139, n = 0, R1 = Me, R2 = Bn, 100 % 
ent-139, n = 0, R1 = Me, R2 = Bn, >99 % 
140, n = 0, R1 = H, R2 = Bn, 84 % 
141, n = 1, R1 = Me, R2 = Bn, >99 % 
Scheme 5.21 Boc-deprotection of the amides. 
 
These primary amines 136-141 were then converted to the corresponding isothiocyanates with 
thiophosgene (CSCl2) following a literature procedure (Scheme 5.22).[39] The isothiocyanates 
142-147 were obtained in excellent yields and used immediately for the thiourea-formation without 
any further purification or characterization. 
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136, n = 0, R1 = R2 = Me 
137, n = 0, R1 = R2 = Et 
138, n = 0, R1 = R2 = i-Bu 
139, n = 0, R1 = Me, R2 = Bn 
ent-139, n = 0, R1 = Me, R2 = Bn 
140, n = 0, R1 = H, R2 = Bn 
141, n = 1, R1 = Me, R2 = Bn 
 142, n = 0, R1 = R2 = Me, 97 % 
143, n = 0, R1 = R2 = Et, 97 % 
144, n = 0, R1 = R2 = i-Bu, 97 % 
145, n = 0, R1 = Me, R2 = Bn, 96 % 
ent-145, n = 0, R1 = Me, R2 = Bn, 95 % 
146, n = 0, R1 = H, R2 = Bn, 99 % 
147, n = 1, R1 = Me, R2 = Bn, 96 % 
Scheme 5.22 Preparation of isothiocyanates from the primary amines. 
 
Reaction of the amine 101 with the isothiocyanates 142-147 according to the standard literature 
procedure afforded a series of thiourea-based bifunctional organocatalysts in moderate to good 
yields (Table 5.2).[39] 
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  Table 5.2 Synthesis of thiourea-based modular bifunctional organocatalysts. 
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75 % 
147 21  
 
The thiourea-derivative 16 was crystallized from acetone to obtain X-ray diffraction quality crystals 
(Figure 5.6). 
 
Figure 5.6 X-ray structure of the catalyst 16. 
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5.1.4 Synthesis of chiral guanidine and guanidinium cation 
 
Besides the bifunctional (thio)urea-tertiary amine organocatalysts described above, a chiral 
guanidine and its corresponding guanidinium cation were also synthesized. The guanidine 148 was 
synthesized in one-step from the amine 101 by refluxing with 1,3-dicyclohexyl carbodiimide 149 
following a literature procedure (Scheme 5.23).[149] The desired guanidine was obtained in good 
yield.  
 
 
 
NH2
NMe2  
 
 
+ 
 
C NN
 
 
t-BuOH 
 
100 °C 
N
H
Me2N
N
H
N
101  149  148, 75 % 
Scheme 5.23 Synthesis of chiral guanidine 148. 
 
This guanidine 148 was protonated with trifluoroacetic acid to obtain the guanidinium cation 150 
in quantitative yield (Scheme 5.24). 
 
N
H
Me2N
N
H
N
 
 
 
CF3CO2H 
 
DCM, RT 
N
H
Me2N
N
H
N
CF3CO2 H
 
148  150, 100 % 
Scheme 5.24 Synthesis of the guanidinium cation 150. 
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5.2 Dynamic kinetic resolution of azlactones 
5.2.1 Catalyst screening 
 
The catalysis experiments were conducted by F. Cleemann with substrates synthesized by himself. 
The alcoholytic ring opening of the tert-leucine derived azlactone rac-22a (Scheme 5.25) was used 
as the test reaction for the bifunctional organocatalysts. Allyl alcohol 23 was used as the 
nucleophile in all screening experiments due to its superior behaviour in terms of enantioselectivity 
over all other alcohol nucleophiles studied.[150] Similarly, toluene was found to be the optimal 
solvent. Unless otherwise stated, all catalysis experiments were carried out at room temperature 
using 1.5 equivalents of allyl alcohol. 
 
 
 
+ 
 
N
O
t-Bu
Ph
O
 
 
 
OH
 
 
Catalyst 
Toluene, RT 
 
N
H
t-Bu
O
O
Ph
O
 
rac-22a  23  24a 
Scheme 5.25 Alcoholytic DKR of tert-leucine derived azlactone rac-22a. 
 
To optimize the Brønsted basic part of the catalyst structure, the bifunctional organocatalysts 
containing different substituents at the tertiary amine moiety were first screened in the 
aforementioned reaction (Scheme 5.25). The catalyst loadings were kept constant at 5 mol % in all 
cases. Conversion and enantiomeric excesses of the product ester 24a obtained after 48 h with each 
of these urea-based catalysts are listed in Table 5.3. The highest enantioselectivity along with good 
conversion was obtained with the N,N-dimethyl substituted catalyst 2 (Entry 1). The exchange of 
the dimethylamino group with a pyrrolidine in catalyst 4 resulted in slightly higher conversion and 
lower enantioselectivity (Entry 2). By increasing the steric demand of the substituents from methyl 
to ethyl, the catalytic activity was diminished significantly although somewhat less pronounced 
drop in enantioselectivity was observed (Entry 3). Further enhancement in steric bulk of the 
substituents by replacing one methyl group with a benzyl group in catalyst 5 deactivates the catalyst 
completely (Entry 4). 
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                Table 5.3 Catalyst screening to optimize the Brønsted basic part of the structure. 
NR1R2
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O
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OH
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(5 mol %) 
Toluene, RT 
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H
t-Bu
O
O
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O
 
rac-22a  23  24a 
 
Entry Catalyst R1 R2 % Conversion % ee  
1 
 
2 
 
Me 
 
Me 
 
67 
 
87 
2 4 -(CH2)4- 75 75 
3 3 Et Et 16 73 
4 5 Me Bn <2 n.d. 
 
Similarly, all catalysts containing a dimethylamino group as the Brønsted basic moiety and various 
substituents on the quasi-Lewis acidic (thio)urea functionality (Scheme 5.26) were screened for the 
same reaction (Scheme 5.25, page 70).  
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Scheme 5.26 Catalyst library with various (thio)urea substituents. 
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The results are summarized in Table 5.4.  
 
               Table 5.4 Catalyst screening to optimize the quasi-Lewis acidic part of the structure. 
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O
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Ph
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OH
 
Catalyst 
(5 mol %) 
Toluene, RT 
 
 
N
H
t-Bu
O
O
Ph
O
rac-22a  23  24a 
 
Entry Catalyst Time (h) % Conversion % ee  
1 
 
1 
 
48 
 
69 
 
83 
2a 1 48 16 91 
3 2 48 67 87 
4 6 48 66 86 
5 7 48 9 84 
6 8 48 12 82 
7 9 48 47 87 
8 10 48 32 87 
9 11 48 30 80 
10 12 72 28 85 
11 13 24 18 88 
12 14 48 33 88 
13 15 24 23 91 
14 16 48 26 90 
15 17 48 15 86 
16 18 48 28 95 
17 19 24 3 77 
18 20 48 38 92 
19 21 48 23 92 
a Reaction was carried out at –20 °C. 
 
From this screening, the parent catalyst 1 was found to be the most active catalyst (Entry 1) 
whereas the catalyst 18 containing a second element of chirality (second-generation catalyst) 
provided the highest enantioselectivity (Entry 16). Among simple alkyl substituted catalysts, the 
highest reactivity and enantioselectivity was observed with the cyclohexyl substituted catalyst 9 
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(Entry 7). The enantioselectivity obtained with this catalyst was even higher than that obtained with 
the parent catalyst 1 at room temperature and equals with the selectivity observed with the 
urea-derivative 2. 
In addition to the bifunctional (thio)urea-tertiary amine catalysts, the chiral guanidine 148 and the 
guanidinium cation 150 (Scheme 5.27) were also tested for the same reaction (Scheme 5.25). 
Although in the presence of 5 mol % of the guanidine 148, the azlactone rac-22a was completely 
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Scheme 5.27 Chiral guanidine 148 and the guanidinium cation 150. 
 
consumed after 24 hours, the product ester 24a was obtained in only 15 % ee. On the other hand, 
the cation 150 did not lead to any product formation even after 48 hours. 
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5.2.2 Substrate scope 
 
After optimization of the catalyst structure, a number of azlactones rac-22a-h derived both from 
natural and non-natural α-amino acids were subjected to alcoholytic ring opening in the presence of 
the most enantiodifferentiating catalyst 18.  
The results are summarized in Table 5.5. 
 
            Table 5.5 Substrate scope for the DKR of azlactones. 
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OH
 
(1.5 eq) 
 
18 (5 mol %) 
 
Toluene, RT 
 
 
N
H
R
O
O
Ph
O
rac-22a-h  23  24a-h 
 
Entry Substrate R Time (h) % Conversion % ee 
 
1 
 
22a 
 
t-Bu 
 
48 
 
28 
 
95 
2 22b i-Bu 48 77 91 
3 22c i-Pr 48 59 92 
4 22d PhCH2 48 77 78 
5 22e t-BuCH2 48 68 90 
6 22f Me 24 94 80 
7 22g Ph 48 29 61 
8 22h MeSCH2CH2 48 72 80 
 
In cases of the alkyl substituted azlactones rac-22a-f and the thioether functionalized azlactone 
rac-22h, the enantiomeric excesses obtained were higher than 75 % (Entries 1-6 and 8). A 
somewhat lower ee of 61 % was observed in the case of aromatic azlactone rac-22g (Entry 7). The 
enantioselectivities listed in the Table 5.5 are the highest achieved so far in the chemically 
catalyzed DKR of azlactones.[151] 
In addition to the monosubstituted azlactones rac-22a-h listed in Table 5.5, the catalyst was also 
applied for the alcoholytic ring opening of the most simple (achiral) disubstituted 
azlactone 22i. But, even after applying the more active catalysts like 1 and 9 over 
prolonged reaction time, no product was observed under the employed reaction 
conditions (see Table 5.5).  
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O
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Me Me
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5.2.3 Mechanistic investigation 
 
To prove the involvement of only one catalyst molecule in the catalytic cycle, the alcoholytic ring 
opening (with allyl alcohol) of the phenylalanine-derived azlactone rac-22d (Scheme 5.28) was 
conducted in the presence of catalyst 9 with varying enantiomeric purities. 
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Scheme 5.28 Alcoholytic DKR of phenylalanine-derived azlactone rac-22d. 
 
A linear relationship was found between ee of the catalyst 9 and ee of the product 24d (Figure 5.7). 
 
 
Figure 5.7 Relationship between catalyst ee and product ee in the DKR of rac-22d with 9. 
 
Interaction between substrate azlactone and (thio)urea moiety of the catalyst was supported by the 
NMR-titration of catalyst with substrate. In the 1H-NMR spectrum, dramatic downfield shifts of the 
urea-NH protons of the catalyst 2 were observed upon addition of 1.0 equivalent of the dimethyl 
azlactone 22i (Figure 5.8). In 1:1 mixture of 2 and 22i, Ha was shifted by 3.34 ppm whereas the 
shift of Hb was found to be 3.66 ppm. Similar but much less pronounced shifts were also observed 
in case of the alanine-derived azlactone 22f (∆δHa = 0.40 ppm, ∆δHb = 0.19 ppm) and almost no 
shifts were observed in case of the phenylalanine-derived azlactone 22d (∆δHa = 0.01 ppm, 
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∆δHb = 0.01 ppm). In addition to the urea-NH protons, other catalyst signals were also shifted 
downfield, particularly in the case of dimethyl azlactone 22i (Figure 5.8). 
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Figure 5.8 1H-NMR spectrum of the free catalyst and the 1:1 substrate-catalyst mixture. 
 
5.3 Kinetic resolution of oxazinones 
5.3.1 Catalyst screening 
 
All catalysis experiments were conducted by F. Cleemann with the substrates synthesized by 
himself. Alcoholytic ring opening of the β-phenylalanine derived oxazinone rac-25a was used as 
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Scheme 5.29 Ring opening of β-phenylalanine derived oxazinone rac-25a with allyl alcohol. 
Results 
 
 77
the test reaction (Scheme 5.29). Allyl alcohol 23 was used as the nucleophile in all screening 
experiments due to its superior behaviour over all other alcohol nucleophiles studied. Similarly, 
toluene was found to be the optimal solvent. All catalysis experiments were carried out at room 
temperature using 1.0 equivalent of allyl alcohol. 
Only the two most enantiodifferentiating thiourea-based bifunctional catalysts 18 and 9 for the 
DKR of azlactones (see Table 5.4, page 72) were screened for the ring opening of rac-25a. The 
results are summarized in Table 5.6. 
 
Table 5.6 Catalyst screening for the ring opening of rac-25a with allyl alcohol. 
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Entry Catalyst Loading 
(mol %) 
Time 
(h) 
% Conversion % ee 
25a 
% ee 
26a 
 
1 
 
18 
 
5 
 
6.5 
 
57 
 
99 
 
86 
2 9 5 12 59 97 81 
3 18 10 4.5 57 >99 84 
4 18 2.5 26 61 98 87 
5a 18 1 10 61 98 85 
a This reaction was carried out with a substrate concentration of 0.5 M; 0.1 M in all other cases. 
 
In the presence of 5 mol % of the catalyst 18, at 57 % conversion, the (S)-enantiomer of the 
oxazinone rac-25a was consumed almost completely (99 % ee in favor of the remaining 
(R)-enantiomer), and the enantiomeric excess of the product (S)-26a was found to be 86 % 
(Entry 1). From these data, the selectivity factor S of the reaction was calculated to be 68. 
Somewhat lower selectivity and activity were observed when the same amount of the cyclohexyl-
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substituted bifunctional catalyst 9 was used (Entry 2). Clearly, 18 is the superior catalyst in this 
reaction. An increase in the catalyst loading to 10 mol % decreased the reaction time to 4.5 h, 
without affecting selectivity (Entry 3). At lower catalyst loading of 2.5 mol %, the reaction time 
was longer but the selectivity remained virtually unaffected (Entry 4). At higher substrate 
concentration (0.5 M instead of 0.1 M) even 1 mol % catalyst is sufficient to catalyze the reaction 
effectively (Entry 5). However, 5 mol % of the catalyst 18 were used for all further experiments. 
 
5.3.2 Substrate scope 
 
A series of oxazinones derived from β-substituted β-amino acids with different steric and electronic 
demand was applied for the ring opening with allyl alcohol 23 in the presence of the bifunctional 
organocatalyst 18 (Table 5.7). Substrates include the electron poor p-chloro- and p-nitrophenyl 
substituted oxazinones 25b-c, electron rich p-methoxyphenyl substituted oxazinone 25d as well as 
 
Table 5.7 Substrates tested in the KR of oxazinones. 
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Ph N
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OR
rac-25a-f  23  (R)-25a-f  (S)-26a-f 
 
Entry Substrate R Time (h) % Conversion % ee 25 % ee 26  
1 
 
25a 
 
Ph 
 
6.5 
 
57 
 
99 
 
86 
2 25b p-ClC6H4 15 59 99 83 
3 25c m-NO2C6H4 3.0 64 99 81 
4 25d p-OMeC6H4 10.5 57 98 87 
5 25e t-Bu 48 54 97 82 
6 25f i-Pr 48 53 98 88 
 
the alkyl substituted oxazinones 25e-f. All substrates were resolved with high degree of 
enantioselectivities. In the presence of 5 mol % of the catalyst 18, the oxazinones (R)-25a-f were 
generally recovered with excellent enantiomeric excess (>97 % ee) whereas the esters (S)-26a-f 
were still produced with 80-90 % ee. 
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5.4 Synthesis of oxazaborolidines and their precursors 
 
The precursors for the chiral oxazaborolidines 29 are chiral α,α-diarylprolinol 97 and achiral 
boronic acid 98 or its dehydration product cyclic boroxine 151 (Scheme 5.30).  
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Scheme 5.30 Retrosynthesis of chiral oxazaborolidines 29. 
 
The chiral α,α-diarylprolinols were synthesized from the chiral pool compound L-proline 37 
according to a modified literature procedure.[152] The synthesis began with the protection of both the 
amine as well as the acid functionality, which was achieved in one step by heating L-proline 37 
with benzyl chloride 152 in DMF (Scheme 5.31). The N,C-doubly protected proline 153 was 
obtained in excellent yield.  
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Scheme 5.31 Double protection of L-proline by benzylation with benzyl chloride. 
 
Addition of the appropriate Grignard reagent to the ester 153 then gave N-benzylated 
α,α-diarylprolinols in moderate to excellent yields (Scheme 5.32). 
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Scheme 5.32 Addition of aryl-Grignard to the ester 153. 
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The N-benzyl group was then removed by hydrogenolysis to obtain the α,α-diarylprolinols in 
moderate to very good yields (Scheme 5.33). 
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Scheme 5.33 Hydrogenolysis of the N-benzyl groups of N-benzylated α,α-diarylprolinols. 
 
The α,α-diphenylprolinol 97a was crystallized from n-heptane to obtain colourless crystals which 
were appropriate for X-ray diffraction. The X-ray structure was determined (Figure 5.9).  
 
 
Figure 5.9 X-ray structure of (S)-α,α-diphenyl-2-pyrrolidin methanol 97a. 
 
Having synthesized the chiral α,α-diarylprolinols, the next target was the achiral boron unit. Several 
boronic acids are commercially available and also the oxazaborolidine 29a (Ar = Ph, R = Me). For 
this work, only the boronic acids with aromatic substituents on the boron atom were employed. The 
cyclic boroxines 151a-b were prepared from phenylboronic acid 98a and o-tolyl boronic acid 98b 
by dehydration via azeotropic distillation with toluene in a Dean-Stark apparatus (Scheme 5.34). 
The products were obtained in quantitative yield. 
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Scheme 5.34 Cyclodehydration of boronic acids to boroxines. 
 
The triphenyl boroxine 151a was crystallized from an n-hexane/toluene mixture to obtain X-ray 
diffraction quality crystals (Figure 5.10). 
 
 
Figure 5.10 X-ray structure of triphenyl boroxine 151a. 
 
The oxazaborolidines 29b-c were then prepared by condensation of α,α-diarylprolinols and triaryl 
boroxines following a literature procedure (Scheme 5.35).[138] The products were obtained in 
quantitative yield. 
 
 
N
H
H
OH
Ar
Ar
 
 
+ O
B
O
B
O
B
Ar'
Ar'Ar'  
 
Toluene 
 
reflux 
N
B
O
Ar'
Ar ArH
 
97a, Ar = Ph 
97b, Ar = m-Xyl 
 151a, Ar′ = Ph 
151b, Ar′ = o-tol 
 29b, Ar = Ph, Ar′ = Ph, 99 % 
29c, Ar = m-Xyl, Ar′ = o-tol, 99 %
Scheme 5.35 Synthesis of oxazaborolidines. 
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In catalysis experiments where protonated oxazaborolidines (oxazaborolidinium cations) were 
employed as the catalysts, protonation of oxazaboroldines was conducted in situ with 
trifluoromethanesulfonic acid (TfOH = CF3SO3H). 
 
5.5 Asymmetric hydrocyanation of imines 
5.5.1 Preparation of imines 
 
The imines were prepared from aldehydes and primary amines following a modified literature 
procedure (Scheme 5.36).[153] In most of the cases, the products were obtained in quantitative 
yields. 
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164, R1 = t-Bu 
 155, R2 = Bn 
156, R2 = Ph2CH 
158, R2 = allyl 
155, R2 = Bn 
 
 27a, R1 = Ph, R2 = Bn, 99 % 
157, R1 = Ph, R2 = Ph2CH, 92 % 
159, R1 = Ph, R2 = allyl, 91 % 
27b, R1 = o-BrC6H4, R2 = Bn, >99 % 
27c, R1 = m-BrC6H4, R2 = Bn, >99 % 
27d, R1 = 2-naphthyl, R2 = Bn, >99 % 
27e, R1 = p-OMeC6H4, R2 = Bn, >99 % 
27f, R1 = t-Bu, R2 = Bn, >99 % 
Scheme 5.36 Preparation of imines. 
 
5.5.2 Catalyst screening and optimization of reaction conditions 
 
The hydrocyanation of N-benzyl-benzylidene imine 27a (see scheme in Table 5.8) was chosen as 
the test reaction. 1.5 equivalents of HCN (generated from TMSCN and MeOH) were used in each 
case. First, the neutral oxazaborolidines (Scheme 5.37) were used as catalysts. 
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29a, Ar = Ph, R = Me 
29b, Ar = Ph, R = Ph 
 
N
B
O
R
Ar ArH
29c, Ar = m-Xyl, R = o-tol
Scheme 5.37 Neutral oxazaborolidines 29. 
 
The results of the catalyst screening and the optimization of the reaction conditions are summarized 
in Table 5.8. 
 
Table 5.8 Optimization of reaction conditions and screening of neutral oxazaborolidines 29. 
 
H
N Ph
 
 
 
+ 
 
 
HCN 
(1.5 eq) 
 
Catalyst 
 
 
CN
HN Ph
S
 
27a    28a 
 
Entry Catalyst Loading 
(mol %) 
Solvent Temperature 
(°C) 
Time 
(h) 
% Conversion % ee 
 
1 
 
- 
 
- 
 
toluene 
 
–25 
 
24 
 
28 
 
- 
2 29a 20 toluene –25 24 94 71 
3 29a 20 toluene –78 24 <2 nd 
4 29a 30 toluene –25 24 99 72 
5 29a 10 toluene –25 24 95 62 
6 29b 20 toluene –25 24 98 70 
7 29c 20 toluene –25 24 >99 73 
8 29a 20 CH2Cl2 –25 8 95 39 
 
Initial investigations showed that in the presence of 20 mol % of oxazaborolidine 29a, 
N-benzyl-benzylidene imine 27a undergoes facile hydrocyanation at –25 °C in toluene to produce 
the α-amino nitrile 28a. After 24 hours, 94 % conversion was obtained with 71 % ee in favour of 
the (S)-enantiomer (Entry 2). The absolute configuration of the product α-amino nitrile was 
determined by comparing the sense of optical rotation with literature data.[154] Interestingly, at this 
temperature the imine 27a undergoes significant hydrocyanation without any catalyst (Entry 1). 
The background reaction was completely suppressed at –78 °C, but 20 mol % 29a did not produce 
any conversion to 28a at this temperature either, even after 24 hours (Entry 3). Little conversion 
was observed when TMSCN was used as the cyanide source. Increasing the amount of catalyst to 
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30 mol % (at –25 °C) did not increase the enantioselectivity (Entry 4), but with lowering the 
catalyst loading to 10 mol %, the ee dropped considerably (Entry 5). Similar conversions were 
obtained in both cases (Entry 4 and 5). Using 20 mol % of 29b or 29c as catalysts, conversions and 
ees similar as with 29a were obtained (Entry 6 and 7). The solution became turbid and a white solid 
precipitated upon addition of HCN to a solution of imine and oxazaborolidines in toluene. In the 
case of oxazaborolidine 29b the solid was isolated and crystallized from dichloromethane to obtain 
 
 
Figure 5.11 X-ray structure of the HCN-adduct 29b·HCN. 
 
X-ray diffraction quality crystals. The X-ray structure revealed this solid as the HCN-adduct of 29b 
(Figure 5.11). When this solid was used as the catalyst in the hydrocyanation reaction, only little 
hydrocyanation product was detected. No such precipitation was observed when the reaction was 
conducted in dichloromethane; using 20 mol % of 29a, the conversion was found to be almost 
complete within 8 hours (Table 5.8, Entry 8). However, the enantioselectivity obtained in this case 
was only 39 % ee. 
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The N-substituents of the imine were then screened using 20 mol % of 29a at –25 °C in toluene. 
The results are summarized in Table 5.9. 
 
Table 5.9 Screening of the N-substituents of the imines. 
 
H
N R
 
 
 
+ HCN
(1.5 eq)  
 
29a 
(20 mol %) 
 
Toluene, –25 °C 
 
CN
HN R
S
 
 
Entry Substrate R Time (h) % Conversion % ee 
 
1 
 
27a 
 
PhCH2 
 
24 
 
94 
 
71 
2 157 Ph2CH 24 <2 n.d. 
3 159 Allyl 24 88 42 
 
Clearly, the N-benzyl substituted imine 27a is the best substrate for the hydrocyanation catalyzed 
by oxazaborolidines (Entry 1). The N-allyl substituted imine 159 gave fairly high conversion, but 
the enantioselectivity was found to be significantly lower (Entry 3). On the other hand, the 
N-benzhydryl substituted imine 157 was completely inactive in this reaction (Entry 2). 
Consequently, the N-benzyl substituted imines were used as substrates in all the following catalysis 
experiments. 
After optimization of the substrate structure and the reaction conditions for the neutral 
oxazaborolidines 29, the performance of protonated oxazaborolidines 30 i.e. oxazaborlidinium 
cations (Scheme 5.38) as catalyst were studied. The cationic species are known to show much 
higher catalytic activity than their neutral counterparts in the Diels-Alder reactions.[138, 139]  
 
 
30a, Ar = Ph, R = Me 
30b, Ar = Ph, R = Ph 
 
N
B
O
R
Ar ArH
H OTf 30c, Ar = m-Xyl, R = o-tol
Scheme 5.38 Oxazaborolidinium cations 30. 
 
The results are summarized in Table 5.10. 
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Table 5.10 Optimization of reaction conditions and screening of cationic oxazaborolidines 30.  
 
H
N Ph
 
 
 
 
+ 
 
 
 
HCN 
(1.5 eq) 
 
 
Catalyst 
 
Toluene 
 
CN
HN
R
Ph
 
27a    ent-28a 
 
Entry Catalyst Loading 
(mol %) 
Temperature 
(°C) 
Time 
(h) 
% 
Conversion 
% ee 
 
1 
 
30a 
 
20 
 
–25 
 
1.0 
 
96 
 
33 
2 30a 20 –70 2.0 >99 38 
3 30b 20 –70 2.0 97 35 
4 30c 20 –70 2.0 98 39 
5a 30a 20 –70 2.0 97 42 
6a 30a 10 –70 2.0 95 42 
7a 30a 5 –70 2.0 26 30 
a HCN solution in toluene was added slowly via a syringe pump over a period of 40 mins.  
 
Initial experiments have proven these cationic oxazaborolidines 30 to be extremely active catalysts 
for the hydrocyanation of imines: in the presence of 20 mol % of 30a, the imine 27a was 
completely consumed within 1 hour at –25 °C (Entry 1). The reaction time was shortened to 1 hour 
(cf. 24 hours with 29a, see Table 5.8, page 83), but the enantioselectivity obtained in this case was 
only 33 % ee. Surprisingly, the sense of stereoinduction of the product amino nitrile obtained with 
catalyst 30a was found to be opposite to the one obtained with neutral oxazaborolidine 29a (see 
Table 5.8, page 83). Using the protonated catalyst 30a, the (R)-enantiomer was formed in excess. 
Taking advantage of the short reaction time, the reaction was carried out at –70 °C. This time it 
took 2 hours for the reaction to reach completion and the enantioselectivity obtained in this case 
was slightly higher (Entry 2). With the catalysts 30b and 30c, not much improvement in 
enantioselectivity was observed (Entry 3 and 4). Enantioselectivity could be increased slightly by 
adding HCN slowly over a period of 40 minutes without affecting the conversion much. In the case 
of catalyst 30a (20 mol %), slow addition of HCN afforded 42 % ee at –70 °C (Entry 5). Lowering 
the catalyst loading to 10 mol % affected neither the conversion nor the enantioselectivity (Entry 6). 
However, further lowering of the catalyst loading to 5 mol % decreased both the conversion and the 
enantioselectivity significantly (Entry 7). It is important to note that these oxazaborolidinium 
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cations are extremely moisture sensitive and the reactions needs to be performed under rigorous 
exclusion of moisture.  
 
5.5.3 Substrate scope 
 
Having optimized the catalyst structure for both neutral and cationic oxazaborolidines, several 
N-benzyl substituted imines were subjected to the hydrocyanation reaction under the established 
 
Table 5.11 Substrate scope for the asymmetric hydrocyanation of imines. 
 
R H
N Ph
27a-f
R
HN
CN
Ph
28a-f
+ HCN
Conditions
A or B
 
 
Entry  Substrate Conditiona Time 
(h) 
% 
Conversion 
% ee 
 
 
1 
 
 
27a 
 
H
N Ph
 
 
A 
B 
 
24 
2 
 
94 
95 
 
71 (S) 
42 (R) 
 
2 
 
27b H
N PhBr
 
 
A 
B 
 
24 
2 
 
10 
97 
 
15 (S) 
10 (R) 
 
3 
 
27c H
N Ph
Br
 
 
A 
B 
 
45 
2 
 
27 
98 
 
10 (S) 
8 (R) 
 
4 
 
27d H
N Ph
 
 
A 
B 
 
24 
2 
 
93 
95 
 
68 (S) 
33 (R) 
 
5 
 
27e H
N Ph
MeO  
 
A 
B 
 
24 
3 
 
95 
75 
 
40 (S) 
10 (R) 
 
6 
 
27f 
 
H
N Ph
 
 
A 
B 
 
24 
3 
 
82 
76 
 
39 (S) 
rac 
a Conditions A: 1.5 eq HCN, 20 mol % 29a, –25 °C; Conditions B: 1.5 eq HCN, 10 mol % 30a, –70 °C. 
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reaction conditions (A and B, Table 5.11) to prove the rather general substrate scope of this 
protonation-induced switch of the sense of induction process. The results are summarized in Table 
5.11. Reversal of the sense of stereoinduction upon catalyst protonation was observed in all cases 
(A and B, Table 5.11). For example, the imine 27a furnished 71 % ee in favour of the 
(S)-enantiomer with free oxazaborolidine 29a (Conditions A), whereas 42 % ee in favour of 
(R)-enantiomer was obtained with protonated oxazaborolidine 30a (Conditions B) (Entry 1). 
Although this trend was also observed with bromo-substituted imines 27b and 27c, the 
enantioselectivities were very low under both conditions (Entry 2 and 3). However, the difference 
in the catalytic activities of the neutral and the cationic oxazaborolidines are evidenced also in the 
conversions obtained for these two substrates. In the case of 2-naphthaldehyde derived imine 27d, 
the (S)-enantiomer was obtained in 68 % ee under conditions A with 93 % conversion after 
24 hours. Changing the reaction conditions to B produced 33 % ee in favour of the (R)-enantiomer 
(Entry 4). p-Methoxy benzaldehyde derived imine 27e showed significantly lower enantiomeric 
excesses with both neutral and protonated catalyst, 40 % and 10 % respectively (Entry 5). A similar 
tendency was observed in the case of the pivalaldehyde derived imine 27f except the fact that 
racemic product was obtained under conditions B (Entry 6). 
 
5.6 Synthesis and application of a new tridentate ligand 
system  
5.6.1 Synthesis of tridentate ligands 
 
The precursors for the new tridentate ligands 31 are chiral α,α-diarylprolinols 97 and achiral 
salicylaldehyde derivatives 100 (Scheme 5.39). 
 
N
H
HO
Ar
Ar
OH
R
R
 
 
 
 
N
H H
OH
ArAr
 
 
 
+ OH
O
H
R
R  
31  97  100 
Scheme 5.39 Retrosynthetic analysis of the new tridentate ligand 31. 
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The ligands were synthesized by C–N bond formation using the reductive amination strategy. For 
the current study, 2,4-disubstituted salicylaldehyde derivatives 100a-c were used as the aldehyde 
component and chiral α,α-diphenylprolinol 97a was used as the secondary amine component 
(Scheme 5.40). The ligands were obtained in moderate to good yields. 
 
OH
O
H
R
R  
 
 
+ 
 
N
H H
OH
PhPh
 
 
NaBH3CN, AcOH 
 
CH3CN, RT 
 
N
H
HO
Ph
Ph
OHR
R
100a, R = t-Bu  97a  31a, R = t-Bu, 46 % 
100b, R = I    31b, R = I, 70 % 
100c, R = Br    31c, R = Br, 65 % 
Scheme 5.40 Synthesis of the tridentate ligands 31. 
 
The tert-butyl substituted ligand 31a was crystallized from ethanol to obtain X-ray diffraction 
quality crystals. X-ray structure of the ligand was determined (Figure 5.12). 
 
 
Figure 5.12 X-ray structure of the tridentate ligand 2,4-di-tert-butyl-6-{(S)-2-(hydroxydiphenyl-methyl)pyrrolidin-1-yl-
methyl}phenol 31a. 
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5.6.2 Preparation of an aluminium-complex and its application for the 
asymmetric hydrocyanation of aldehydes 
 
To demonstrate the potential of this new ligand system, an aluminium complex of the ligand 31a 
was synthesized by stirring the ligand with dimethylaluminium chloride in abs. toluene (Scheme 
5.41). The aluminium-complex of a similar but C2-symmetric ligand (see Scheme 4.11, page 52) 
has previously been reported by Trost et al. for the asymmetric cyanosilylation of aldehydes.[155] 
 
N
H
HO
Ph
Ph
OHt-Bu
t-Bu  
 
Me2AlCl 
 
Toluene, RT, 2h O
Al
N
O
Ph
Ph
Cl
H
t-Bu
t-Bu
 
31a  32 
Scheme 5.41 Preparation of the proposed aluminium complex of the tridentage ligand 31a. 
 
The complex 32 was not isolated and characterized; hence the structure shown in Scheme 5.41 is 
only a logical speculation. The aluminium-complex in solution was applied immediately for the 
hydrocyanation of benzaldehyde 33 (Scheme 5.42).[156] 
 
 
O
H
 
 
 
 
+ 
 
 
 
HCN
 
32 
(10 mol %) 
 
Toluene, –40 °C 
 
∗ CN
OH
 
33    34 
Scheme 5.42 Asymmetric hydrocyanation of benzaldehyde with 32. 
 
In the presence of 10 mol % of the complex 32 at –40 °C, benzaldehyde 33 was completely 
converted into the cyanohydrin 34 within 17 hours. The enantioselectivity of the product 
cyanohydrin 34 was found to be only moderate (50 % ee). 
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6 Discussion 
 
6.1 Synthesis of bifunctional organocatalysts 
 
The (thio)urea based bifunctional organocatalysts 1-21 as well as the guanidine derivatives 148 and 
150 (see structure table, page 247) were synthesized using enantiomerically pure trans-1,2-
diaminocyclohexane 102 as the chiral backbone. In most cases, the desired products were obtained 
in good to satisfying yields. Although the parent catalyst 1 could be synthesized via a shorter route 
by monothiourea formation followed by dimethylation (Scheme 6.1), the longer route with the 
 
NH2
NH2
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N
H
N
H
S
CF3
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NMe2
O
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NMe2
NMe2
N
H
N
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1
NCS
CF3
F3C
105 106 101  
Scheme 6.1 Two different routes to the catalyst 1 from the diamine 102. 
 
protection-deprotection sequence was followed due to the general applicability of this route: the 
direct monourea formation from the diamine 102 is not possible as in most cases the bis-urea is the 
major, if not the exclusive product.[157] Furthermore, the selective alkylation of the amine by alkyl 
halides is not possible without alkylation of the thiourea NHs. 
 
6.2 Dynamic kinetic resolution of azlactones 
 
Highly efficient alcoholytic ring opening of azlactones was effected with the bifunctional 
organocatalyst 18 (see structure table). The level of enantioselectivity of the product esters obtained 
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is the highest ever achieved in the chemically catalyzed DKR of azlactones.[150, 151] A fairly broad 
range of azlactones containing both aliphatic and aromatic substituents was employed in the DKR. 
In these bifunctional organocatalysts, the quasi-Lewis acidic (thio)urea moiety is responsible for the 
substrate (azlactone) activation whereas the Brønsted basic tertiary amine activates the alcohol by 
hydrogen bonding. The activation of azlactones occurs by bridging hydrogen bonding from the 
(thio)urea hydrogens as evidenced from the similar downfield shifts of both the urea hydrogens in 
the NMR-titrations (see section 5.2.3, page 75). The hydrogen-bond donor ability of the (thio)ureas 
towards carbonyl acceptors is well-known in the literature[28] and was also observed, particularly in 
the case of the urea-based bifunctional organocatalysts employed in this work. For example, in the 
X-ray structure of 2, intermolecular hydrogen bonds exist between the urea N–H groups of one 
molecule and the urea oxygen atom of a neighbouring molecule (Figure 6.1). The lengths of these 
two hydrogen bonds are 2.05 and 2.30 Å, respectively. The urea moiety of 2 is planar, and the  
 
 
Figure 6.1 Intermolecular bifurcated hydrogen bonding in 2. 
 
planes of the urea moieties of neighbouring molecules intersect at an angle of about 80°. However, 
in contrast to the explanation (for higher solubility of such bifunctional catalysts in non-polar 
solvents) by Takemoto et al.,[53] no intra- or intermolecular H-bonds from the urea to the 
Brønsted-basic tertiary amine moietiy were observed. Such hydrogen bonding would “neutralize” 
the bifunctional character of the catalyst and therefore would be detrimental for the catalytic 
activity. Again, from the work of Jacobsen et al. it is known that the imine nitrogen atom could also 
act as hydrogen bond acceptors and do so in a bifurcated manner where the imine plane remains 
perpendicular to the urea plane.[39] This is in contrast to the H-bond acceptor behavior of the 
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carbonyls where the carbonyl plane in most cases, tends to remain coplanar with the urea plane. 
This kind of co-planarity is clearly seen in the X-ray structure of 7 (Figure 6.2). 
 
 
Figure 6.2 Co-planarity of the urea moieties in 7. 
 
Due to the presence of both a carbonyl and an imine functionality in the azlactone, its binding to the 
(thio)urea moiety of the catalyst can either occur via the carbonyl oxygen or the imine nitrogen 
atom. The absence of any non-linear effect (when the reaction was conducted with catalysts of 
varying ees) indicates the nature of the catalytically active species as monomeric.[158] Therefore, the 
possibility of substrate activation by more than one catalyst molecule can be ruled out. The 
monomeric nature of the catalyst was further supported by the molecular weight of the catalysts 1 
and 2 determined by the vapour-pressure-osmometry method.[159] No evidence for the aggregated 
catalysts was obtained as the molecular weights of the catalysts 1 and 2 were found to be 
503 (± 40) g/mol and 533 (± 30) g/mol respectively. Although the observed molecular weights are 
higher than those of the monomers, they are much lower than those for the dimers. 
From the computational studies by K. Etzenbach-Effers,[160] it was found that in the absence of 
alcohol, the binary complex A1 (where the binding occurs via the imine nitrogen) is energetically 
more favorable than the corresponding adduct (A) via the carbonyl oxygen (Scheme 6.2). But in the 
presence of alcohol, the binding mode of the substrate changes completely. In the ternary complex, 
the pattern of hydrogen bonding changes from bifurcated mode to the “normal” mode where both 
the carbonyl oxygen and the ring oxygen atom individually act as single H-bond acceptors (B and 
B1). In the ternary complex the alcohol is triggered by the tertiary amine towards the activated 
carbonyl carbon and the attack of the alcohol leads to the ring opening of azlactone to generate the 
zwitterion C and C1. The zwitterion C is energetically more favorable as compared to C1 because 
C1 suffers from severe charge separation. This also accounts for the higher stability of the ternary 
complex B and therefore the reaction proceeds via the pathway A1 → A → B → C. 
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Scheme 6.2 Plausible mechanistic pathway for the DKR of azlactones. 
 
Proton transfer from the tertiary nitrogen to the oxygen (in C) followed by tautomerization affords 
the product N-acyl α-amino acid ester 24 (Scheme 6.3). 
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Scheme 6.3 Proton transfer in the zwitterion C followed by tautomerization to the product 24. 
 
The formation of the complex A1 also explains the little shift of the urea hydrogens in the 
NMR-titration of the phenylalanine derived azlactone 22d. Due to the steric bulk and the flexibility 
of the benzyl group, the binary complex (of type A1) of 22d is less favorable than the binary 
complex of alanine derived azlactone 22f and dimethyl azlactone 22i. So, the binding constant of 
22d with 2 is expected to be much less than that of the other two azlactones (22f and 22i). 
Screening of the catalysts with different substitutents on the tertiary-amine part (Table 5.3, page 71) 
in the alcoholytic ring opening of the tert-leucine derived azlactone rac-22a (Scheme 6.4) revealed 
that dimethylamine is optimum for this part of the structure. An increase in steric bulk of the 
substituents led to a decrease in conversion and even more significantly in enantioselectivity. 
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Replacement of even one methyl group of the tertiary amine with a benzyl group in 5 is sufficient 
to deactivate the catalyst. Besides steric bulk, flexibility of the substituents is another decisive 
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O
 
rac-22a  23  24a 
Scheme 6.4 Alcoholytic DKR of tert-leucine derived azlactone rac-22a. 
 
factor for catalytic efficiency. Although the diethylamine (in catalyst 3) and pyrrolidine (in 
catalyst 4) are expected to exert similar steric effect, the flexibility of the ethyl groups in diethyl 
catalyst 3 is the reason for its diminished catalytic activity. The rotation of the ethyl groups would 
hinder the substrate binding to the urea moiety and hence the activation. A similar steric effect of a 
diethylamino moiety (R' = Et) was previously demonstrated by Wang et al. for the Morita-Baylis-
Hillman reaction (Scheme 6.5).[58] 
 
 
O
R H
O
O
R
OH
+
Catalyst
(10 mol %)
CH3CN, 0 °C  
N
H
NR'2
S
N
H
Ar
Ar = 3,5-(CF3)2C6H3  
Scheme 6.5 Organocatalytic Morita-Baylis-Hillman reaction by Wang et al.[58] 
 
The same explanation holds for the catalyst 5 with the benzyl group that needs even more space for 
its rotation and therefore would prevent the substrate binding completely. 
The screening of the catalysts with various (thio)urea substituents (Table 5.4, page 72) in the 
aforementioned reaction showed the importance of the quasi-Lewis acidity of the (thio)urea moiety 
for the catalytic activity. The electron withdrawing substituents on the (thio)urea nitrogen would 
increase the quasi-Lewis acidity and would result in stronger activation. This effect was observed in 
the cases of the catalysts with electron-withdrawing substituents like 3,5-bis(trifluoromethyl)phenyl 
(in catalyst 1 and 2) or 3,5-dinitrophenyl (in catalyst 6). The opposite effect was observed in the 
cases of catalysts with electron rich substituents like mesityl (in catalyst 7) or 3-pyridyl (in catalyst 
8). These catalysts afforded higher selectivities, but the conversions were significantly lower. In the 
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case of the mesityl-substituted catalyst 7, an even lower reactivity was observed. This might be due 
to the methyl groups at the ortho positions of the aromatic ring that would further hinder the 
substrate binding. The aliphatic substituents in catalysts 9, 10 and 11 showed an intermediate 
reactivity in between the two above cases. Interestingly, the C2-symmetric catalyst 14 showed 
lower reactivity compared to the cyclohexyl-substituted catalyst 9. This might be due to the 
presence of a bulky dimethylamino group on both sides of the thiourea moiety. 
The tert-leucine and neopentylglycine derived catalysts in general afforded better 
enantioselectivities although the conversions were rather low. The diminished activity of the high 
enantioselective catalysts compared to the less-selective or non-selective catalysts is a common 
phenomenon in asymmetric catalysis. This is due to the reduction in the number of pathways that 
lead to the (undesired) product formation. Moreover, the presence of bulky tert-butyl or neopentyl 
groups close to the thioure moiety in these catalysts presumably hinder the H-bonding between the 
azlactone and the thiourea NHs. Considerably lower conversions and enantioselectivities were 
obtained with the catalyst 19 compared to its diastereomer 18 due to the mismatched-nature of the 
catalyst 19 (Scheme 6.6). This is the so-called matched-/mismatched-pairing of chiralities in the 
diastereomeric catalysts. 
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Scheme 6.6 The matched- and mismatched-catalyst pair 18 and 19. 
 
The guanidine derivative 148 (see structure table, page 247) was proven to be a very active catalyst 
for this reaction although the enantioselectivity was found to be very low. This is not surprising, as 
the alcoholytic ring opening of azlactones is known to be effected by strong Brønsted bases like 
DMAP.[74] Guanidine derivatives are very strong bases (the pKa of guanidine is 13.6) and the 
distant positioning of the Brønsted basic guanidine site from the chiral center in catalyst 148 is 
unlikely to exhibit any stereodiscrimination between the azlactone enantiomers. Besides, the 
catalyst 148 does not posses any (quasi-Lewis acidic) binding/activation site for the substrate 
azlactones. In contrast, the guanidinium trifluroacetate 150 (see structure table) containing a 
quasi-Lewis acidic binding site was found to be catalytically inactive. Most likely the ion pairing 
between the guanidinium cation and the trifluoroactate anion prevents the binding and activation of 
neutral azlactone by the quasi-Lewis acidic NHs of the guanidinium cation. A neutral bifunctional 
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organocatalyst of type 148 with an electron deficient guanidine moiety should serve the purpose of 
double activation with efficient enantiodiscrimination (see section 7.1, page 102). 
6.3 Kinetic resolution of oxazinones 
 
The efficiency of the catalyst 18 for the alcoholytic ring opening of azlactones via DKR was 
logically extended to the alcoholytic ring opening of the β-amino acid analog oxazinones 25 (see 
section 5.3, page 76). The oxazinones are configurationally stable and therefore only one 
enantiomer underwent ring opening by alcohols selectively, i.e. kinetic resolution (KR) was 
observed. The other enantiomers of oxazinones were generally recovered with excellent 
enantiomeric excesses. A fairly broad range of oxazinones containing both aromatic and aliphatic 
substituents were employed for the KR. 
Although achiral and enantiomerically pure oxazinones have been utilized in peptide chemistry for 
coupling to amino acid esters[161] as well as for the ring-opening polymerization reaction,[162] no 
catalytic ring opening reaction has been reported so far. Therefore, this is the first catalytic 
alcoholytic ring-opening of oxazinones with kinetic resolution. 
The same sense of stereoinduction as well as similar level of enantioselectivities (as in the case of 
DKR of azlactones) observed for the KR of oxazinones point towards a similar mechanism for their 
alcholytic ring opening (Scheme 6.7). Attack of the alcohol (triggered by the Brønsted basic tertiary 
amine) to the thiourea-activated oxazinones generates the zwitterion A. Proton transfer from the 
tertiary nitrogen followed by tautomerization leads to the product N-acyl β-amino acid ester 26. 
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Scheme 6.7 Plausible mechanism for the alcoholytic ring opening of oxazinones. 
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6.4 Asymmetric hydrocyanation of imines 
 
The asymmetric hydrocyanation of aldimines was carried out using neutral and protonated 
(cationic) oxazaborolidines as the catalysts 29a and 30a (see structure table), respectively. Low to 
moderate levels of enantioselectivity were obtained for a series of aromatic and aliphatic aldimines. 
In the case of the aromatic aldimines, the products with opposite sense of stereoinduction were 
obtained upon protonation of the catalyst (oxazaborolidine). This is the first successful application 
of oxazaborolidines and oxazaborolidinium cations for the asymmetric hydrocyanation of imines. 
Although salt[163] and temperature-induced[164] reversal of stereoinductions were previously reported 
for different reactions, this is to the best of my knowledge the first example of protonation-induced 
reversal of stereoinduction. 
Both in the oxazaborolidine and the oxazaborolidinium cation, the Lewis acidic boron atom can be 
regarded as the active center of the catalysts, and the activation of the imine occurs via coordination 
of the nitrogen lone pair of the imine to the Lewis acidic boron center. This is similar to the 
activation of prochiral ketones for the enantioselective reduction by borane (I in Scheme 6.8) as 
demonstrated by Corey et al.[45] The carbonyl and the imine group differ in the number of available  
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Scheme 6.8 Pre-transition-state assembly for the borane reduction of prochiral ketones (I) and four possible 
pre-transition-state assemblies for the hydrocyanation of imine by 29a. 
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lone pairs for coordination: whereas the carbonyl oxygen has two lone pairs and therefore two 
coordination sites, the imine nitrogen atom provides only one lone pair of electrons. Moreover, 
imines can have two interconvertable stereoisomeric forms: E and Z.[39]  
In the case of the neutral oxazaborolidine 29a, assuming that the pre-transition-state assembly for 
the hydrocyanation of imine resembles that for the borane reduction of prochiral ketones, four 
possibilities of such an assembly exist (Scheme 6.8). In the pre-transition-state assembly A and B, 
the imine coordinates in the Z-configuration whereas in C and D, the coordination occurs in the 
E-configuration. Clearly, the most logical and likely pre-transition-state assembly is D, where the 
imine is coordinating in E-configuration and cis to the vicinal HCN. This manner of binding 
minimizes unfavorable steric interaction between the oxazaborolidine and the imine (like in A, B 
and C), and aligns the electrophlilic imine carbon atom and the coordinated HCN for 
stereoelectronically favorable, face-selective cyanide addition via a six-membered transition state to 
form the observed hydrocyanation adduct (S)-28a (Scheme 6.9). 
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Scheme 6.9 Formation of (S)-28a from the pre-transition-state assembly D. 
 
The activation of Z-imines by the catalyst 29a should also be possible when the coordination of the 
Z-imine to the Lewis acidic boron center leads to an organized C–H···O hydrogen bonded complex 
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Scheme 6.10 Plausible pre-transition-state assembly E for the activation of Z-imine. 
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E (Scheme 6.10). Such hydrogen bonds are known to have a very important role in the 
enantioselective Lewis acid catalyzed reactions of aldehydes.[165] In this assembly E, tertiary 
nitrogen activated HCN attack should occur to the re face of the imine to produce (S)-α-amino 
nitrile (S)-28a. Neither the pre-transition-state assembly D nor E is possible for the imines with 
bulkier N-substituent. This explains the inertness of the N-benzhydryl substituted imine towards 
HCN addition in the presence of catalyst 29a (see Table 5.9, page 85). 
In the oxazaborolidinium cation 30a, the Lewis acidity of the boron center is much higher than that 
in the neutral oxazaborolidine 29a due to the presence of a cationic nitrogen next to boron.[138] The 
difference in Lewis acidity of the boron center in the two catalysts accounts for their reactivity 
difference. In the case of the catalyst 30a, only one pre-transition-state assembly is possible where 
the coordination of Z-imine to the Lewis acidic boron center leads to an C–H···O hydrogen bonded 
complex F (Scheme 6.11) analogous to the pre-transition-state assembly E. In the complex F, the 
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Scheme 6.11 Plausible pre-transition-state assembly for the hydrocyanation of imine by 30a and the product formation. 
 
electron deficient aromatic ring of the imine can attract the cis phenyl group on the C(5) of the 
oxazaborolidine ring by a π–π donor-acceptor interaction. Also, the structure F is fixed with regard 
to rotation about the coordination link between B and N by the C–H···O hydrogen bond.[140] 
Therefore, the cyanide attack on the imine carbon should occur at the si (front) face because of 
shielding of the re (rear) face by the neighboring phenyl ring of the oxazaborolidine. Cyanide 
addition from si face of the imine generates the observed (R)-α-amino nitrile (R)-28a. Interestingly, 
this is the same face selectivity that has been observed for the cyanosilylation of aldehydes[140] and 
ketones[141] reported by Corey et al. The importance of the π–π donor-acceptor interaction is 
evidenced by the formation of racemic products from the aliphatic pivalaldehyde derived imine 27f. 
Since such π-stacking is not possible with this imine, the desired face selectivity was not observed. 
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Alternatively, in the oxazaborolidinium cation 30a, the protonated tertiary nitrogen atom can 
activate the imine by N–H···N hydrogen bonding as depicted in Scheme 6.12. Undissociated HCN 
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Scheme 6.12 Plausible double activation of substrates by oxazaborolidinium cation 30a. 
 
can then be activated by coordinating to the Lewis acidic boron atom via the available nitrogen lone 
pair. In this doubly activated pre-transition-state assembly G, the attack of HCN to the si face of the 
Z-imine followed by proton transfer (from HCN) generates the observed (R)-α-amino nitrile 
(R)-28a. 
This type of activation is not favorable in the case of neutral oxazaborolidine because, protonation 
of the tertiary nitrogen of the catalyst by HCN generates the counter ion CN-. The cyanide anion, 
due to its higher coordinating ability, binds to the Lewis acidic boron via the negatively charged 
carbon atom to produce a stable HCN-adduct as evidenced by the X-ray structure (see Figure 5.11, 
page 84). 
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7 Outlook 
 
7.1 DKR of azlactones and KR of oxazinones 
 
The dynamic kinetic resolution (DKR) of azlactones described herein is a versatile method that is 
applicable to numerous azlactones for the synthesis of a variety of α-amino acid derivatives with 
good to excellent enantiomeric purities. Nevertheless, only low to moderate levels of conversion in 
most of the cases in the presence of the optimum catalyst 18 (see structure table, page 247) is a 
drawback of this method. Therefore, the design and synthesis of a more active and at the same time 
highly enantioselective catalyst would be of practical importance. The thiourea-based bifunctional 
organocatalysts with a cyclohexane residue on the thiourea nitrogen were found to be quite active 
for the aforementioned reaction. On the other hand, the second-generation catalysts derived from 
α-amino acids produced high enantioselectivities. A catalyst of type 165 (Scheme 7.1) should fulfill 
the requirements of an active as well as a highly enantioselective catalyst. This catalyst can be 
synthesized from the β-amino acid trans-2-aminocyclohexanecarboxylic acid 166. The β-amino 
acid 166 is readily accessible as its synthesis and resolution was already reported by Berkessel et 
al.[166] 
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Scheme 7.1 Potential bifunctional organocatalyst 165 and its precursor 166. 
 
Furthermore, a catalyst containing a Brønsted basic tertiary amine and an electron-deficient 
guanidine moiety (which may act as a quasi-Lewis acid) of type A (EWG = electron withdrawing 
group; e.g. CN) should also be efficient for the ring opening of 
azlactones. 
It was shown that the concept of DKR of azlactones can be logically 
extended to the KR of oxazinones. Therefore, the synthesis of 
enantiomerically pure higher amino acid homologs (e.g. γ-amino 
acids) might be possible via KR of their cyclic derivatives (analogous to azlactones and 
oxazinones). 
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7.2 Bifunctional organocatalysts: possible applications 
 
The bifunctional organocatalysts described in this work have huge potential for several other 
applications. Miller et al. reported the kinetic resolution of trans-1,2-acetamidocyclohexanol 167 
(Scheme 7.2) using small peptides as the catalysts.[167] Although high levels of enantioselectivities 
were reported, the main disadvantage of this method is the use of catalysts with high molecular 
weight. This reaction could be effected by much lower molecular weight bifunctional 
 
HO NHAc
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AcO NHAc  
+
HO NHAc
 
rac-167     
Scheme 7.2 Kinetic resolution of trans-1,2-acetamidocyclohexanol. 
 
organocatalysts presented herein. The substrate binding to the (thio)urea moiety of the catalyst can 
be envisaged with the acetamide group whereas the tertiary amine is expected to transfer the acetyl 
group (via an acylammonium cation) to the OH-functionality of the substrate (Scheme 7.3). As can 
be seen in the scheme below, the OH-group in only one substrate enantiomer is in a favorable 
orientation in the catalyst-bound complex to undergo acetylation from the acylammonium cation. 
Therefore, a kinetic resolution can be expected. 
 
NN
X
R'
H H
N
Me
Me
OH
N
H
O
Me
MeO
HO
N
H
O
Me
 
Scheme 7.3 Mechanistic model for the proposed enantioselective acylation. 
 
The enantioselective reduction of prochiral imines to chiral amines is among the most important 
and challenging topics in chemistry. Recently, Rueping et al. reported an organocatalytic transfer 
hydrogenation of imines using the chiral Brønsted acid 39 (Scheme 7.4).[27] The Hantzsch 
dihydropyridine was used as the hydride source for this process. Using a readily available and 
inexpensive hydride source would be more desirable. The (thio)urea-tertiary amine bifunctional 
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organocatalysts might be useful for the reduction of prochiral imines using borane (BH3) as the 
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Scheme 7.4 Enantioselective transfer hydrogenation to imines by Rueping et al.[27] 
 
hydride source. Activation of imine by (thio)urea moiety is well-established from the work of 
Jacobsen and co-workers[39] whereas the enhancement of hydride donor ability of borane via 
coordination to a tertiary amine is known from the work of Corey et al.[45] The double activation of 
the imine as well as the borane by the bifunctional organocatalyst can be expected and might effect 
the enantioselective borane reduction of imines by the face selective hydride transfer (Scheme 7.5). 
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Scheme 7.5 Proposed double activation of the imine and the borane by the bifunctional organocatalysts. 
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7.3 New catalyst concept 
 
The potential of (thio)urea-tertiary amine type bifunctional organocatalysts or, in general, 
(thio)urea-based organocatalysts has already been realized from the work of various groups. These 
catalysts were known to effect a wide range of different asymmetric transformations rather 
efficiently. However, till to date there is no report of a catalyst that combine a cyclic secondary 
amine and a (thio)urea functionality. The utility of cyclic secondary amines in enamine- or 
iminium ion-catalysis (see section 3.1, page 9) is well-established from the work of List, MacMillan 
and co-workers.[12] A catalyst of such (thio)urea-secondary amine type 168 (Scheme 7.6) can easily 
be prepared from L-proline 37. This catalyst might be applicable for the enantioselective addition 
reaction of enamine or iminium ion intermediates to (thio)urea activated carbonyls, imines or nitro 
compounds. 
 
N
H H
N
H
N
H
X
R
  
N
H
CO2H
H
168  37 
Scheme 7.6 L-Proline derived (thio)urea-secondary amine catalyst 168. 
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8 Experimental Part 
 
8.1 General experimental conditions 
 
Solvents and reagents 
All solvents were purified by distillation before use following standard procedures.[168] Absolute 
diethyl ether, tetrahydrofuran and toluene were obtained by distilling over sodium, using 
benzophenone as indicator. Absolute acetonitrile, chloroform and dichloromethane were obtained 
by distillation over calcium hydride. Absolute tert-butanol was obtained by distilling over calcium 
oxide. Ethanol, iso-propanol and methanol were dried by distilling over magnesium. 
Dimethylformamide was refluxed over calcium hydride and distilled under an inert atmosphere 
with reduced pressure (15 mbar, 75 °C). Commercial reagents were obtained from various 
commercial sources and used as received.  
 
Inert gas atmosphere 
Air and moisture-sensitive reactions were conducted under an argon atmosphere. Argon obtained 
from the company Linde with a purity of 99.998 % was dried with silical gel and phosphorous 
pentoxide (both with color indicator for humidity), and deoxygenated with the BTS-catalyst from 
BASF before use. 
 
Thin layer chromatography (TLC) 
Materials:  Macherey-Nagel MN POLYGRAM Sil G/UV254 plates (0.25 mm thick) 
The spots were visualized in UV-light (λ = 254 nm) and/or by staining with iodine, ninhydrin, 
vanilline or phosphomolybdic acid. 
 
Column chromatography 
Materials:  Macherey-Nagel MN Silicagel 60, 230-400 mesh (0.04-0.063 mm) 
 
Analytical high performance liquid chromatography (HPLC) 
Apparatus:  Merck-Hitachi L-6200A Intelligent Pump and L-4500 Diode-Array Detector. 
Materials:  Daicel Chiralpak AD column (0.46 cm × 25 cm) 
  Daicel Chiralcel OJ column (0.46 cm × 25 cm) 
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High performance liquid chromatography with mass spectrometric detector 
(HPLC/MS) 
Apparatus: Agilent 1100 Series Purification Platform 
 
Gas chromatography (GC) 
Apparatus:  Hewlett Packard GC 5890 E Series II Plus (Carrier gas: Nitrogen) with HP 6890 
Series Injector 
Hewlett Packard GC 5890 A Series II (Carrier gas: Nitrogen) with HP 6890 Series 
Injector 
Hewlett Packard GC 6890 A Series Plus (Carrier gas: Nitrogen) with HP 6890 
Series Injector 
Materials: Chrompak CP-Chirasil-Dex CB (25 m, 0.25 mm ID, 0.25 µm film thickness) 
  Chiraldex γ-TA ( 20 m, 0.25 mm ID, 0.125 µm film thickness) 
 
Gas chromatography with mass spectrometric detector (GC/MS) 
Apparatus:  Hewlett Packard GC 6890 Series and MSD 5973 (Carrier gas: Helium) with HP 
6890 Series Injector 
Materials:  Hewlett Packard HP-5: Crosslinked Silicone Gum capillary column (Film thickness: 
25 m × 0.25 mm × 0.33 µm) 
Unless otherwise stated, all the analyses were carried out using the following temperature 
programs: 
Standard: 100 °C (5 min), 20 °C/min → 200 °C (25 min), 20 °C/min → 280 °C (10 min). 
Quick: 100 °C (5 min), 20 °C/min → 280 °C (20 min) 
 
Nuclear magnetic resonance spectroscopy (NMR) 
Apparatus:  Bruker AC 250 (1H: 250 MHz, 13C: 62.5 MHz) 
 Bruker AC 300 (1H: 300 MHz, 13C: 75 MHz) 
  Bruker DPX 300 (1H: 300 MHz, 13C: 75 MHz) 
 Bruker DRX 500 (1H: 500 MHz, 13C: 125 MHz) 
Spectra were recorded at room temperature (298 K) unless otherwise stated. Chemical shifts for 
protons and carbons were reported in parts per million (ppm) downfield from tetramethylsilane 
(TMS) and were referenced to residual proton in the NMR solvents (e.g. CHCl3: δ 7.24) and carbon 
resonances of the solvents (e.g. CDCl3: δ 77.0) respectively. The coupling constants (J) were 
reported in Hertz (Hz). For the fine-structure interpretation the abbreviations of the signals are the 
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following: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. The signal multiplicities 
for the 13C-spectra were determined by DEPT or APT experiments.  
 
Fourier transform infrared spectroscopy (FT-IR) 
Apparatus: Perkin Elmer 1600 Series FT-IR spectrometer 
  Perkin-Elmer Paragon 1000 FT-IR spectrometer with ATR technique 
The samples were measured as thin films, potassium bromide or caesium iodide discs, unless 
otherwise stated. The positions of the bands are reported in cm-1. The intensities are reported as: 
s = strong, m = medium, w = weak, br = broad, sh = sharp and the kind of bands as: ν = stretching, 
δ = deformation (oop = out of plane). 
 
Mass spectrometry (MS) 
Apparatus:  Finnigan MAT 900S (EB-Trap-Geometry) 
  Syringes pump Model 22 
 
X-Ray structure analysis (X-RAY) 
Apparatus:  Nonius Kappa CCD diffractometer with Denzo as measurement and analysis 
program packet 
The structures were solved by using the program SHELXS97[169] and the refinements were done by 
using the program SHELXL97.[170] All measurements and structure determination present in this 
work were performed by Dr. J. Lex and Dr. J.-M. Neudörfl, Institut für Organische Chemie, 
Universität zu Köln, Greinstraße 4, D-50939 Köln, Germany. 
 
Elemental analysis (EA) 
Apparatus: Elementar Analysensysteme GmbH Vario EL 
Unless otherwise stated, the samples were recrystallized and/or dried in high vacuum (< 10-4 mbar) 
before analysis. The percentages of the elements carbon, hydrogen and nitrogen in the samples were 
determined.  
 
Melting point (mp) 
Apparatus: Büchi 535 Melting Point 
All the melting points were measured in open glass capillary and the values are uncorrected. In the 
cases where the samples were recrystallized prior to the measurements, the solvents are mentioned 
along with the melting point.  
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Specific rotation ([α]) 
Apparatus:  Perkin Elmer 343plus 
Optical rotations were measured using a 1 mL cell with a 1 dm path length. Measurements were 
carried out in different wavelengths using sample solution in chloroform at 20 °C. The sample 
concentrations are given in g/100 mL unit. 
 
Bulb-to-bulb distillation (Kugelrohr) 
Apparatus:  Oven: Built in the Feinmechaniker-Werkstatt, Controller: Werma HBC 2/10 S011, 
Motor: Büchi Rotavap-R 
 
Laboratory notebook number 
All the experiments are characterized by a number within the bracket: [SMU-xx-xx]. The roman 
number after the three-letter-code indicates the volume number of the laboratory notebook whereas 
the number after the roman number indicates the page number of the corresponding notebook 
volume. 
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8.2 Synthesis of bifunctional organocatalysts 
8.2.1 Preparation of (1R,2R)-N-phthaloyl-N′-ammonium-1,2-diamino-
cyclohexyl-p-toluene sulfonate 104[146] 
 
[SMU-III-49] 
 
NH2
NH2  
 O
O
O  
 N
NH3
O
O
CH3
SO3  
102  103  104 
     
    
102 + 103 104 
   
p-TsOH·H2O 
o-xylene, reflux, 8 h 
  
 
In a 500 mL round bottom flask equipped with a Dean-Stark apparatus and a reflux condenser, a 
solution of p-toluene sulfonic acid monohydrate (8.33 g, 43.8 mmol, 1.00 eq) in 220 mL o-xylene 
was dehydrated by azeotropic distillation for 6 hours. After cooling the resulting solution to ambient 
temperature, (1R,2R)-1,2-diaminocyclohexane 102 (5.00 g, 43.8 mmol, 1.00 eq) was added 
followed by phthalic anhydride 103 (6.48 g, 43.8 mmol, 1.00 eq). The resulting thick suspension 
was heated to reflux until a homogeneous solution resulted and the product begun to crystallize. 
The reaction mixture was cooled to room temperature and the product was collected by filtration 
with suction, washed with o-xylene/n-hexane (1:1) mixture and dried in vacuo to obtain an off-
white amorphous solid (17.7 g, 97 %). 
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104 
 
C21H24N2O5S (416.49 g/mol) 
 
 
N
NH3
O
O
1
2
3
4
5
6
1'
2'
3'
4'
CH3
SO3  Yield 
 
17.72 g (42.6 mmol, 97 %) 
(Lit.[146]: 92 %) 104 
 
 
Melting Point 
 
250 °C (Lit.[146]: 249-252 °C) 
 
TLC 
 
Rf = 0.82 (Silicagel, dichloromethane/methanol 3:1) 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.20-2.11 (m; 8H, H-3, H-4, H-5, H-6), 2.32 (s; 3H, 
CH3), 3.88 (dt, J = 3.75, 11.2 Hz; 1H, H-1), 4.15 (dt, J = 3.75, 11.4 Hz; 1H, 
H-2), 6.97 (d, J = 8.13 Hz; 2H, Har-3′), 7.24 (d, J = 8.13 Hz; 2H, Har-2′), 
7.42-7.45 (m; 2H, Har), 7.55-7.58 (m; 2H, Har). 
The NH3 protons could not be detected. 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.3 (CH3), 23.6 (CH2), 24.5 (CH2), 28.9 (CH2), 
30.0 (CH2), 50.6 (C-1), 52.4 (C-2), 122.9 (CHar), 125.9 (CHar), 128.6 
(CHar), 132.1 (Cqar), 133.2 (CHar), 139.8 (Cqar), 141.0 (Cqar), 168.5 (CO). 
The NMR data are in agreement with the literature.[146] 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3475 (w), 3056 (w), 2948 (m), 2860 (w), 1775 (w), 
1711 (s), 1606 (m), 1388 (m), 1374 (m), 1222 (s), 1193 (s), 1126 (m), 1106 
(w), 1139 (m), 1013 (m), 814 (w), 718 (m), 683 (s). 
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8.2.2 Preparation of (1S,2S)-N-phthaloyl-N′-ammonium-1,2-diamino-
cyclohexyl-p-toluene sulfonate ent-104 
 
[SMU-VI-57] 
 
NH2
NH2  
 O
O
O  
 N
NH3
O
O
CH3
SO3  
ent-102  103  ent-104 
     
    
ent-102 + 103 ent-104 
   
p-TsOH·H2O 
o-xylene, reflux, 8 h 
  
 
The same procedure as before (see section 8.2.1 on page 110) was followed on a 17.0 mmol scale. 
The product was obtained as a colorless powder (6.85 g, 97 %). 
 
ent-104 
 
C21H24N2O5S (416.49 g/mol)  
 
 
N
NH3
O
O
1
2
3
4
5
6
1'
2'
3'
4'
CH3
SO3  Yield 
 
6.85 g (16.5 mmol, 97 %)  
 ent-104 
 
 
Melting Point 
 
250 °C 
 
1H-NMR 
 
(250 MHz, CDCl3): δ = 1.19-2.08 (m; 8H, H-3, H-4, H-5, H-6), 2.31 (s; 3H, 
CH3), 3.87 (dt, J = 3.74, 11.2 Hz; 1H, H-1), 4.15 (dt, J = 3.74, 11.4 Hz; 1H, 
H-2), 6.96 (d, J = 8.17 Hz; 2H, Har-3′), 7.27 (d, J = 8.17 Hz; 2H, Har-2′), 
7.38-7.44 (m; 2H, Har), 7.50-7.55 (m; 2H, Har). 
The NH3 protons could not be detected. 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 21.3 (CH3), 23.6 (CH2), 24.4 (CH2), 28.9 (CH2), 
30.0 (CH2), 50.6 (C-1), 52.4 (C-2), 122.9 (CHar), 125.8 (CHar), 128.6 
(CHar), 132.0 (Cqar), 133.2 (CHar), 139.8 (Cqar), 141.0 (Cqar), 168.5 (CO). 
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FT-IR (ATR): ν~ [cm-1] = 3465 (w), 3041(w), 2935 (m), 2863 (w), 1772 (m), 
1708 (s), 1612 (m), 1528 (m), 1467 (w), 1387 (s), 1370 (s), 1331 (m), 1176 
(s), 1122 (s), 1033 (s), 1009 (s), 814 (m), 719 (s), 682 (s). 
 
8.2.3 Preparation of (1R,2R)-N-phthaloyl-1,2-diaminocyclohexane 
105[146] 
 
[SMU-IV-02] 
 
N
NH3
O
O
CH3
SO3  
 N
NH2
O
O
 
104  105 
   
  
104 105 
 
sat. NaHCO3, DCM 
 
RT, 12 h 
 
 
 
In a 1000 mL round bottom flask, a solution of 104 (10.5 g, 25.3 mmol) in 600 mL of DCM was 
stirred vigorously with 120 mL of saturated NaHCO3 solution for 12 hours. The organic layer was 
separated and the aqueous layer was extracted with DCM (2 × 100 mL). The combined organic 
layers were the dried over anh. MgSO4 and the solvent was removed in vacuo to obtain a colorless 
solid (5.74 g, 93 %). 
 
 
105 
 
C14H16N2O2 (244.29 g/mol) 
 
 
N
NH2
O
O
1
2
3
4
5
6
 Yield 
 
5.74 g (23.5 mmol, 93 %) 
(Lit.[146]: 83 %) 105 
 
 
Melting Point 
 
125-126 °C (Lit.[146]: 123-125 °C) 
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1H-NMR (300 MHz, CDCl3): δ = 1.09 (s; 2H, NH2), 1.11-1.44 (m; 3H, H-3, H-4, 
H-5, H-6), 1.69-1.79 (m; 3H, H-3, H-4, H-5, H-6), 1.95-2.19 (m; 2H, H-3, 
H-4, H-5, H-6), 3.34 (dt, J = 4.02, 10.9 Hz; 1H, H-2), 3.74 (dt, J = 4.02, 
11.5 Hz; 1H, H-1), 7.61-7.67 (m; 2H, Har), 7.73-7.79 (m; 2H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 25.0 (CH2), 25.5 (CH2), 29.2 (CH2), 36.6 (CH2), 
50.7 (C-2), 58.4 (C-1), 123.0 (CHar), 131.8 (Cqar), 133.7 (CHar), 168.7 
(CO). 
The NMR data are in agreement with the literature.[146] 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3554 (w), 3367 (w), 3158 (br w), 2937 (m), 2864 (w), 
1759 (m), 1701 (s), 1606 (m), 1472 (w), 1395 (s), 1370 (m), 1331 (w), 
1067 (m), 727 (s), 714 (s), 641 (s). 
 
8.2.4 Preparation of (1S,2S)-N-phthaloyl-1,2-diaminocyclohexane 
ent-105 
 
[SMU-VI-57a] 
 
N
NH3
O
O
CH3
SO3  
 N
NH2
O
O
 
ent-104  ent-105 
   
  
ent-104 ent-105 
 
sat. NaHCO3, DCM 
 
RT, 12 h 
 
 
The same procedure as before (see section 8.2.3 on page 113) was followed on a 15.7 mmol scale. 
The product was obtained as an off-white crystalline solid (3.19 g, 83 %). 
 
 
 
Experimental Part 
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ent-105 
 
C14H16N2O2 (244.29 g/mol) 
 
 
N
NH2
O
O
1
2
3
4
5
6
 Yield 
 
5.74 g (23.5 mmol, 93 %) 
 ent-105 
 
 
Melting Point 
 
125-126 °C  
 
1H-NMR 
 
(250 MHz, CDCl3): δ = 1.10 (s; 2H, NH2), 1.17-1.47 (m; 3H, H-3, H-4, H-
5, H-6), 1.70-1.80 (m; 3H, H-3, H-4, H-5, H-6), 1.97-2.22 (m; 2H, H-3, H-
4, H-5, H-6), 3.36 (dt, J = 4.03, 10.86 Hz; 1H, H-2), 3.75 (dt, J = 4.03, 
11.41 Hz; 1H, H-1), 7.63-7.69 (m; 2H, Har), 7.74-7.79 (m; 2H, Har). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 25.0 (CH2), 25.6 (CH2), 29.3 (CH2), 36.7 (CH2), 
50.8 (C-2), 58.5 (C-1), 123.1 (CHar), 131.8 (Cqar), 133.8 (CHar), 168.7 
(CO). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3546 (w), 3367 (w), 3133 (br w), 2924 (s), 2853 (s), 
1753 (s), 1611 (m), 1465 (m), 1389 (s), 1367 (s), 1328 (s), 1064 (s), 716 
(s), 639 (sh). 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
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8.2.5 Preparation of (1R,2R)-N-phthaloyl-N',N'-dimethyl-1,2-diamino-
cyclohexane 106[146] 
 
via Eschweiler-Clark methylation of 105 
 
[SMU-III-53] 
 
N
NH2
O
O
 
 
N
NMe2
O
O
 
105  106 
   
  
105 106 
 
HCHOaq, HCO2H 
 
reflux, 6 h 
 
 
In a 50 mL round bottom flask, a solution of (1R,2R)-N-phthaloyl-1,2-diaminocyclohexane 105 
(4.00 g, 16.4 mmol, 1.00 eq) in 37 % aqueous HCHO (3.00 mL, 36.1 mmol, 2.20 eq) and HCO2H 
(6.80 mL, 180 mmol, 11.0 eq) was heated to reflux for 6 hrs. The resulting mixture was then cooled 
to ambient temperature and the solvent was removed in vacuo to obtain a yellow oil. It was 
dissolved in DCM and saturated NaHCO3 solution was added to it with stirring until pH >8. The 
organic layer was separated and the aqueous layer was extracted with DCM (3 × 50 mL). The 
combined organic layer was dried over anh. MgSO4 and the solvent was removed at low pressure to 
obtain a yellowish white solid. This was further purified by recrystallization from hexane/toluene to 
afford a yellowish white crystalline solid (3.32 g, 75 %).  
 
106 
 
C16H20N2O2 (272.34 g/mol) 
 1
2
3
4
5
6
1'
2' 3'
N
NMe2
O
O
 Yield 
 
3.32 g (12.2 mmol, 75 %) 
(Lit.[146]: 86 %) 106 
 
 
Melting Point 
 
124-126 °C (Lit.[146]: 117-120 °C) 
 
TLC 
 
Rf = 0.57 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
Experimental Part 
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1H-NMR (300 MHz, CDCl3): δ = 1.06-1.38 (m; 3H, H-3, H-4, H-5), 1.73-1.91 (m; 
5H, H-3, H-4, H-5, H-6), 2.12 (s; 6H, NCH3), 3.26 (dt, J = 3.6, 11.4 Hz; 
1H, H-2), 4.07 (dt, J = 3.6, 11.6 Hz; 1H, H-1), 7.60-7.66 (m; 2H, Har), 
7.73-7.79 (m; 2H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 22.6 (C-3), 25.0 (C-4 or C-5), 25.7 (C-4 or C-5), 
30.2 (C-6), 40.2 (NCH3), 52.2 (C-1), 62.0 (C-2), 122.9 (C-2′), 132.2 (C-1′), 
133.5 (C-3′), 168.6 (CO). 
Assignments were made by 2D-NMR. The NMR data are in agreement with the 
literature.[146] 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3454 (w), 2932 (m), 2864 (w), 2830 (w), 2784 (w), 1763 
(m), 1701 (s), 1611 (m), 1471 (m), 1453 (m), 1390 (s), 1372 (m), 1332 
(w), 1273 (w), 1195 (w), 1141 (s), 1082 (s), 1067 (w), 1046 (m), 1018 (w), 
956 (w), 906 (w), 872 (m), 848 (w), 826 (w), 794 (w), 719 (s), 640 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C16H20N2O2] ([M]+): 272.1525 
                                                                 Found: 272.152 
 
8.2.6 Preparation of (1R,2R)-N-phthaloyl-N',N'-dimethyl-1,2-diamino-
cyclohexane 106[147] 
 
via reductive methylation of 105 
 
[SMU-IV-45] 
 
N
NH2
O
O
 
 
N
NMe2
O
O
 
105  106 
   
  
105 106 
 
HCHOaq, NaBH3CN, AcOH 
 
CH3CN, RT, 2 h 
 
 
Experimental Part 
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To a solution of (1R,2R)-N-phthaloyl-1,2-diaminocyclohexane 105 (2.0 g, 8.2 mmol, 1.00 eq) in 50 
mL of acetonitrile, 37 % aqueous formaldehyde (3.32 mL, 41.0 mmol, 5.00 eq) was added and the 
resulting mixture was stirred for 15 minutes at room temperature. NaBH3CN (1.03 g, 16.4 mmol, 
2.00 eq) was then added, followed 15 minutes later by acetic acid (2.40 mL, 41.0 mmol). After 
stirring 2 hours at room temperature, the reaction mixture was diluted with 2% CH3OH-CHCl3 (125 
mL), washed with 1N NaOH (3 × 100 mL). The aqueous layer was re-extracted with CHCl3 (70 
mL), the combined organic layers were dried over anh. MgSO4 and the solvent was removed in 
vacuo to obtain a yellowish white crystalline solid. This was dissolved in diethylether and the 
residue was filtered off. The filtrate was concentrated in vacuo to obtain pure (1R,2R)-N-phthaloyl-
N′,N′-dimethyl-1,2-diaminocyclohexane 106 as a pale yellow crystalline solid (2.00 g, 90 %). 
 
For analytical and spectral data of the compound 106, see section 8.2.5 on page 116. 
 
8.2.7 Preparation of (1S,2S)-N-phthaloyl-N',N'-dimethyl-1,2-diamino-
cyclohexane ent-106 
 
[SMU-VI-61] 
 
N
NH2
O
O
 
 
N
NMe2
O
O
 
ent-105  ent-106 
   
  
ent-105 ent-106 
 
HCHOaq, NaBH3CN, AcOH 
 
CH3CN, RT, 2 h 
 
 
The same procedure as before (see section 8.2.6 on page 117) was followed on a 10.2 mmol scale. 
The product was obtained as a yellowish white crystalline solid (2.55 g, 92 %). 
 
 
 
Experimental Part 
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ent-106 
 
C16H20N2O2 (272.34 g/mol) 
 1
2
3
4
5
6
1'
2' 3'
N
NMe2
O
O
 Yield 
 
2.55 g (9.36 mmol, 92 %) 
 ent-106 
 
 
Melting Point 
 
125 °C  
 
1H-NMR 
 
(250 MHz, CDCl3):δ = 1.13-1.31 (m; 3H, H-3, H-4, H-5, H-6), 1.79-1.92 
(m; 5H, H-3, H-4, H-5, H-6), 2.11 (s; 6H, NCH3), 3.27 (dt, J = 3.4, 11.3 
Hz; 1H, H-2), 4.05 (dt, J = 3.4 , 11.5 Hz; 1H, H-1), 7.63-7.66 (m; 2H, Har), 
7.75-7.78 (m; 2H, Har). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 22.7 (C-3), 25.1 (C-4 or C-5), 25.7 (C-4 or C-5), 
30.2 (C-6), 40.2 (NCH3), 52.3 (C-1), 62.1 (C-2), 122.9 (C-2′), 132.2 (C-1′), 
133.5 (C-3′), 168.7 (CO). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 2928 (m), 2860 (w), 2826 (w), 2781 (w), 1760 (m), 
1701 (s), 1611 (w), 1467 (m), 1450 (m), 1386 (s), 1368 (m), 1329 (w), 
1272 (w), 1193 (w), 1137 (m), 1078 (m), 1064 (w), 1042 (w), 1014 (w), 
953 (w), 904 (w), 870 (w), 846 (w), 823 (w), 793 (w), 716 (s), 638 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C16H20N2O2] ([M]+): 272.1525 
                                                                 Found: 272.153 
 
 
 
 
 
 
 
 
 
 
Experimental Part 
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8.2.8 Preparation of (1R,2R)-N,N-dimethyl-1,2-diaminocyclohexane 
101[146] 
 
[SMU-IV-65] 
 
N
NMe2
O
O
 
 
NH2
NMe2  
106  101 
   
  
106 101 
 
NH2-NH2·H2O, EtOH 
 
reflux, 45 min 
 
 
In a 100 mL round bottom flask equipped with a reflux condenser, a solution of 
(1R,2R)-N-phthaloyl-N′,N′-dimethyl-1,2-diaminocyclohexane 106 (2.25 g, 8.28 mmol, 1.00 eq) in 
25 mL ethanol was refluxed with hydrazine monohydrate (1.00 mL, 20.7 mmol, 2.50 eq) for 45 
minutes. The reaction mixture was then cooled to room temperature, diethyl ether was added and 
the white solid was filtered off. The filtrate was concentrated to afford a pale yellow oil (1.06 g, 
90 %). 
 
101 
 
C8H18N2 (142.24 g/mol) 
 
1
2
3
4
5
6
NH2
NMe2   
Yield 
 
 
1.06 g (7.45 mmol, 90 %) 
 [Lit.[146]: 85-95 %] 101 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 0.89-1.17 (m; 4H), 1.53-1.67 (m; 3H), 1.80-1.95 
(m; 2H), 1.99 (br s; 2H, NH2), 2.12 (s; 6H, NCH3), 2.46 (dt, J = 4.1, 10.15 
Hz; 1H). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 20.4 (CH2), 24.9 (CH2), 25.4 (CH2), 35.0 (CH2), 
40.0 (NCH3), 51.2 (C-2), 69.6 (C-1). 
The NMR data are in agreement with the literature.[147] 
 
Experimental Part 
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8.2.9 Preparation of (1S,2S)-N,N-dimethyl-1,2-diaminocyclohexane 
ent-101 
 
[SMU-VI-62] 
 
N
NMe2
O
O
 
 
NH2
NMe2  
ent-106  ent-101 
   
  
ent-106 ent-101 
 
NH2-NH2·H2O, EtOH 
 
reflux, 40 min 
 
 
The same procedure as before (see section 8.2.8 on page 120) was followed on a 3.30 mmol scale. 
The product was obtained as a pale yellow oil (450 mg, 96 %). 
 
ent-101 
 
C8H18N2 (142.24 g/mol) 
 
1
2
3
4
5
6
NH2
NMe2   
Yield 
 
 
450 mg (3.16 mmol, 96 %)  
  ent-101 
 
 
1H-NMR 
 
(250 MHz, CDCl3): δ = 0.93-1.09 (m; 2H), 1.57-1.71 (m; 5H), 1.85-2.00 
(m; 2H), 2.17 (s; 6H, NCH3), 2.50 (dt, J = 4.15, 10.0 Hz; 1H). 
The NH2 protons could not be detected. 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 20.5 (CH2), 25.0 (CH2), 25.6 (CH2), 35.2 (CH2), 
40.1 (NCH3), 51.4 (C-2), 69.8 (C-1). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 2925 (s), 2855 (m), 2823 (w), 2776 (w), 2398 (w), 1572 
(m), 1449 (s), 1377 (w), 1336 (w), 1267 (m), 1152 (w), 1097 (w), 1056 
(w), 1034 (m), 942 (w), 871 (sh), 819 (w).  
 
Experimental Part 
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8.2.10 Preparation of 1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-
(dimethylamino)cyclohexyl}thiourea 1[51] 
 
[SMU-IV-66] 
 
NH2
NMe2  
 
CF3
F3C NCS  
 
NMe2
N
H
N
H
S
CF3
F3C
101  107  1 
     
    
101 + 107 1 
   
THF (abs.) 
 
RT, 18 h 
  
 
To a solution of (1R,2R)-N,N-dimethyl-1,2-diaminocyclohexane 101 (526 mg, 3.69 mmol, 1.00 eq) 
in absolute  in 1.50 mL abs. THF, was added 3,5-bis(trifluoromethyl)phenyl isothiocyanate 107 
(670 µL, 3.69 mmol, 1.00 eq) and the resulting mixture was stirred under argon for 18 hours. The 
reaction mixture was then concentrated in vacuo to obtain an orange foam. Purification by column 
chromatography on silica gel (CHCl3/CH3OH/TEA = 100:5:1 as eluant) afforded a yellowish white 
foam (1.28 g, 84 %). 
 
1 C17H21F6N3S (413.42 g/mol) 
 
1
2
3
4
5
61'
2'
3'
4'
NMe2
N
H
N
H
S
CF3
F3C
 Yield 
 
1.28 g (3.10 mmol, 84 %) 
[Lit.[51]: 65 %] 1 
 
 
Melting Point 
 
111-113 °C 
Specific Rotation 
 
 
 
[ ]20589α = -30.9°, [ ]20546α = -39.5°, [ ]20405α = -166.2° (c = 1.035, CHCl3) 
[Lit.[51]: [ ]20589α  = -32.7° (c = 0.99, CHCl3)] 
 
TLC 
 
Rf = 0.25 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
Experimental Part 
 
 123
1H-NMR (300 MHz, CDCl3): δ = 1.07-1.36 (m; 4H, H-3, H-4, H-5, H-6), 1.69-1.91 
(m; 3H, H-4, H-5, H-6), 2.26 (s; 6H, NCH3), 2.41-2.55 (m; 2H, H-1, H-3), 
3.88 (m; 1H, H-2), 7.58 (s; 1H, H-4′), 7.83 (s; 2H, H-2′). 
The NH protons could not be detected. 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.87 (C-6), 24.52 (C-4 or C-5), 24.81 (C-4 or C-5), 
32.83 (C-3), 40.10 (NCH3), 56.56 (C-2), 67.37 (C-1), 118.27 (C-4′), 122.98 
(q, J = 271.05 Hz; CF3), 123.26 (C-2′), 132.49 (q, J = 33.15 Hz; C-3′), 
140.40 (C-1′), 178.71 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3225 (br w), 2944 (m), 2867 (w), 1544 (s), 1474 (m), 
1386 (s), 1280 (s), 1181 (s), 1132 (s), 885 (m), 683 (m). 
 
HR-EI-MS 
 
 
Exact molecular mass for [C17H21F6N3S] ([M]+): 413.1360 
                                                                   Found: 413.138 
 
Elemental Analysis 
 
 
Anal. Calcd. for C17H21F6N3S: C 49.39,  H 5.12,  N 10.16 
                                      Found: C 49.19,  H 5.15,  N 10.12 
 
8.2.11 Preparation of 1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-
(dimethylamino)cyclohexyl}urea 2[53] 
 
[SMU-IV-37] 
 
NH2
NMe2  
 
CF3
F3C NCO  
 
NMe2
N
H
N
H
O
CF3
F3C
101  108  2 
     
    
101 + 108 2 
   
THF (abs.) 
 
RT, 18 h 
  
 
Experimental Part 
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The same procedure as before (see section 8.2.10 on page 122) was followed on a 5.17 mmol scale. 
Purification in the same way afforded an off-white crystalline solid (1.79 g, 87 %). This was 
crystallized from chloroform to obtain colorless needles. 
 
2 C17H21F6N3O (397.36 g/mol) 
 
1
2
3
4
5
61'
2'
3'
4'
NMe2
N
H
N
H
O
CF3
F3C
 
 
Yield 
 
 
1.79 g (4.50 mmol, 87 %) 
[Lit.[53]: 80 %] 2 
 
 
Melting Point 
 
163-165 °C (CHCl3) (Lit.[53]: 166-167 °C) 
 
Specific Rotation 
 
 
[ ]20589α = -35.1°, [ ]20546α = -41.5°, [ ]20405α = -83.1°, [ ]20365α = -106.8° (c = 1.00, 
CHCl3) [Lit.[53]: [ ]25589α  = -35.3° (c = 0.93, CHCl3)] 
 
TLC 
 
Rf = 0.25 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ =  1.09-1.35 (m; 4H, H-3, H-4, H-5, H-6), 1.67-1.89 
(m; 3H, H-4, H-5, H-6), 2.20-2.25 (m; 1H, H-1), 2.26 (s; 6H, NCH3), 2.34-
2.38 (m; 1H, H-3), 3.47-3.55 (m; 1H, H-2),  5.76 (br s; 2H, C-2-NH), 7.36 
(s; 1H, H-4′), 7.76 (s; 2H, H-2′), 8.06 (br s; 1H, C-1′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.4 (C-6), 24.7 (C-4 or C-5), 25.0 (C-4 or C-5), 
33.8 (C-3), 40.1 (NCH3), 51.6 (C-2), 67.4 (C-1), 115.3 (C-4′), 118.5 (C-2′), 
123.2 (q, J = 271.0 Hz; CF3), 131.9 (q, J = 32.97 Hz; C-3′), 140.9 (C-1′), 
155.6 (CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3320 (br), 2941 (m), 2866 (w), 2787 (w), 1853 (s), 1604 
(s), 1574 (s), 1516 (m), 1474 (m), 1388 (s), 1342 (m), 1279 (s), 1235 (w), 
1175 (s), 1132 (s), 1067 (w), 1045 (w), 942 (w), 884 (m), 849 (w), 704 
(m), 685 (m), 664 (w). 
 
HR-EI-MS 
 
Exact molecular mass for [C17H21F6N3O] ([M]+): 397.1588 
                                                                   Found: 397.159 
Experimental Part 
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Elemental Analysis 
 
Anal. Calcd. for C17H21F6N3O: C 51.38,  H 5.33,  N 10.57 
                                      Found: C 51.29,  H 5.40,  N 10.41 
 
For the X-ray structure see Figure 5.1 on page 55 
Colourless needles from chloroform 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]: 
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:             
C17H21F6N3O 
397.37 g/mol 
100(2) K 
0.71073 Å 
orthorhombic 
P212121 
a = 8.849(1) Å     α = 90° 
b = 17.212(1) Å     β = 90° 
c = 24.025(1) Å     γ = 90°   
3659.2(5) Å3  
8 
1.443 g/cm3 
0.133 mm-1 
1648 
0.3 × 0.1 × 0.1 mm 
1.46° to 27.00°  
-11 ≤ h ≤ 8 
-21 ≤ k ≤ 20 
-29 ≤ l ≤ 30 
21188 
7809 [Rint = 0.1746] 
2669 
99.0 % 
Full-matrix least-squares on F2 
7809 / 0 / 493 
0.961 
R1 = 0.0979       ωR2 = 0.2213 
R1 = 0.2931       ωR2 = 0.2891 
0.683 and -0.336 e·Å-3  
Experimental Part 
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8.2.12 Preparation of (1R,2R)-N,N-diethyl-N′-phthaloyl-1,2-diamino-
cyclohexane 109 
 
[SMU-V-11] 
 
N
NH2
O
O
 
 
N
NEt2
O
O
 
105  109 
   
  
105 109 
 
EtI, K2CO3, CH3CN 
reflux, 24 h 
 
 
To a solution of (1R,2R)-N-phthaloyl-1,2-diaminocyclohexane 105 (1.00 g, 4.10 mmol, 1.00 eq) in 
20 mL abs. CH3CN and K2CO3 (1.30 g, 9.40 mmol, 2.30 eq) was added ethyl iodide (1.34 g, 8.60 
mmol, 2.10 eq) and the resulting mixture was heated to reflux for 24 hours. The reaction mixture 
was cooled to ambient temperature and concentrated in vacuo. The residue was dissolved in DCM 
(20 mL) and water (20 mL), the organic layer was separated and the aqueous layer (pH ~10) was 
extracted with DCM (3 × 15 mL). The combined organic extracts were dried over anh. Na2CO3 and 
the solvent was removed in vacuo to obtain an off-white crystalline solid (1.21 g, 99 %). 
 
109 C18H24N2O2 (300.4 g/mol) 
 
1'
N
N
O
O
1
2
3
4
5
6
2'1''
2''3''
 Yield 1.21 g (4.03 mmol, 99 %) 
109 
 
 
Melting Point 
 
132-133 °C 
 
TLC 
 
Rf = 0.77 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
Experimental Part 
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1H-NMR (300 MHz, CDCl3): δ = 0.73 (t, J = 7.05 Hz; 6H, H-2′), 1.11-1.39 (m; 3H, 
H-3, H-4, H-5), 1.75-1.91 (m; 4H, H-3, H-4, H-5, H-6), 2.17-2.38 (m; 3H, 
H-1′, H-6), 2.41-2.50 (m; 2H, H-1′), 3.27 (dt, J = 3.71, 11.57 Hz; 1H, H-2), 
4.10 (dt, J = 3.71, 11.24 Hz; 1H, H-1), 7.62-7.67 (m; 2H, H-3′′), 7.74-7.80 
(m; 2H, H-2′′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 14.6 (C-2′), 24.7 (C-3), 25.5 (C-4 or C-5), 25.9 (C-4 
or C-5), 29.8 (C-6), 43.0 (C-1′), 52.4 (C-1), 59.0 (C-2), 122.8 (C-2′′), 
132.2 (C-1′′), 133.5 (C-3′′), 168.8 (CO). 
 
FT-IR 
 
 
 
 
(CsI): ν~ [cm-1] = 3456 (w), 2974 (m), 2932 (m), 2870 (w), 2813 (w), 1764 
(m), 1704 (s), 1614 (w), 1468 (m), 1395 (s), 1376 (s), 1335 (w), 1298 (w), 
1255 (w), 1209 (w), 1144 (m), 1112 (m), 1087 (m), 1066 (w), 1024 (m), 
956 (w), 904 (m), 871 (w), 844 (w), 796 (m), 718 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C18H24N2O2] ([M]+): 300.1838 
                                                                 Found: 300.183 
 
8.2.13 Preparation of (1R,2R)-N,N-diethyl-1,2-diaminocyclohexane 114 
 
[SMU-V-08] 
 
N
NEt2
O
O
 
 
NH2
NEt2  
105  114 
   
  
105 114 
 
NH2-NH2·H2O, EtOH 
 
reflux, 40 min 
 
 
The same procedure as before (see section 8.2.8 on page 120) was followed on a 2.02 mmol scale. 
The product was obtained as a pale yellow oil (325 mg, 95 %). 
 
Experimental Part 
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114  
 
C10H22N2 (170.30 g/mol) 
 
1
2
3
4
5
6
NH2
N
1'
2'
  
Yield 
 
 
325 mg (1.91 mmol, 95 %)  
  114 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 0.86 (t, J = 7.13 Hz; 6H, H-2′), 0.93-1.04 (m; 3H), 
1.45-1.63 (m; 3H), 1.77-1.87 (m; 3H), 1.92-2.00 (m; 1H, H-2), 2.12-2.23 
(m; 2H, H-1′), 2.36-2.50 (m; 3H, H-1′, H-1). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 14.8 (C-2′), 22.9 (CH2), 24.9 (CH2), 25.8 (CH2), 
34.9 (CH2), 43.1 (C-1′), 51.0 (C-2), 66.1 (C-1). 
 
GC-MS 
 
τR = 7.8 min (Method: Standard) 
m/z = 170 [M]+ 
 
8.2.14 Preparation of 1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2- 
(diethylamino)cyclohexyl}urea 3 
 
[SMU-V-09] 
 
NH2
NEt2  
 
CF3
F3C NCO  
 
NEt2
N
H
N
H
O
CF3
F3C
114  108  3 
     
    
114 + 108 3 
   
THF (abs.) 
 
RT, 23 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 1.91 mmol scale. 
Purification in the same way afforded a colorless crystalline solid (580 mg, 71 %). 
 
Experimental Part 
 
 129
3 
 
C19H25F6N3O (425.41 g/mol) 
 
 
Yield 
 
580 mg (1.36 mmol, 71 %) 
 
1''
2''
1
2
3
4
5
61'
2'
3'
4' 6'
5'
N
N
H
N
H
O
CF3
F3C
 
Melting Point 
 
195-197 °C (CHCl3) 3 
 
 
Specific Rotation 
 
 
 
[ ]20589α = -58.1°, [ ]20546α = -68.7°, [ ]20405α = -134.5°, [ ]20365α = -174.0°, [ ]20334α = 
-226.1° (c = 1.01, CHCl3) 
 
TLC 
 
Rf = 0.29 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.98 (t, J = 7.13 Hz; 6H, H-2′′), 1.04-1.31 (m; 4H, 
H-3, H-4, H-5, H-6), 1.63-1.81 (m; 3H, H-4, H-5, H-6), 2.28-2.73 (m; 6H, 
H-1, H-1′′, H-3), 3.35-3.41 (m; 1H, H-2), 5.92 (br s; 1H, C-2-NH), 7.42 (s; 
1H, H-4′), 7.86 (s; 2H, H-2′, H-6′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 14.2 (C-2′′), 23.5 (C-6), 24.5 (C-4 or C-5), 25.5 (C-
4 or C-5), 33.4 (C-3), 43.2 (C-1′′), 51.9 (C-2), 63.0 (C-1), 115.5 (C-4′), 
118.6 (C-2′, C-6′), 123.2 (q, J = 271.1 Hz; CF3), 132.1 (q, J = 32.97 Hz; C-
3′, C-5′), 141.0 (C-1′), 155.8 (CO). 
The assignments were made by 2d-NMR. 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3286 (s), 3099 (m), 2974 (m), 2937 (m), 2867 (w), 1667 
(s), 1623 (w), 1581 (s), 1493 (s), 1476 (s), 1389 (s), 1338 (m), 1279 (s), 
1238 (m), 1169 (s), 1140 (s), 1073 (w), 1000 (w), 957 (m), 882 (m), 734 
(m). 
 
HR-ESI-MS 
 
Exact molecular mass for [C19H26F6N3O] ([M+H]+): 426.1975 
                                                                        Found: 426.199 
 
Elemental Analysis 
 
Anal. Calcd. for C19H25F6N3O: C 53.64,  H 5.92,  N 9.88 
                                      Found: C 53.56,  H 5.93,  N 9.85 
 
 
Experimental Part 
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8.2.15 Preparation of 2-{(1R,2R)-2-(pyrrolidin-1-yl)cyclohexyl}-iso-
indoline-1,3-dione 111 
 
[SMU-V-23] 
 
N
NH2
O
O
 
 I
I
 
 
N
N
O
O
 
105  110  111 
     
    
105 + 110 111 
   
K2CO3 
 
CH3CN, reflux, 6 h 
  
 
To a solution of (1R,2R)-N-phthaloyl-1,2-diaminocyclohexane 105 (1.00 g, 4.10 mmol, 1.00 eq) in 
20 mL abs. CH3CN and K2CO3 (1.30 g, 9.40 mmol, 2.30 eq) was added 1,4-diiodobutane 110 (1.27 
g, 4.10 mmol, 1.00 eq) and the resulting mixture was heated to reflux for 6 hours. The reaction 
mixture was cooled to ambient temperature and concentrated in vacuo. The residue was dissolved in 
DCM (20 mL) and water (20 mL), the organic layer was separated and the aqueous layer (pH ~10) 
was extracted with DCM (2 × 20 mL). The combined organic extracts were dried over anh. Na2CO3 
and the solvent was removed in vacuo to obtain a highly viscous yellow oil which solidified on 
standing at room temperature. This solid was then dried in high vacuum (10-5 mbar) at 60 °C to 
remove the unreacted 1,4-diiodobutane. The pure product was obtained as a pale yellow solid (1.21 
g, 99 %).  
 
111 
 
C18H22N2O2 (298.38 g/mol) 
 
Yield 
 
1.21 g (4.06 mmol, 99 %) 
 
 
1
2
3
4
5
6
1'
2'
1''
3''2''
N
N
O
O
 
Melting Point 93-95 °C 
111 
 
 
  
Experimental Part 
 
 131
1H-NMR (300 MHz, CDCl3): δ = 1.19-1.38 (m; 3H, H-3, H-4, H-5), 1.42-1.55 (m; 
4H, H-2′), 1.78-1.94 (m; 4H, H-3, H-4, H-5, H-6), 2.13-2.27 (m; 1H, H-6), 
2.46-2.60 (m; 4H, H-1′), 3.50-3.57 (m; 1H, H-2), 4.09 (dt, J = 3.90, 11.72 
Hz; 1H, H-1), 7.62-7.69 (m; 2H, H-3′′), 7.74-7.82 (m; 2H, H-2′′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 23.8 (C-2′), 23.9 (C-3), 25.1 (C-4 or C-5), 25.8 (C-4 
or C-5),  30.2 (C-6), 47.3 (C-1′), 53.6 (C-1), 57.7 (C-2), 122.9 (C-2′′), 
132.2 (C-1′), 133.5 (C-3′′), 168.7 (CO). 
 
FT-IR 
 
(KBr): ν~ [cm-1] = 3452 (w), 2932 (s), 2856 (m), 2802 (w), 1764 (s), 1699 
(s), 1612 (w), 1467 (m), 1389 (s), 1370 (s), 1332 (m), 1284 (w), 1116 (m), 
1077 (s), 1017 (m), 1002 (w), 957 (w), 903 (m), 870 (m), 796 (w), 718 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C18H22N2O2] ([M]+): 298.1681 
                                                                 Found: 298.168 
 
8.2.16 Preparation of (1R,2R)-2-(pyrrolidin-1-yl)cyclohexanamine 115 
 
[SMU-V-05] 
 
N
N
O
O
 
 
NH2
N
 
111  115 
   
  
111 115 
 
NH2-NH2·H2O, EtOH 
 
reflux, 30 min 
 
 
The same procedure as before (see section 8.2.8 on page 120) was followed on a 2.18 mmol scale. 
The product was obtained as a pale yellow oil (325 mg, 89 %). 
 
 
Experimental Part 
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115  
 
C10H20N2 (168.28 g/mol) 
 
NH2
N1
2
3
4
5
6
1'
2'
  
Yield 
 
 
325 mg (1.93 mmol, 89 %)  
  115 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 0.95-1.22 (m; 4H), 1.55-1.92 (m; 10H), 2.16-2.26 
(m; 1H), 2.40-2.60 (m; 5H). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.4 (CH2), 23.6 (C-2′), 24.9 (C-4 or C-5), 25.4 
(C-4 or C-5), 34.8 (CH2), 47.0 (C-1′), 52.6 (C-2), 65.1 (C-1). 
 
GC-MS 
 
τR = 9.1 min (Method: Standard) 
m/z = 168 [M]+ 
 
8.2.17 Preparation of 1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-
(pyrrolidin-1-yl)cyclohexyl}urea 4 
 
[SMU-V-06] 
 
NH2
N
 
 
CF3
F3C NCO  
 
N
N
H
N
H
O
CF3
F3C
115  108  4 
     
    
115 + 108 4 
   
THF (abs.) 
 
RT, 17 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 1.93 mmol scale. 
Purification in the same way afforded a pale yellow foam (578 mg, 71 %). 
 
Experimental Part 
 
 133
4 
 
C19H23F6N3O (423.40 g/mol) 
 
 
Yield 
 
 
578 mg (1.37 mmol, 71 %) 
 
 
1''
2''
1
2
3
4
5
61'
2'
3'
4' 6'
5'
N
N
H
N
H
O
CF3
F3C
 
Melting Point 98-100 °C 
4 
 
 
Specific Rotation 
 
[ ]20589α = -18.7°, [ ]20546α = -21.9°, [ ]20405α = -37.7° (c = 1.00, CHCl3) 
 
TLC 
 
Rf = 0.23 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.07-1.36 (m; 4H, H-3, H-4, H-5, H-6), 1.62-1.86 
(m; 7H, H-4, H-5, H-6, H-2′′), 2.25-2.29 (m; 1H, H-3), 2.44-2.48 (m; 1H, 
H-1), 2.62-2.71 (m; 4H, H-1′′), 3.50 (m; 1H, H-2), 5.87 (br s; 1H, C-2-
NH), 7.36 (s; 1H, H-4′), 7.80 (s; 2H, H-2′, H-6′), 8.56 (br s; 1H, C-1′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 23.1 (C-6), 23.6 (C-2′′), 24.3 (C-4 or C-5), 24.6 
(C-4 or C-5), 33.1 (C-3), 48.0 (C-1′′), 53.3 (C-2), 63.4 (C-1), 115.2 (C-4′), 
118.2 (C-2′, C-6′), 123.0 (q, J = 271.1 Hz; CF3), 132.0 (q, J = 32.97 Hz; C-
3′, C-5′), 141.1 (C-1′), 155.9 (CO). 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3320 (br), 3112 (w), 2940 (m), 1863 (w), 2813 (w), 1663 
(s),  1575 (s), 1508 (w), 1475 (m), 1390 (s), 1340 (w), 1278 (s), 1235 (w), 
1182 (s), 1133 (s), 1040 (w), 941 (w), 881 (m), 848 (w). 
 
HR-ESI-MS 
 
Exact molecular mass for [C19H24F6N3O] ([M+H]+): 424.1823 
                                                                        Found: 424.183 
 
Elemental Analysis 
 
Anal. Calcd. for C19H23F6N3O: C 53.90,  H 5.48,  N 9.92 
                                      Found: C 53.58,  H 5.47,  N 9.81 
 
 
 
 
Experimental Part 
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8.2.18 Preparation of 2-{(1R,2R)-2-(benzylideneamino)cyclohexyl}-
isoindoline-1,3-dione 113 
 
[SMU-V-47] 
 
N
NH2
O
O
 
 
O
H
 
 
N
N
O
O
Ph  
105  33  113 
     
    
105 + 33 113 
   
anh. MgSO4, abs. DCM 
RT, 2 h 
  
 
A solution of (1R,2R)-N-phthaloyl-1,2-diaminocyclohexane 105 (1.00 g, 4.10 mmol, 1.00 eq) in 25 
mL of abs. DCM was stirred with anh. MgSO4 (985 mg, 8.18 mmol, 2.00 eq) and benzaldehyde 33 
(420 µL, 4.09 mmol, 1.00 eq) for 2 hours at room temperature. MgSO4 was then filtered off and the 
solvent was removed in vacuo to obtain an off-white crystalline solid (1.32 g, 97 %). 
 
113 
 
C21H20N2O2 (332.40 g/mol) 
 
 
Yield 
 
 
 
1.32 g (3.97 mmol, 97 %) 
 
 
 
1
2
3
4
5
6
1'
2' 3'
N
N
O
O
 
Melting Point 135-136 °C 
113 
 
 
1H-NMR (300 MHz, CDCl3): δ = 1.47-1.61 (m; 2H, H-4, H-5), 1.71-1.92 (m; 5H, 2 
× H-3, H-4, H-5, H-6), 2.22-2.36 (m; 1H, H-6), 4.08 (dt, J = 4.41, 9.68 Hz; 
1H, H-2), 4.45 (dt, J = 3.81, 9.68 Hz; 1H, H-1), 7.24-7.34 (m; 3H, Har), 
7.49-7.63 (m; 4H, H-3′, Har), 7.70-7.80 (m; 2H, H-2′), 8.21 (s; 1H, N=CH). 
Experimental Part 
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13C-NMR (75 MHz, CDCl3): δ = 24.1 (C-4 or C-5), 25.5 (C-4 or C-5), 28.7 (C-6), 
34.1 (C-3), 55.6 (C-1), 69.3 (C-2), 122.9 (C-2′), 128.0 (Car), 128.3 (Car), 
130.4 (Car), 131.7 (C-1′), 133.6 (C-3′), 136.1 (Cqar), 160.7 (N=C), 168.4 
(CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(KBr): ν~ [cm-1] = 3459 (w), 3063 (w), 3029 (w), 2943 (m), 2920 (s), 2851 
(s), 1768 (s), 1703 (s), 1649 (s), 1582 (w), 1450 (m), 1392 (s), 1371 (s), 
1330 (w), 1250 (w), 1170 (m), 1155 (m), 1098 (s), 1075 (m), 1045 (m), 
1016 (m), 967 (w), 944 (w), 909 (m), 870 (m), 858 (w), 836 (m), 788 (m), 
752 (s), 716 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C21H20N2O2] ([M]+): 332.1525 
                                                                 Found: 332.152 
 
8.2.19 Preparation of 2-{(1R,2R)-2-(N-benzyl-N-methylamino)cyclohexyl} 
isoindoline-1,3-dione 112 
 
[SMU-V-55] 
 
N
N
O
O
Ph  
 
N
N
O
O
Me
Ph  
113  112 
   
  
113 112 
 
HCHOaq, NaBH3CN, AcOH 
 
CH3CN, RT, 2 h 
 
 
To a solution of 2-{(1R,2R)-2-(benzylideneamino)cyclohexyl}isoindoline-1,3-dione 113 (500 mg, 
1.50 mmol, 1.00 eq) in 25 mL of acetonitrile, NaBH3CN (189 mg, 3.00 mmol, 2.00 eq) was added 
and the resulting mixture was stirred for 15 minutes at room temperature. 37 % Aqueous 
formaldehyde (250 µL, 3.00 mmol, 2.00 eq) was then added, followed 15 minutes later by AcOH 
Experimental Part 
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(350 µL, 6.00 mmol, 4.00 eq). After stirring the mixture for 2 hours at room temperature, the 
reaction mixture was diluted with 2% CH3OH-CHCl3 (25 mL), washed with 1N NaOH (3 × 50 
mL). The aqueous layer was re-extracted with CHCl3 (3 × 50 mL). The combined organic layers 
were dried over anh. MgSO4 and the solvent was removed in vacuo to obtain a yellowish white 
semisolid. This was taken in diethylether and the residue was filtered off. The filtrate was 
concentrated in vacuo to obtain a highly viscous yellow oil (512 mg, 98 %). 
 
112 
 
 
C22H24N2O2 (348.44 g/mol) 
 
 
 
N
N
O
O
Me
1
2
3
4
5
6
1'
2' 3'
1''
2''
3''
4''
 
 
Yield 
 
 
 
 
512 mg (1.47 mmol, 98 %) 
 
 
 112 
 
 
1H-NMR (300 MHz, CDCl3): δ = 1.25-1.44 (m; 3H, H-3, H-4, H-5), 1.78-1.89 (m; 
3H, H-4, H-5, H-6), 1.98-2.02 (m; 1H, H-3), 2.04 (s; 3H, NCH3), 2.20-
2.33 (m; 1H, H-6), 3.38-3.47 (m; 1H, H-2), 3.42 (d, J = 13.3 Hz; 1H, 
NCH2), 3.57 (d, J = 13.3 Hz; 1H, NCH2), 4.20 (dt, J = 3.85, 11.6 Hz; 1H, 
H-1), 6.87-7.07 (m; 5H, H-2′′, H-3′′, H-4′′), 7.65-7.71 (m; 2H, H-3′), 
7.77-7.82 (m; 2H, H-2′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 24.1 (C-3), 25.2 (C-4 or C-5), 25.7 (C-4 or C-5), 
30.0 (C-6), 36.0 (NCH3), 52.2 (C-1), 58.3 (NCH2), 62.2 (C-2), 122.9 (C-
2′), 126.3 (C-4′′), 127.7 (C-2′′ or C-3′′), 128.1 (C-2′′ or C-3′′), 132.1 (C-
1′), 133.5 (C-3′), 140.0 (C-1′′), 168.6 (CO). 
The assignments were made by 2D-NMR. 
 
HR-EI-MS 
 
Exact molecular mass for [C22H24N2O2] ([M]+): 348.1838 
                                                                 Found: 348.184 
 
 
 
Experimental Part 
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8.2.20 Preparation of (1R,2R)-N-benzyl-N-methylcyclohexane-1,2-
diamine 116 
 
[SMU-V-56] 
 
N
N
O
O
Me
Ph  
 
NH2
N
Me
Ph  
112  116 
   
  
112 116 
 
NH2-NH2.H2O, EtOH 
reflux, 30 mins 
 
 
The same procedure as before (see section 8.2.8 on page 120) was followed on a 2.50 mmol scale. 
The product was obtained as a yellow oil (530 mg, 97 %). 
 
116  
 
C14H22N2 (218.34 g/mol) 
 
1
2
3
4
5
6
1'
2'
NH2
N
Me
3'
4'  
 
Yield 
 
 
530 mg (2.43 mmol, 97 %)  
  116 
 
 
TLC 
 
Rf = 0.47 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 0.95-1.08 (m; 3H), 1.57-1.92 (m; 7H), 2.07 (s; 3H, 
CH3), 2.10-2.15 (m; 1H, H-2), 2.60 (dt, J = 4.1, 10.13 Hz; 1H, H-1), 3.38 
(d, J = 13.1 Hz; 1H, NCH2), 3.60 (d, J = 13.1 Hz; 1H, NCH2), 7.12-7.26 
(m; 5H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.9 (CH2), 24.9 (C-4 or C-5), 25.6 (C-4 or C-5), 
34.9 (CH2), 36.2 (CH3), 51.2 (C-2), 57.9 (NCH2), 69.3 (C-1), 126.6 (C-4′), 
128.0 (C-2′ or C-3′), 128.4 (C-2′ or C-3′), 140.1 (C-1′). 
  
Experimental Part 
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GC-MS τR = 12.5 min (Method: Standard) 
m/z = 218 [M]+ 
 
8.2.21 Preparation of 1-{3,5-bis(trifluoromethyl)phenyl}-3-{(1R,2R)-2-(N-
benzyl-N-methylamino)cyclohexyl}urea 5 
 
[SMU-V-57] 
 
NH2
N
Me
Ph  
 
CF3
F3C NCO  
 
N
N
H
N
H
O
CF3
F3C
Me
Ph
116  108  5 
     
    
116 + 108 5 
   
THF (abs.) 
 
RT, 16 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 1.93 mmol scale. 
Purification in the same way afforded an off-white foam (980 mg, 87 %). 
 
5 
 
C23H25F6N3O (473.45 g/mol) 
 
 
1
2
3
4
5
6
1'
2'
3'
4'
1''
2''
3''
4''
5''
6''
N
N
H
N
H
O
CF3
F3C
Me
 
 
Yield 
 
 
980 mg (2.07 mmol, 87 %) 
 
Melting Point 63-65 °C 
5 
 
 
 
TLC 
 
Rf = 0.42 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.99-1.25 (m; 4H, H-3, H-4, H-5, H-6), 1.57-1.89 
(m; 3H, H-4, H-5, H-6), 2.09 (s; 3H, NCH3), 2.26-2.37 (m; 2H, H-1, H-3), 
3.34 (d, J = 13.1 Hz; 1H, NCH2), 3.40-3.47 (m; 1H, H-2), 3.61 (d, J = 13.1 
Hz; 1H, NCH2), 5.71 (br s; 1H, C-2-NH), 7.15 (s; 5H, H-2′, H-3′, H-4′), 7.38 
Experimental Part 
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(s; 1H, H-4′′), 7.68 (s; 2H, H-2′′, H-6′′), 8.18 (br s; 1H, C-1′′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 22.7 (C-6), 24.5 (C-4 or C-5), 25.2 (C-4 or C-5), 33.4 
(C-3), 36.3 (NCH3), 52.0 (C-2), 57.9 (NCH2), 66.4 (C-1), 115.5 (C-4′′), 
118.8 (C-2′′, C-6′′), 123.2 (q, J = 271.4 Hz; CF3), 127.1 (C-4′), 128.3 (C-2′ 
or C-3′), 128.7 (C-2′ or C-3′), 132.1 (q, J = 32.97 Hz; C-3′′, C-5′′), 139.0 (C-
1′), 140.9 (C-1′′), 156.0 (CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(KBr): ν~ [cm-1] = 3346 (br s), 3091 (w), 2939 (s), 2861 (m), 2800 (w), 1659 
(s), 1624 (m), 1571 (s), 1497 (m), 1474 (s), 1454 (m), 1388 (s), 1278 (s), 
1235 (m), 1182 (s), 1132 (s), 1063 (w), 1042 (w), 1026 (m), 958 (w), 940 
(m), 882 (s), 849 (m), 734 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C23H25F6N3O] ([M]+): 473.1902 
                                                                   Found: 473.190 
 
For the X-ray structure see Figure 5.2 on page 58 
Colourless needles from ethanol 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
C23H25N3OF6·CH3CH2OH 
519.53 g/mol 
293(2) K 
0.71073 Å 
triclinic 
P1 
a = 8.486(1) Å     α = 65.73(1)° 
b = 12.777(1) Å   β = 88.64(1)° 
c = 13.460(1) Å     γ = 87.43(1)° 
1329.1(2) Å3 
2 
1.298 g/cm3 
0.111 mm-1 
544 
0.48 × 0.35 × 0.32 mm 
2.40° to 25.00°  
Experimental Part 
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 Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]: 
Completeness to Θ (= 27°): 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole: 
-8 ≤ h ≤ 10 
-15 ≤ k ≤ 13 
-15 ≤ l ≤ 16 
6127 
6127 
3963 
99.0 % 
Full-matrix least-squares on F2 
6127 / 3 / 681 
1.341 
R1 = 0.0981       ωR2 = 0.2160 
R1 = 0.1455       ωR2 = 0.2359 
0.810 and -0.460 e·Å-3  
 
8.2.22 Preparation of 1-(3,5-dinitrophenyl)-3-{(1R,2R)-2-(dimethylamino)-
cyclohexyl}urea 6 
 
[SMU-IV-79] 
 
NH2
NMe2  
 
NO2
O2N NCO  
 
NMe2
N
H
N
H
O
NO2
O2N
101  117  6 
     
    
101 + 117 6 
   
THF (abs.) 
 
RT, 19 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 2.07 mmol scale. 
Purification in the same way afforded a yellow foam (584 mg, 80 %).  
 
Experimental Part 
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6 C15H21N5O5 (351.36 g/mol) 
 
1
2
3
4
5
61'
2'
3'
4'
NMe2
N
H
N
H
O
NO2
O2N
 
 
Yield 
 
 
584 mg (1.66 mmol, 80 %) 
 6 
 
 
Melting Point 
 
97-99 °C 
 
Specific Rotation 
 
[ ]20589α = -40.3°, [ ]20546α = -48.4° (c = 1.00, CHCl3) 
 
TLC 
 
Rf = 0.18 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.13-1.28 (m; 4H, H-3, H-4, H-5, H-6), 1.66-1.89 
(m; 3H, H-4, H-5, H-6), 2.28 (s; 6H, NCH3), 2.31-2.35 (m; 2H, H-1, H-3), 
3.47-3.50 (m; 1H, H-2), 5.87 (br s; 1H, C-2-NH), 8.44-8.46 (m; 1H, H-4′), 
8.53-8.54 (m; 2H, H-2′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.6 (C-6), 24.6 (C-4 or C-5), 24.9 (C-4 or C-5), 
33.6 (C-3), 40.1 (NCH3), 51.9 (C-2), 67.2 (C-1), 110.9 (C-4′), 117.8 (C-2′), 
142.5 (C-1′), 148.6 (C-3′), 155.4 (CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3330 (br), 3113 (w), 2940 (m), 2865 (w), 1780 (w), 1677 
(s), 1601 (s), 1547 (s), 1475 (m), 1346 (s), 1261 (m), 1225 (m), 1068 (m), 
1044 (w), 894 (m), 829 (w), 731 (s). 
 
HR-ESI-MS 
 
Exact molecular mass for [C15H22N5O5] ([M+H]+): 352.1615 
                                                                      Found: 352.162 
 
Elemental Analysis 
 
Anal. Calcd. for C15H21N5O5: C 51.28,  H 6.02,  N 19.93 
                                    Found: C 51.20,  H 6.32,  N 19.55 
 
For the X-ray structure see Figure 5.3 on page 59 
Colourless needles from CH3OH/H2O mixture 
 
Crystallographic 
Data  
Empirical formula: 
Formula weight (M): 
C15H21N5O5·H2O 
369.38 g/mol 
Experimental Part 
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 Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]: 
Completeness to Θ (= 27°): 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole: 
100(2) K 
0.71073 Å 
monoclinic 
P21 
a = 8.138(1) Å     α = 90.00° 
b = 22.998(2) Å   β = 107.357(8)° 
c = 15.575(1) Å     γ = 90.00° 
1800.0(6) Å3 
4 
1.363 g/cm3 
0.107 mm-1 
784 
0.2 × 0.3 × 0.3 mm 
1.77° to 27.00°  
-10 ≤ h ≤ 10 
-27 ≤ k ≤ 26 
-12 ≤ l ≤ 12 
5944 
5944 
3042 
92.4 % 
Full-matrix least-squares on F2 
5944 / 1 / 631 
1.019 
R1 = 0.0737       ωR2 = 0.1592 
R1 = 0.1639       ωR2 = 0.1980 
0.376 and -0.345 e·Å-3  
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8.2.23 Preparation of 1-{(1R,2R)-2-(dimethylamino)cyclohexyl}-3-mesityl 
urea 7 
 
[SMU-IV-70] 
 
NH2
NMe2  
 NCO
Me
Me
Me
 
 
NMe2
N
H
N
H
O
Me Me
Me
101  118  7 
     
    
101 + 118 7 
   
THF (abs.) 
 
RT, 19 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 2.62 mmol scale. 
Purification in the same way afforded a white crystalline solid (513 mg, 65 %).  
 
7 C18H29N3O (303.44 g/mol) 
 
1
2
3
4
5
61'
2'
3'
4'
NMe2
N
H
N
H
O
Me
MeMe
  
Yield 
 
513 mg (1.70 mmol, 65 %) 7 
 
 
Melting Point 
 
168-169 °C (EtOH) 
 
Specific Rotation 
 
 
 
[ ]20589α = -43.1°, [ ]20546α = -50.9°, [ ]20405α = -103.9°, [ ]20365α = -136.1° (c = 1.02, 
CHCl3) 
 
TLC 
 
Rf = 0.31 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.89-1.32 (m; 4H, H-3, H-4, H-5, H-6), 1.55-1.74 
(m; 3H, H-4, H-5, H-6), 1.99-2.02 (m; 1H, H-1), 2.08 (s; 6H, NCH3), 2.22 
(s; 6H, 2′-CH3), 2.25 (s; 3H, 4′-CH3), 2.30-2.38 (m; 1H, H-3), 3.33-3.43 
(m; 1H, H-2), 4.97 (br s; 1H, C-2-NH), 5.91 (br s; 1H, C-1′-NH), 6.87 (s; 
2H, H-3′). 
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13C-NMR (75 MHz, CDCl3): δ = 18.0 (2′-CH3), 20.9 (4′-CH3), 21.6 (C-6), 24.7 (C-4 
or C-5), 25.3 (C-4 or C-5), 33.8 (C-3), 39.8 (NCH3), 51.5 (C-2), 66.5 (C-
1), 129.0 (C-3′), 131.8 (C-4′), 137.0 (C-2′), 157.6 (CO). 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3343 (m), 2937 (m), 2859 (w), 1638 (s), 1559 (s), 1458 
(w), 1316 (w), 1264 (w), 1051 (w), 846 (m), 707 (w). 
 
HR-ESI-MS 
 
Exact molecular mass for [C18H29N3NaO] ([M+Na]+): 326.2208 
                                                                           Found: 326.221 
 
Elemental Analysis 
 
Anal. Calcd. for C18H29N3O: C 71.25,  H 9.63,  N 13.85 
                                   Found: C 70.87,  H 9.60, N  13.75 
 
For the X-ray structure see Figure 5.4 on page 60 
Long colourless flakes from ethanol 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
C18H29N3O 
303.44 g/mol 
100(2) K 
0.71073 Å 
orthorhombic 
P212121 
a = 11.817(1) Å     α = 90° 
b = 16.662(1) Å     β = 90° 
c = 18.201(1) Å      γ = 90° 
3583.7(4) Å3 
8 
1.125 g/cm3 
0.071 mm-1 
1328 
0.3 × 0.2 × 0.1 mm 
1.66° to 27.00°  
-13 ≤ h ≤ 15 
-17 ≤ k ≤ 21 
-23 ≤ l ≤ 16 
18006 
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 Unique reflections: 
Reflections observed [I>2σ (I)]: 
Completeness to Θ (= 27°): 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole: 
7785 [Rint = 0.0785] 
4125 
99.8 % 
Full-matrix least-squares on F2 
7785 / 0 / 631 
0.941 
R1 = 0.0548       ωR2 = 0.0709 
R1 = 0.1504       ωR2 = 0.0885 
0.222 and -0.193 e·Å-3  
 
 
8.2.24 Preparation of 1-{(1R,2R)-2-(dimethylamino)cyclohexyl}-3-
(pyridine-3-yl)thiourea 8 
 
[SMU-VII-68] 
 
NH2
NMe2  
 N
NCS  
 
NMe2
N
H
N
H
S
N
 
101  119  8 
     
    
101 + 119 8 
   
THF (abs.) 
 
RT, 15 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 2.11 mmol scale. 
Purification by column chromatography on silica gel using DCM/MeOH/TEA (100:5:1 to 100:10:2) 
as the eluant afforded a yellow foam (415 mg, 71 %). 
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8 C14H22N4S (278.42 g/mol) 
 
NMe2
N
H
N
H
S
N
1
2
3
4
5
61'
2'
3'
4'
5'
6'
  
Yield 
 
415 mg (1.49 mmol, 71 %) 8 
 
 
TLC 
 
Rf = 0.20 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.14-1.27 (m; 5H), 1.65-1.92 (m; 3H), 2.31 (m; 1H), 
2.45 (s; 6H, NCH3), 2.86-2.92 (m; 1H), 4.26 (br s; 1H, C-2-NH), 6.14 (br s; 
1H, C-1′-NH), 7.13-7.17(m; 1H, Har), 7.94-7.96 (m; 1H, Har), 8.23-8.24 (m; 
1H, Har), 8.53 (s; 1H, H-2′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 22.6 (C-6), 24.2 (C-4 or C-5), 24.3 (C-4 or C-5), 32.4 
(C-3), 39.9 (NCH3), 54.5 (C-2), 67.0 (C-1), 123.0 (Car), 131.0 (Car), 136.0 
(Cqar), 144.7 (Car), 145.3 (Car), 181.5 (CS). 
Assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3234 (br), 3027 (br), 2931 (s), 2857 (sh), 2783 (w), 1538 
(s), 1481 (m), 1425 (m), 1316 (s), 1229 (m), 1185 (w), 1160 (sh), 1096 (m), 
1062 (w), 1043 (w), 1025 (w), 991 (sh), 954 (w), 938 (w), 910 (w), 883 (m), 
851 (w), 804 (s), 725 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C14H23N4S] ([M+H]+): 279.1643 
                                                                    Found: 279.165 
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8.2.25 Preparation of 1-{(1R,2R)-2-dimethylamino-cyclohexyl}-3-cyclo-
hexyl-thiourea 9 
 
[SMU-VI-14] 
 
NH2
NMe2  
 
NCS  
 N
H NMe2
N
H
S
 
101  120  9 
     
    
101 + 120 9 
   
THF (abs.) 
 
RT, 19 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 2.74 mmol scale. 
Purification by column chromatography on silica gel using DCM/MeOH/TEA 100:5:1 as the eluant 
afforded a colorless foam (600 mg, 77 %). 
 
9 C15H29N3S (283.48 g/mol) 
 
N
H NMe2
N
H
S
12
3
4
5
61'
2'
3'
4'
5'
6'
  
Yield 
 
600 mg (2.12 mmol, 77 %) 9 
 
 
Melting Point 
 
59-60 °C 
 
Specific Rotation 
 
 
 
[ ]20589α = +23.4°, [ ]20546α = +27.9°, [ ]20405α = +45.0°, [ ]20365α = +29.3° (c = 1.01, 
CHCl3) 
 
TLC 
 
Rf = 0.35 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.01-1.41, 1.54-1.83, 1.91-2.01 (3m; 17H, H-3, 
2×H-4, 2×H-5, 2×H-6, 2×H-2′, 2×H-3′, 2×H-4′, 2×H-5′, 2×H-6′), 2.21 (s; 
6H, NCH3), 2.28-2.43 (m; 2H, H-1, H-3), 3.50-3.55 (m; 1H, H-2), 3.73 
Experimental Part 
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(br m; 1H, H-1′), 6.28 (s; 1H, C-2-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 22.1 (C-6), 24.4, 24.7, 24.8, 24.9, 25.4 (C-4, C-5, C-
3′, C-4′, C-5′), 32.8, 32.9, 33.1 (C-3, C-2′, C-6′), 40.2 (NCH3), 52.8 (C-1′), 
56.1 (C-2), 67.3 (C-1), 181.1 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3259 (br), 3050 (w), 2926 (s), 2852 (s), 2783 (m), 1539 
(s), 1473 (w), 1448 (m), 1360 (m), 1321 (m), 1271 (w), 1254 (m), 1239 (w), 
1207 (w), 1187 (w), 1152 (w), 1081 (w), 1061 (w), 1040 (w), 978 (w), 946 
(w), 889 (w), 872 (w), 847 (w), 734 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C15H29N3S] ([M]+): 283.2082 
                                                               Found: 283.209 
 
Elemental 
Analysis 
 
Anal. Calcd. for C15H29N3S: C 63.55,  H 10.31,  N 14.82 
                                  Found: C 63.26,  H 10.22,  N 14.75 
 
8.2.26 Preparation of 1-{(1S,2S)-2-dimethylamino-cyclohexyl}-3-cyclo-
hexyl-thiourea ent-9 
 
[SMU-VI-63] 
 
NH2
NMe2  
 
NCS  
 N
H NMe2
N
H
S
 
ent-101  120  ent-9 
     
    
ent-101 + 120 ent-9 
   
THF (abs.) 
 
RT, 19 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 2.67 mmol scale. 
Purification by column chromatography on silica gel using DCM/MeOH/TEA 100:5:1 as the eluant 
afforded a colorless foam (585 mg, 77 %).  
Experimental Part 
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ent-9 C15H29N3S (283.48 g/mol) 
 
N
H NMe2
N
H
S
12
3
4
5
61'
2'
3'
4'
5'
6'
  
Yield 
 
585 mg (2.06 mmol, 77 %) ent-9 
 
 
Melting Point 
 
59-60 °C 
 
Specific Rotation 
 
 
 
[ ]20589α = -23.1°, [ ]20546α = -27.4°, [ ]20405α = -44.4°, [ ]20365α = -29.3° (c = 1.01, 
CHCl3) 
 
TLC 
 
Rf = 0.36 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.06-1.34 (m; 9H), 1.52-1.98 (m; 8H) [H-3, 2×H-4, 
2×H-5, 2×H-6, 2×H-2′, 2×H-3′, 2×H-4′, 2×H-5′, 2×H-6′], 2.18 (s; 6H, 
NCH3), 2.27-2.40 (m; 2H, H-1, H-3), 3.52 (m; 1H, H-2), 3.72 (m; 1H, H-1′), 
6.33 (br s; 1H, C-2-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 22.1 (C-6), 24.4, 24.6, 24.8, 24.8, 25.4 (C-4, C-5, C-
3′, C-4′, C-5′), 32.8, 32.9, 33.0 (C-3, C-2′, C-6′), 40.2 (NCH3), 52.7 (C-1′), 
56.0 (C-2), 67.2 (C-1), 181.0 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3260 (br), 3049 (w), 2926 (s), 2852 (s), 2785 (m), 1538 
(s), 1473 (w), 1448 (m), 1360 (m), 1321 (m), 1271 (w), 1254 (m), 1238 (w), 
1207 (w), 1186 (w), 1151 (w), 1081 (w), 1060 (w), 1040 (w), 978 (w), 946 
(w), 915 (w), 889 (w), 873 (w), 847 (w), 773 (w), 734 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C15H29N3S] ([M]+): 283.2082 
                                                               Found: 283.208 
 
Elemental 
Analysis 
 
Anal. Calcd. for C15H29N3S: C 63.55,  H 10.31,  N 14.82 
                                  Found: C 63.32,  H 10.34,  N 14.62  
 
Experimental Part 
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8.2.27 Preparation of 1-adamantan-1-yl-3-{(1R,2R)-2-dimethylamino-
cyclohexyl}-thiourea 10 
 
[SMU-VII-65] 
 
NH2
NMe2  
 NCS
 
 N
H
S
N
H NMe2  
101  121  10 
     
    
101 + 121 10 
   
THF (abs.) 
 
RT, 24 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 2.11 mmol scale. 
Purification by column chromatography on silica gel using DCM/MeOH/TEA 100:5:1 as the eluant 
afforded a colorless foam (550 mg, 78 %). 
 
10 C19H33N3S (335.55 g/mol) 
 
N
H
S
N
H NMe2
12
3
4
5
61'
2'
3'
4'
5'6'
7' 8'
9'
10'
 
 
Yield 
 
550 mg (1.64 mmol, 78 %) 10 
 
 
Melting Point 
 
78-79 °C 
 
Specific Rotation 
 
 
 
[ ]20589α = -69.0°, [ ]20546α = -81.8°, [ ]20405α = -158.6°, [ ]20365α = -194.8° (c = 1.00, 
CHCl3) 
 
TLC 
 
Rf = 0.28 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 0.93-1.35 (m; 4H), 1.55-1.66 (m; 7H), 1.80-1.82 (m; 
2H), 1.94 (s; 6H), 2.05 (s; 3H), 2.17 (s; 6H, NCH3), 2.31-2.38 (m; 1H, H-1), 
2.93-2.97 (m; 1H), 3.45-3.55 (m; 1H, H-2), 6.09 (br s; 1H, C-1′-NH), 6.61 
Experimental Part 
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(br s; 1H, C-2-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.4 (CH2), 24.3 (CH2), 25.3 (CH2), 29.3 (CH), 32.6 
(CH2), 36.0 (CH2), 39.6 (NCH3), 41.8 (CH2), 53.4 (Cq), 56.8 (C-2), 67.2 
(C-1), 180.8 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3273 (br), 2904 (s), 2849 (sh), 2784 (m), 1521(s), 1473 
(w), 1450 (m), 1399 (w), 1370 (w), 1356 (sh), 1340 (w), 1306 (m), 1294 
(m), 1250 (w), 1228 (w), 1203 (m), 1186 (w), 1149 (w), 1114 (w), 1088 (m), 
1060 (m), 1039 (m), 979 (w), 957 (w), 914 (m), 872 (w), 836 (sh), 730 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C19H34N3S] ([M+H]+): 336.2473 
                                                                    Found: 336.247 
 
Elemental 
Analysis 
 
Anal. Calcd. for C19H33N3S: C 68.01,  H 9.91,  N 12.52 
                                  Found: C 67.65,  H 9.78,  N 12.58 
 
8.2.28 Preparation of 1,6-di-{3-(1R,2R)-2-dimethylamino-cyclohexyl}-
ureado hexane 11 
 
[SMU-VII-75] 
 
NH2
NMe2  
 NCO
OCN
3
 
 N
H NMe2
N
H
OH
N
H
N
O
Me2N
3
101  122  11 
     
    
101 + 122 11 
   
THF (abs.) 
RT, 16 h 
  
 
To a solution of (1R,2R)-N,N-dimethyl-1,2-diaminocyclohexane 101 (300 mg, 2.11 mmol, 2.27 eq) 
in absolute  in 2 mL abs. THF, was added 1,6-diisocyanatohexane 122 (150 µL, 930 µmol, 1.00 eq) 
and the resulting mixture was stirred under argon for 16 hours at room temperature. The solvent 
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was removed in vacuo to yield an off-white foam. This was taken in DCM (10 mL) and washed 
with water (3 × 10 mL). The DCM layer was dried over anh. Na2CO3 and the filtrate was 
concentrated in vacuo to obtain a colorless foam (330 mg, 79 %). 
 
11 
 
 
C24H48N6O2 
(452.68 g/mol) 
 
 
N
H
NMe2
N
H
OH
N
H
N
O
Me2N
12
3
4
5
6
1'
2'
3'
 
Yield 
 
330 mg (730 µmol, 79 %) 11 
 
Melting Point 
 
56-58 °C 
 
1H-NMR (300 MHz, CDCl3): δ = 0.92-1.78 (m; 24H), 2.15 (s; 12H, NCH3), 2.26-2.30 
(m; 2H), 3.02-3.08 (m; 4H), 3.27-3.37 (m; 2H), 4.96-4.98 (m; 2H), 5.35-5.36 
(m; 2H). 
 
13C-NMR (75 MHz, CDCl3): δ = 21.4 (C-6), 24.6 (C-4 or C-5), 25.2 (C-4 or C-5), 26.3 
(C-3′), 29.8 (C-2′), 34.0 (C-3), 39.9 (NCH3), 40.1 (C-1′), 51.3 (C-2), 66.7 
(C-1), 159.1 (CO). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3315 (br), 2926 (s), 2854 (sh), 2774 (m), 1632 (s), 1562 
(s), 1453 (w), 1314 (w), 1262 (m), 1238 (m), 1188 (w), 1084 (w), 1043 (m), 
871 (sh), 848 (w), 729 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C24H49N6O2] ([M+H]+): 453.3917 
                                                                      Found: 453.391 
 
 
 
 
 
 
 
 
Experimental Part 
 
 153
8.2.29 Preparation of 1-{(1R,2R)-2-(dimethylamino)cyclohexyl}-3-{(R)-1-
phenylethyl}urea 12 
 
[SMU-V-37] 
 
NH2
NMe2  
 NCO
CH3
 
 N
H NMe2
N
H
OCH3
 
101  123  12 
     
    
101 + 123 12 
   
THF (abs.) 
 
RT, 19 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 2.21 mmol scale. 
Purification in the same way afforded a colorless crystalline solid (445 mg, 70 %). 
 
12 C17H27N3O (289.42 g/mol) 
 
Yield 
 
445 mg (1.54 mmol, 70 %) 
 
N
H NMe2
N
H
OCH3
2'
1
2
3
4
5
6
1'
2''
3''
4''
1''
  
Melting Point 
 
137 °C (CHCl3) 12 
 
 
Specific Rotation 
 
 
[ ]20589α = -33.3°, [ ]20546α = -38.6°, [ ]20405α = -66.5°, [ ]20365α = -77.0°, [ ]20334α = -82.1° 
(c = 1.015, CHCl3) 
 
TLC 
 
Rf = 0.31 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.88-1.30 (m; 4H, H-3, H-4, H-5, H-6), 1.37 (d, J = 
6.82 Hz; 3H, H-2′), 1.54-1.71 (m; 3H, H-4, H-5, H-6), 1.91 (s; 6H, NCH3), 
2.03-2.11 (m; 1H, H-1), 2.37-2.43 (m; 1H, H-3), 3.11-3.19 (m; 1H, H-2), 4.64 
(dq, J = 6.53, 6.82 Hz; 1H, H-1′), 5.11 (d, J = 6.53 Hz; 1H, C-1′-NH), 5.35 
(br s; 1H, C-2-NH), 7.16-7.25 (m; 1H, H-4′′), 7.28 (d, J = 4.41 Hz; 4H, H-2′′, 
H-3′′). 
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13C-NMR 
 
(75 MHz, CDCl3): δ = 21.1 (C-6), 23.8 (C-2′), 24.5 (C-4 or C-5), 25.2 (C-4 or 
C-5), 33.5 (C-3), 39.4 (NCH3), 50.5 (C-1′), 51.7 (C-2), 66.5 (C-1), 125.8 (C-
2′′ or C-3′′), 127.0 (C-4′′), 128.5 (C-2′′ or C-3′′), 144.6 (C-1′′), 158.8 (CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(KBr): ν~ [cm-1] = 3359 (s), 3298 (s), 3060 (w), 2970 (m), 2933 (s), 2858 (s), 
2820 (m), 2778 (m), 1670 (w), 1622 (s), 1570 (s), 1449 (m), 1375 (w), 1321 
(w), 1262 (m), 1239 (m), 1190 (w), 1095 (m), 1027 (w), 872 (m), 764 (m). 
 
HR-ESI-MS 
 
Exact molecular mass for [C17H28N3O] ([M+H]+): 290.2227 
                                                                     Found: 290.223 
 
Elemental 
Analysis 
 
Anal. Calcd. for C17H27N3O: C 70.55,  H 9.40,  N 14.52 
                                   Found: C 70.05,  H 9.22,  N 14.45 
 
For the X-ray structure see Figure 5.5 on page 63 
Colourless needles from chloroform 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
C17H27N3O 
289.42 g/mol 
100(2) K 
0.71073 Å 
monoclinic 
P21 
a = 8.727(1) Å     α = 90° 
b = 22.143(1) Å     β = 101.78(1)° 
c = 9.924(1) Å     γ = 90° 
1877.3(3) Å3 
4 
1.024 g/cm3 
0.065 mm-1 
632 
0.20 × 0.15 × 0.15 mm 
2.10° to 27.00° 
-11 ≤ h ≤ 11 
-26 ≤ k ≤ 28 
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Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]:   
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:        
-11 ≤ l ≤ 11 
9720 
6657 [ Rint = 0.0405] 
4339 
91.7 % 
Full-matrix least-squares on F2 
6657 / 1 / 597 
1.032 
R1 = 0.0553        ωR2 = 0.0914 
R1 = 0.1076        ωR2 = 0.1076 
0.189 and -0.219 e·Å-3  
 
 
8.2.30 Preparation of 1-{(1R,2R)-2-(dimethylamino)cyclohexyl)-3-{(S)-1-
phenylethyl)urea 13 
 
[SMU-V-49] 
 
NH2
NMe2  
 NCO
CH3
 
 N
H NMe2
N
H
OCH3
 
101  ent-123  13 
     
    
101 + ent-123 13 
   
THF (abs.) 
 
RT, 24 h 
  
 
The same procedure as before (see section 8.2.10 on page 122) was followed on a 1.58 mmol scale. 
Purification in the same way afforded a colorless crystalline solid (345 mg, 75 %). 
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13 C17H27N3O (289.42 g/mol) 
 
Yield 
 
345 mg (1.19 mmol, 75 %) 
 
N
H NMe2
N
H
OCH3
2'
1
2
3
4
5
6
1'
2''
3''
4''
1''
  
Melting Point 
 
146 °C (CHCl3) 13 
 
 
Specific Rotation 
 
 
[ ]20589α = -57.2°, [ ]20546α = -67.7°, [ ]20405α = -137.1°, [ ]20365α = -179.5°, [ ]20334α = 
-230.2° (c =1.00, CHCl3) 
 
TLC 
 
Rf = 0.31 (Silicagel, CHCl3/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.88-1.29 (m; 4H, H-3, H-4, H-5, H-6), 1.42 (d, 
J = 6.93 Hz; 3H, H-2′), 1.56-1.77 (m; 3H, H-4, H-5, H-6), 2.09-2.14 (m, 
1H, H-1), 2.16 (s; 6H, NCH3), 2.36-2.42 (m; 1H, H-3), 3.19-3.28 (m; 1H, 
H-2), 4.79 (dq, J = 6.93, 6.85 Hz; 1H, H-1′), 4.98 (br s; 1H, C-1′-NH), 5.18 
(br s; 1H, C-2-NH), 7.17-7.31 (m; 5H, Har).  
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.4 (C-6), 23.1 (C-2′), 24.5 (C-4 or C-5), 25.2 (C-4 
or C-5), 33.6 (C-3), 39.9 (NCH3), 50.0 (C-1′), 51.9 (C-2), 66.8 (C-1), 
126.0 (C-2′′ or C-3′′), 127.0 (C-4′′), 128.5 (C-2′′ or C-3′′), 144.6 (C-1′′), 
158.4 (CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(KBr): ν~ [cm-1] = 3335 (s), 3302 (s), 2976 (m), 2921 (s), 2859 (m), 2821 
(m), 2777 (m), 1674 (w), 1622 (s), 1559 (s), 1456 (m), 1372 (w), 1330 
(m), 1255 (m), 1235 (m), 1208 (m), 1106 (m), 1074 (m), 1052 (w), 1020 
(m), 873 (w), 830 (w), 745 (w). 
 
HR-ESI-MS 
 
Exact molecular mass for [C17H27N3NaO] ([M+Na]+): 312.2052 
                                                                           Found: 312.206 
 
Elemental Analysis 
 
Anal. Calcd. for C17H27N3O: C 70.55,  H 9.40,  N 14.52 
                                   Found: C 70.32,  H 9.34,  N 14.47 
 
Crystallographic 
Data 
 
For the X-ray structure see Figure 5.5 on page 63 
Colourless needles from chloroform 
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 Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]:   
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:        
C17H27N3O 
289.42 g/mol 
100(2) K 
0.71073 Å 
orthorhombic 
P212121 
a = 9.1661(4) Å     α = 90° 
b = 11.3191(6) Å     β = 90° 
c = 15.5757(8) Å     γ = 90° 
1616.01(14) Å3 
4 
1.190 g/cm3 
0.075 mm-1 
632 
0.1 × 0.2 × 0.3 mm 
2.22° to 26.99° 
-11 ≤ h ≤ 11 
-14 ≤ k ≤ 11 
-18 ≤ l ≤ 19 
7841 
2021 [ Rint = 0.0444] 
1677 
100.0 % 
Full-matrix least-squares on F2 
2021 / 0 / 298 
1.004 
R1 = 0.0339        ωR2 = 0.0678 
R1 = 0.0475        ωR2 = 0.0718 
0.132 and -0.187 e·Å-3   
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8.2.31 Preparation of 1,3-bis{(1R,2R)-2-(dimethylamino)cyclohexyl} 
thiourea 14 
 
[SMU-V-85] 
 
NH2
NMe2  
NCS
NMe2  
N
H NMe2
N
H
S
Me2N  
101 124 14 
   
  
101 14 
 
 
1. CSCl2, sat. NaHCO3, CH2Cl2 
0 °C, 30 min 
      2. 101, CH2Cl2, RT, 6 h 
  
 
Saturated aqueous sodium bicarbonate solution (10 mL) was added to a solution of (1R,2R)-
N,N-dimethyl-1,2-diaminocyclohexane 101 (240 mg, 1.69 mmol, 1.00 eq) in 10 mL of DCM and 
the resulting biphasic mixture was cooled to 0 °C. Thiophosgene (140 µL, 1.86 mmol, 1.10 eq) was 
added to the organic (lower) phase by a syringe. The resulting mixture was then vigorously stirred 
at 0°C for 30 minutes. The mixture was then diluted with dichloromethane (20 mL) and the organic 
phase was separated. The aqueous phase was extracted with DCM (5 × 15 mL). The combined 
organic layers were dried over anh. Na2SO4 and concentrated under reduced pressure to afford 
(1R,2R)-2-isothiocyanato-N,N-dimethylcyclohexanamine 124 as an brown semisolid which was 
used immediately in the following step without purification. The crude isothiocyanate 124 was 
dissolved in 3 mL of abs. DCM and a solution of 101 (250 mg, 1.76 mmol, 1.04 eq) in 7 mL abs. 
DCM was added in one portion. The resulting mixture was then stirred at room temperature for 6 
hours and then concentrated in vacuo. The crude product was purified by column chromatography 
on silica gel (CH2Cl2/MeOH/TEA = 100:5:1 to 25:25:1 as eluant) to obtain an off-white foam (330 
mg, 60 %). 
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14 
 
C17H34N4S (326.54 g/mol) 
 
 
5
N
H NMe2
N
H
S
Me2N
12
3
4
6
 
 
Yield 
 
 
330 mg (1.01 mmol, 60 %) 
 14 
 
 
TLC 
 
Rf = 0.18 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.99-1.33 (m; 8H, H-3, H-4, H-5, H-6), 1.61-1.84 
(m; 6H, H-4, H-5, H-6), 2.21 (s; 12H, NCH3), 2.33-2.41 (m; 4H, H-1, H-3), 
3.60-3.69 (m; 2H, H-2), 7.17 (br s; 2H, NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.9 (C-6), 24.5 (C-4 or C-5), 25.0 (C-4 or C-5), 33.0 
(C-3), 39.1 (NCH3), 55.7 (C-2), 66.7 (C-1), 182.6 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(KBr): ν~ [cm-1] = 3265 (br), 2931 (s), 2857 (s), 2783 (m), 1540 (s), 
1457 (m), 1362 (m), 1323 (m), 1270 (m), 1240 (w), 1187 (w), 1165 (w), 
1085 (w), 1038 (m), 957 (w), 871 (m), 739 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C17H34N4S] ([M]+): 326.2504 
                                                               Found: 326.251 
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8.2.32 Preparation of (S)-2-tert-butoxycarbonylamino-3,3-dimethyl-
butanoic acid 128 
 
[SMU-V-92] 
 
NH2
HO
O  
 
O
O
OO
O
 
N
H
HO
O
O
O
 
126  125  128 
     
    
126 + 125 128 
   
Na2CO3 
MeOH/H2O, RT, 18 h 
  
 
To a solution of L-tert-leucine 126 (1.00 g, 7.62 mmol, 1.00 eq) and Na2CO3 (888 mg, 8.38 mmol, 
1.10 eq) in 30 mL MeOH/H2O (1:1), was added di-tert-butyl dicarbonate 125 (1.83 g, 8.38 mmol, 
1.10 eq) and the resulting mixture was stirred at room temperature for 18 hours. Methanol was 
removed completely; the aqueous solution was acidified with sat. citric acid solution (pH ~4) and 
extracted with DCM (4 × 25 mL) and Et2O (2 × 25 mL). The combined organic layers were dried 
over anh. Na2CO3 and the solvent was removed in vacuo to obtain a colorless amorphous solid 
(1.61 g, 91 %). 
 
128 C11H21NO4 (231.29 g/mol) 
 
Yield 
 
1.61 g (6.96 mmol, 91 %) 
 
N
H
HO
O
O
O
1
2
3
4
1' 2' 3'
 
 
Melting Point 
 
99-100 °C [Lit.[171]: 100-101 °C] 
128 
 
 
 
1H-NMR (300 MHz, CD3OD): δ = 0.96 (s; 9H, H-4), 1.42 (s; 9H, H-3′), 3.78 (s; 1H, 
H-2). 
The OH and NH protons could not be detected. 
 
13C-NMR 
 
(75 MHz, CD3OD): δ = 27.5 (C-4), 28.8 (C-3′), 35.0 (C-3), 65.7 (C-2), 79.8 
(C-2′), 157.6 (C-1′), 178.4 (C-1). 
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FT-IR (KBr): ν~ [cm-1] = 3422 (br), 2976 (s), 1690 (s), 1590 (s), 1501 (s), 1392 (s), 
1366 (s), 1334 (w), 1250 (m), 1175 (s), 1059 (m), 1013 (m), 914 (w), 
862 (w), 818 (w), 772 (w). 
 
8.2.33 Preparation of (R)-2-tert-butoxycarbonylamino-3,3-dimethyl-
butanoic acid ent-128 
 
[SMU-VI-22] 
 
NH2
HO
O  
 
O
O
OO
O
 N
H
HO
O
O
O
 
ent-126  125  ent-128 
     
    
ent-126 + 125 ent-128 
   
Na2CO3 
 
MeOH/H2O, RT, 20 h 
  
 
The same procedure as before (see section 8.2.32 on page 160) was followed on a 15.3 mmol scale. 
Pure product was obtained as a colorless crystalline solid (3.44 g, 98 %). 
 
ent-128 C11H21NO4 (231.29 g/mol) 
 
Yield 
 
3.44 g (14.9 mmol, 98 %) 
 
N
H
HO
O
O
O
1
2
3
4
1' 2' 3'
 
 
Melting Point 
 
100 °C [Lit.[171]: 100-101 °C] ent-128 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 0.99 (s; 9H, H-4), 1.41 (s; 9H, H-3′), 4.09 (d, 
J = 9.35 Hz; 1H, H-2), 5.11 (d, J = 9.35 Hz; 1H, NH), 9.71 (br s; 1H, OH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 26.5 (C-4), 28.3 (C-3′), 34.5 (C-3), 61.6 (C-2), 80.0 
(C-2′), 155.6 (C-1′), 176.7 (C-1). 
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FT-IR (ATR): ν~ [cm-1] = 3318 (br), 2967 (m), 2671 (w), 1710 (s), 1658 (s), 
1506 (m), 1478 (w), 1454 (w), 1394 (s), 1367 (s), 1329 (m), 1233 (m), 1159 
(s), 1059 (m), 1034 (w), 1011 (m), 909 (w), 854 (w), 776 (w), 732 (w). 
 
8.2.34 Preparation of (S)-2-tert-butoxycarbonylamino-4,4-dimethyl-
pentanoic acid 129 
 
[SMU-VI-59] 
 
NH2
HO
O  
 
O
O
OO
O
 
N
H
HO
O
O
O
 
127  125  129 
     
    
127 + 125 129 
   
Na2CO3 
 
MeOH/H2O, RT, 24 h 
  
 
The same procedure as before (see section 8.2.32 on page 160) was followed on a 20.7 mmol scale. 
Pure product was obtained as a colorless solid (4.64 g, 92 %). 
 
 
129 
 
C12H23NO4 (245.32 g/mol) 
 
Yield 
 
4.64 g (18.9 mmol, 92 %) 
 
N
HO
HO
O
O
1
2
345
1' 2' 3'
 
 
Melting Point 
 
102 °C [Lit.[172]: 102-103 °C] 129 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.96 (s; 9H, H-5), 1.42 (s; 9H, H-3′), 1.76-1.81 (m; 1H, 
H-3), 4.29-4.34 (m; 1H, H-2), 4.81-4.84 (m; 1H, H-3), 10.66 (br s; 1H, OH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 28.3 (C-5), 29.5 (C-3′), 30.7 (C-4), 46.0 (C-3), 51.3 (C-2), 
80.2 (C-2′), 155.4 (C-1′), 178.9 (C-1). 
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FT-IR (ATR): ν~ [cm-1] = 3321 (br), 2955 (m), 1714 (s), 1663 (s), 1518 (m), 1477 (w), 
1454 (w), 1392 (s), 1366 (sh), 1300 (w), 1243 (m), 1164 (s), 1051 (m), 1022 (w), 
909 (w), 868 (w), 778 (w), 733(w). 
 
8.2.35 Preparation of (S)-(1-dimethylcarbamoyl-2,2-dimethyl-propyl) 
carbamic acid-tert-butyl ester 130 
 
[SMU-VIII-15] 
 
N
H
HO
O
O
O
 
 N
H
Me2N
O
O
O
 
128  130 
   
  
128 130 
 
Me2NH·HCl, HBTU, i-Pr2NEt 
 
CH2Cl2, RT, 16 h 
 
 
To a suspension of (S)-2-tert-butoxycarbonylamino-3,3-dimethylbutyric acid 128 (578 mg, 2.50 
mmol, 1.00 eq) and O-benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium hexafluorophosphate 
(HBTU) (1.04 g, 2.75 mmol, 1.10 eq) in 30 mL DCM, was added diisopropyl ethylamine (0.94 mL, 
5.5 mmol, 2.20 eq) followed by dimethylamine hydrochloride (224 mg, 2.75 mmol, 1.10 eq) at 
room temperature. The resulting mixture was then stirred at room temperature for 16 hours. The 
reaction mixture was then diluted with diethylether (50 mL), washed with 1 M hydrochloric acid (2 
× 50 mL), sat. NaHCO3 solution (2 × 50 mL) and finally with brine (50 mL). The organic layer was 
dried over anh. Na2SO4 and concentrated in vacuo to obtain a pale yellow oil (643 mg, >99 %). It 
was used in the following step (see section 8.2.42 on page 171) without further purification. 
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130  
 
C13H26N2O3 (258.36 g/mol) 
 
 
N
H
N
O
O
OMe
Me 1
2
3
1' 2' 3'
1''
  
Yield 
 
 
643 mg (2.49 mmol, >99 %) 
 
130 
 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.86 (s; 9H, H-3), 1.31 (s; 9H, H-3′), 2.85 (s; 3H, 
NCH3), 3.02 (s; 3H, NCH3), 4.41 (d, J = 9.47 Hz; 1H, H-1), 5.24 (d, 
J = 9.47 Hz; 1H, NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 26.2 (C-3), 28.2 (C-3′), 35.3 (NCH3), 35.6 (C-2), 38.2 
(NCH3), 55.6 (C-1), 79.1 (C-2′), 155.5 (C-1′), 171.73 (C-1′′). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3435 (m), 3315 (br), 2961 (s), 1707 (s), 1636 (s), 
1490 (s), 1392 (s), 1364 (sh), 1327 (m), 1244 (s), 1167 (s), 1128 (w), 
1054 (sh), 1032 (w), 1008 (sh), 969 (m), 933 (w), 909 (w), 873 (sh), 
847 (w), 779 (w), 744 (w). 
 
 
8.2.36 Preparation of (S)-(1-diethylcarbamoyl-2,2-dimethyl-propyl)-
carbamic acid-tert-butyl ester 131 
 
[SMU-V-76] 
 
N
H
HO
O
O
O
 
 
N
H
Et2N
O
O
O
 
128  131 
   
  
128 131 
 
Et2NH, HBTU, i-Pr2NEt 
CH2Cl2, RT, 28 h 
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The same procedure as before (see section 8.2.35 on page 163) was followed to obtain a thick oil 
(611 mg, 85 %). It was used in the following step (see section 8.2.43 on page 173) without further 
purification. 
 
131 
 
C15H30N2O3 (286.41 g/mol) 
 
 
N
H
N
O
O
O
1
2
3
1' 2' 3'
1''
2''
3''
  
Yield 
 
 
611 mg (2.13 mmol, 85 %) 
 
131 
 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.92 (s; 9H, H-3), 1.06 (t, J = 7.17 Hz; 3H, H-3′), 
1.15 (t, J = 7.17 Hz; 3H, H-3′′), 1.37 (s; 9H, H-3′), 2.90-3.02 (m; 1H, H-2′′), 
3.13-3.25 (m; 1H, H-2′′), 3.53-3.76 (m; 2H, H-2′′), 4.40 (d, J = 10.0 Hz; 1H, 
H-1), 5.24 (d, J = 10.0 Hz; 1H, NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 12.9 (C-3′′), 14.4 (C-3′′), 26.4 (C-3), 28.2 (C-3′), 35.6 
(C-2), 40.1 (C-2′′), 42.7 (C-2′′), 55.7 (C-1), 79.2 (C-2′), 155.5 (C-1′), 170.9 
(C-1′′). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3439 (w), 3316 (br), 2970 (s), 1716 (s), 1636 (s), 
1497 (s), 1458 (m), 1433 (m), 1365 (s), 1335 (w), 1244 (m), 1173 (s), 1058 
(m), 1009 (w), 906 (w), 863 (w), 835 (w). 
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8.2.37 Preparation of (S)-(1-diisobutylcarbamoyl-2,2-dimethyl-propyl)-
carbamic acid-tert-butyl ester 132 
 
[SMU-VI-20] 
 
N
H
HO
O
O
O
 
 N
H
i-Bu2N
O
O
O
 
128  132 
   
  
128 132 
 
i-Bu2NH, HBTU, i-Pr2NEt 
 
CH2Cl2, RT, 44 h 
 
 
The same procedure as before (see section 8.2.35 on page 163) was followed to obtain a pale yellow 
crystalline solid (865 mg, >99 %). It was used in the following step (see section 8.2.44 on page 174) 
without further purification. 
 
132 
 
C19H38N2O3 (342.52 g/mol) 
 
 
N
H
N
O
O
O
1
2
3
1' 2'
3'
1''
2''3''
4''
 
 
Yield 
 
 
865 mg (2.53 mmol, >99 %) 
 132 
 
 
1H-NMR (250 MHz, CDCl3): δ = 0.78-0.88 (m; 12H, H-4′′), 0.92 (s; 9H, H-3), 1.34 (s; 
9H, H-3′), 1.84-2.00 (m; 2H, H-3′′), 2.49 (dd, J = 7.8, 13.2 Hz; 1H, H-2′′), 
2.96 (dd, J = 6.1, 14.7 Hz; 1H, H-2′′), 3.38 (dd, J = 9.3, 14.7 Hz; 1H, H-2′′), 
3.73 (dd, J = 6.7, 13.3 Hz; 1H, H-2′′), 4.47 (d, J = 9.7 Hz; 1H, H-1), 5.31 (d, 
J = 9.7 Hz; 1H, NH). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 18.7 (C-4′′), 20.0 (C-4′′), 20.3 (C-4′′), 20.5 (C-4′′), 
26.4 (C-3), 26.5 (C-3′′), 27.3 (C-3′′), 28.1 (C-3′), 36.0 (C-2), 53.4 (C-2′′), 
56.0 (C-1), 56.3 (C-2′′), 78.8 (C-2′), 155.1 (C-1′), 171.9 (C-1′′). 
The assignments were made by 2D-NMR. 
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FT-IR (ATR): ν~ [cm-1] = 3344 (s), 2959 (s), 2871 (m), 1689 (s), 1626 (s), 1521 (s), 
1444 (m), 1420 (w), 1386 (w), 1367 (m), 1348 (w), 1241 (s), 1173 (s), 
1133 (w), 1101 (w), 1057 (s), 1035 (w), 1012 (m), 938 (w), 898 (w). 
 
8.2.38 Preparation of {(S)-1-(benzyl-methyl-carbamoyl)-2,2-dimethyl-
propyl}-carbamic acid-tert-butyl ester 133 
 
[SMU-V-93] 
 
N
H
HO
O
O
O
 
 N
H
N
O
O
OMe
Ph
 
128  133 
   
  
128 133 
 
Me(Bn)NH, HBTU, i-Pr2NEt 
 
CH2Cl2, RT, 28 h 
 
 
The same procedure as before (see section 8.2.35 on page 163) was followed to obtain 133 
contaminated with tetramethyl urea as a thick yellowish oil (760 mg, 91 %). It was used in the 
following step (see section 8.2.45 on page 175) without further purification. 
 
133 
 
C19H30N2O3 (334.45 g/mol) 
 
 
N
H
N
O
O
OMe
Ph 1
2
3
1' 2' 3'
1''
2''
  
Yield 
 
 
760 mg (2.27 mmol, 91 %) 
 
133 
 
 
 
1H-NMR (250 MHz, CDCl3): δ = 0.95 (s; 9H, H-3), 1.39 (s; 9H, H-3′), 3.00 (s; 3H, 
NCH3), 4.44-4.51 (m; 2H, H-1, H-2′′), 4.62-4.67 (m; 1H, H-2′′), 5.32-5.33 
(m; 1H, NH), 7.14-7.28 (m; 5H, Har). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 26.3 (C-3), 28.2 (C-3′), 35.5 (C-2), 35.7 (NCH3), 
Experimental Part 
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51.0 (C-2′′), 56.0 (C-1), 79.3 (C-2′), 127.3 (Car), 128.0 (Car), 128.5 (Car), 
136.8 (Cqar), 155.8 (C-1′), 172.1 (C-1′′). 
The assignments were made by 2D-NMR. 
 
8.2.39 Preparation of {(R)-1-(benzyl-methyl-carbamoyl)-2,2-dimethyl-
propyl}-carbamic acid-tert-butyl ester ent-133 
 
[SMU-VI-23] 
 
N
H
HO
O
O
O
 
 
N
H
N
O
O
OMe
Ph
 
ent-128  ent-133 
   
  
ent-128 ent-133 
 
Me(Bn)NH, HBTU, i-Pr2NEt 
 
CH2Cl2, RT, 28 h 
 
 
The same procedure as before (see section 8.2.35 on page 163) was followed to obtain a thick 
yellowish oil (880 mg, >99 %). It was used in the following step (see section 8.2.46 on page 176) 
without further purification. 
 
ent-133 C19H30N2O3 (334.45 g/mol) 
 
N
H
N
O
O
OMe
Ph 1
2
3
1' 2' 3'
1''
2''
  
Yield 
 
880 mg (2.63 mmol, >99 %) ent-133 
 
 
1H-NMR (250 MHz, CDCl3): δ = 0.97 (s; 9H, H-3), 1.41 (s; 9H, H-3′), 3.02 (s; 3H, 
NCH3), 4.45-4.53 (m; 2H, H-1, H-2′′), 4.64-4.70 (m; 1H, H-2′′), 5.31-
5.35 (m; 1H, NH), 7.16-7.31 (m; 5H, Har). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 26.4 (C-3), 28.3 (C-3′), 35.5 (C-2), 35.8 (NCH3), 
51.0 (C-2′′), 56.0 (C-1), 79.4 (C-2′), 127.3 (Car), 128.0 (Car), 128.5 (Car), 
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136.9 (Cqar), 155.8 (C-1′), 172.2 (C-1′′). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3436 (w), 3327 (br), 2968 (s), 1714 (s), 1646 (s), 
1496 (s), 1456 (w), 1401 (w), 1394 (w), 1366 (sh), 1339 (w), 1246 (m), 
1171 (s), 1111 (w), 1056 (m), 1031 (w), 1010 (m), 909 (w), 875 (w), 
736 (w). 
 
8.2.40 Preparation of (S)-(1-benzylcarbamoyl-2,2-dimethyl-propyl)-
carbamic acid-tert-butyl ester 134 
 
[SMU-VIII-40] 
 
N
H
HO
O
O
O
 
 
N
H
H
N
O
O
O
Ph
 
128  134 
   
  
128 134 
 
BnNH2, HBTU, i-Pr2NEt 
 
CH2Cl2, RT, 17 h 
 
 
The same procedure as before (see section 8.2.35 on page 163) was followed on a 2.00 mmol scale 
to obtain a colourless oil (667 mg, >99 %). It was used in the following step (see section 8.2.47 on 
page 177) without further purification. 
 
134  
 
C18H28N2O3 (320.43 g/mol) 
 
 
N
H
H
N
O
O
O
Ph 1
2
3
1' 2' 3'
1''
2''
  
Yield 
 
 
667 mg (2.08 mmol, >99 %) 
 
134 
 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.93 (s; 9H, H-3), 1.29 (s; 9H, H-3′), 4.04-4.17 (m; 
2H, H-2′′), 4.34-4.43 (m; 1H, H-1), 5.60 (d, J = 9.3 Hz; 1H, C-1-NH), 
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7.10-7.23 (m; 5H, Har), 7.50 (br s; 1H, C-1′′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 26.4 (C-3), 28.1 (C-3′), 34.2 (C-2), 42.9 (C-2′′), 61.9 
(C-1), 79.1 (C-2′), 126.8 (Car), 127.3 (Car), 128.1 (Car), 138.1 (Cqar), 155.9 
(C-1′), 171.1 (C-1′′). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3307 (br), 2965 (m), 1697 (s), 1649 (s), 1536 (m), 
1518 (s), 1503 (s), 1453 (sh), 1391 (w), 1365 (s), 1243 (s), 1169 (s), 
1069 (sh), 1028 (w), 1006 (m), 908 (m), 859 (m), 729 (m). 
 
8.2.41 Preparation of {(S)-1-(benzyl-methyl-carbamoyl)-3,3-dimethyl-
butyl}-carbamic acid-tert-butyl ester 135 
 
[SMU-VI-72] 
 
N
H
HO
O
O
O
 
 
N
H
N
O
Me
Ph O
O
 
129  135 
   
  
129 135 
 
Me(Bn)NH, HBTU, i-Pr2NEt 
 
CH2Cl2, RT, 26 h 
 
 
The same procedure as before (see section 8.2.35 on page 163) was followed on a 2.50 mmol scale 
to obtain a thick yellowish oil (940 mg, >99 %). It was used in the following step (see section 
8.2.48 on page 178) without further purification. 
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135 
 
C20H32N2O3 (348.48 g/mol) 
 
1
2 3
4
1' 2'
3'
1''
2''
N
H
N
O
Me
Ph O
O
  
Yield 
 
 
940 mg (2.70 mmol, >99 %) 
 135 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.83, 0.96 (2s; 9H, H-4), 1.39, 1.41 (2s; 9H, H-3′), 
1.49-1.51 (m; 2H), 2.90, 2.98 (2s; 3H, NCH3), 4.47-4.63 (m; 2H), 4.70-4.82 
(m; 1H), 5.13-5.22 (m; 1H), 7.17-7.34 (m; 5H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 28.35, 29.60, 29.76, 30.47, 30.67, 34.07, 34.54, 
38.56, 46.40, 46.74, 47.51, 47.87, 51.16, 53.10, 79.50, 126.80, 127.37, 
127.66, 127.88, 128.59, 128.79, 136.23, 136.82, 155.02, 155.39, 173.79, 
174.09. 
Two sets of signals were obtained due to dynamic NMR. 
 
8.2.42 Preparation of (S)-2-amino-N,N-dimethyl-3,3-dimethyl-butanamide 
136 
 
[SMU-VIII-16] 
 
N
H
Me2N
O
O
O
 
 NH2
Me2N
O  
130  136 
   
  
130 136 
 
TFA 
 
CH2Cl2, RT, 1 h 
 
 
To a solution of (S)-(1-dimethylcarbamoyl-2,2-dimethyl-propyl)-carbamic acid-tert-butyl ester 130 
(635 mg, 2.46 mmol, 1.00 eq) in 10 mL of DCM, trifluoroacetic acid (1.89 mL, 24.6 mmol, 10.0 
eq) was added in one portion and the resulting solution was stirred at room temperature for 1 hour. 
The reaction mixture was cooled to 0 °C and a 20 % aqueous Na2CO3 solution was added slowly 
until pH ~ 10. The biphasic mixture was then diluted with chloroform (20 mL). The organic layer 
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was separated and washed with 20 % aqueous Na2CO3 solution (3 × 10 mL). The combined 
aqueous layers were extracted with chloroform (3 × 20 mL). Combined organic extracts were 
washed with brine (20 mL) and dried over anh. Na2SO4. The solvent was removed in vacuo to 
obtain a pale yellow oil (300 mg, 77 %). This was used in the following step (see section 8.2.49 on 
page 179) without any further purification. 
 
136 C8H18N2O (158.14 g/mol) 
 
NH2
N
O
Me
Me
1
2
3
4
  
Yield 
 
300 mg (1.90 mmol, 77 %) 136 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.82 (s; 9H, H-4), 1.62 (s; 2H, NH2), 2.81 (s; 3H, 
NCH3), 2.93 (s; 3H, NCH3), 3.39 (H-2). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 26.0 (C-4), 35.1 (C-3), 35.3 (NCH3), 38.3 (NCH3), 
57.3 (C-2), 174.3 (C-1). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3373 (br), 2950 (s), 2868 (m), 1626 (s), 1504 (w), 
1478 (w), 1419 (w), 1395 (m), 1360 (sh), 1255 (sh), 1230 (w), 1137 (s), 
1088 (m), 1056 (w), 1032 (m), 970 (m), 913 (m), 866 (w), 812 (m), 781 (w). 
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8.2.43 Preparation of (S)-2-amino-N,N-diethyl-3,3-dimethyl-butanamide 
137 
 
[SMU-V-77] 
 
N
H
Et2N
O
O
O
 
 NH2
Et2N
O  
131  137 
   
  
131 137 
 
TFA 
 
CH2Cl2, RT, 1 h 
 
 
The same procedure as before (see section 8.2.42 on page 171) was followed on a 2.13 mmol scale 
to obtain a clear oil (394 mg, 99 %). This was used in the following step (see section 8.2.50 on page 
180) without further purification. 
 
137 C10H22N2O (186.29 g/mol) 
 
NH2
N
O
1
2
3
4
1'
2'
  
Yield 
 
394 mg (2.11 mmol, 99 %) 137 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.85 (s; 9H, H-4), 0.99 (t, J = 7.17 Hz; 3H, H-2′), 
1.06 (t, J = 7.17 Hz; 3H, H-2′), 1.48 (s; 2H, NH2), 2.89-3.00 (m; 1H, H-1′), 
3.00-3.13 (m; 1H, H-1′), 3.26 (s; 1H, H-2), 3.40-3.62 (m; 2H, H-1′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 12.8 (C-2′), 14.5 (C-2′), 26.2 (C-4), 34.9 (C-3), 40.1 
(C-1′), 42.2 (C-1′), 57.5 (C-2), 173.6 (C-1). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3384 (br), 2961 (s), 2871 (w), 2241 (m), 1630 (s), 
1464 (m), 1380 (w), 1360 (m), 1268 (m), 1218 (w), 1137 (m), 1097 (w), 
1034 (w), 925 (m), 732 (m). 
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HR-ESI-MS Exact molecular mass for [C10H23N2O] ([M+H]+): 187.1810 
                                                                     Found: 187.181 
 
8.2.44 Preparation of (S)-2-amino-N,N-diisobutyl-3,3-dimethyl-butan-
amide 138 
 
[SMU-VI-21] 
 
N
H
i-Bu2N
O
O
O
 
 NH2
i-Bu2N
O  
132  138 
   
  
132 138 
 
TFA 
 
CH2Cl2, RT, 2 h 
 
 
The same procedure as before (see section 8.2.42 on page 171) was followed on a 2.24 mmol scale 
to obtain a pale yellow oil (557 mg, >99 %). This was used in the following step (see section 8.2.51 
on page 181) without further purification. 
 
138 
 
C14H30N2O (242.4 g/mol) 
 
 
NH2
N
O
1
2
3
4
1'2'3'
 
 
Yield 
 
 
557 mg (2.30 mmol, >99 %) 
 138 
 
 
1H-NMR (250 MHz, CDCl3): δ = 0.75-0.85 (m; 12H, H-3′), 0.87 (s; 9H, H-4), 1.49 
(br s; 2H, NH2), 1.72-1.99 (m; 2H, H-2′), 2.42 (dd, J = 8.2, 13.3 Hz; 1H, 
H-1′), 2.81 (dd, J = 6.8, 14.7 Hz; 1H, H-1′), 3.31 (s; 1H, H-2), 3.32 (dd, 
J = 8.5, 14.7 Hz; 1H, H-1′), 3.70 (dd, J = 6.4, 13.4 Hz; 1H, H-1′). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 19.6 (C-3′), 20.2 (C-3′), 20.3 (C-3′), 20.5 (C-3′), 
26.4 (C-4), 26.7 (C-2′), 28.1 (C-2′), 35.1 (C-3), 54.3 (C-1′), 56.5 (C-1′), 57.8 
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(C-2), 175.0 (C-1). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3385 (br), 2959 (s), 2871 (m), 1638 (s), 1500 (w), 
1467 (m), 1426 (w), 1387 (w), 1367 (m), 1340 (w), 1259 (m), 1206 (w), 
1141 (m), 1099 (m), 1031 (w), 913 (w), 870 (w), 806 (w), 756 (w). 
 
8.2.45 Preparation of (S)-2-amino-N-benzyl-3,3,N-trimethyl-butanamide 
139 
 
[SMU-V-94] 
 
N
H
N
O
O
OMe
Ph
 
 NH2
N
O
Me
Ph
 
133  139 
   
  
133 139 
 
TFA 
 
CH2Cl2, RT, 1 h 
 
 
The same procedure as before (see section 8.2.42 on page 171) was followed on a 2.27 mmol scale 
to obtain a pale yellow oil (531 mg, 100 %). This was used in the following step (see section 8.2.52 
on page 181) without further purification. 
 
139 
 
C14H22N2O (234.34 g/mol) 
 
 
NH2
N
O
Me
1
2
3
4
  
Yield 
 
 
531 mg (2.27 mmol, 100 %) 
 139 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.99 (s; 9H, H-4), 1.59 (s; 2H, NH2), 2.97 (s; 3H, 
NCH3), 3.54 (s; 1H, H-2), 4.48 (d, J = 14.37 Hz; 1H, NCH2), 4.73 (d, 
J = 14.37 Hz; 1H, NCH2), 7.17-7.30 (m; 5H, Har). 
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13C-NMR (75 MHz, CDCl3): δ = 26.2 (C-4), 35.1 (C-3), 35.3 (NCH3), 50.9 (NCH2), 
57.8 (C-2), 126.3 (Car), 128.1 (Car), 128.4 (Car), 137.2 (Cqar), 174.6 (CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3384 (br), 2954 (s), 2869 (w), 1636 (s), 1496 (w), 
1456 (w), 1363 (m), 1260 (w), 1179 (w), 1082 (w), 1029 (w), 953 (w), 
915 (w), 820 (w), 736 (w). 
 
8.2.46 Preparation of (R)-2-amino-N-benzyl-3,3,N-trimethyl-butanamide 
ent-139 
 
[SMU-VI-28] 
 
N
H
N
O
O
OMe
Ph
 
 NH2
N
O
Me
Ph
 
ent-133  ent-139 
   
  
ent-133 ent-139 
 
TFA 
 
CH2Cl2, RT, 1 h 
 
 
The same procedure as before (see section 8.2.42 on page 171) was followed on a 2.50 mmol scale 
to obtain a pale yellow oil (588 mg, >99 %). This was used in the following step (see section 8.2.53 
on page 182) without further purification. 
 
 
ent-139 
 
C14H22N2O (234.34 g/mol) 
 
 
NH2
N
O
Me
Ph 1
2
3
4
  
Yield 
 
 
588 mg (2.51 mmol, >99 %) 
 
ent-139 
 
 
1H-NMR (250 MHz, CDCl3): δ = 0.93 (s; 9H, H-4), 1.66 (s; 2H, NH2), 2.90 (s; 3H, 
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NCH3), 3.49 (s; 1H, H-2), 4.40 (d, J = 14.37 Hz; 1H, NCH2), 4.67 (d, 
J = 14.37 Hz; 1H, NCH2), 7.10-7.32 (m; 5H, Har). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 26.2 (C-4), 35.0 (C-3), 35.3 (NCH3), 50.9 (NCH2), 
57.7 (C-2), 126.2 (Car), 128.1 (Car), 128.4 (Car), 137.1 (Cqar), 174.5 (CO). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3376 (br), 2953 (s), 2868 (w), 1637 (s), 1496 (w), 
1473 (w), 1454 (w), 1418 (w), 1362 (m), 1259 (w), 1180 (w), 1112 (w), 
1083 (w), 1030 (w), 986 (w), 951 (w), 914 (w), 860 (w), 816 (w), 736 (m). 
 
8.2.47 Preparation of (S)-2-amino-N-benzyl-3,3-dimethyl-butanamide 140 
 
[SMU-VIII-41] 
 
N
H
H
N
O
O
O
Ph
 
 NH2
H
N
O
Ph
 
134  140 
   
  
134 140 
 
TFA 
 
CH2Cl2, RT, 1 h 
 
 
The same procedure as before (see section 8.2.42 on page 171) was followed on a 2.00 mmol scale 
to obtain a pale yellow oil (370 mg, 84 %). This was used in the following step (see section 8.2.54 
on page 183) without further purification. 
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140 
 
C13H20N2O (220.31 g/mol) 
 
NH2
H
N
O
1
2
3
4
  
Yield 
 
 
370 mg (1.68 mmol, 84 %) 
 140 
 
 
1H-NMR (250 MHz, CDCl3): δ = 0.91 (H-4), 1.57 (br s; 2H, NH2), 3.02 (s; 1H, H-2), 
4.32 (d, J = 5.88 Hz; 2H, PhCH2), 7.13-7.26 (m; 6H, Har, NH). 
 
13C-NMR 
 
(62.5 MHz, CDCl3): δ = 26.5 (C-4), 33.9 (C-3), 42.8 (PhCH2), 64.0 (C-2), 
127.0 (Car), 127.5 (Car), 128.3 (Car), 138.4 (Cqar), 173.4 (C-1). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3307 (br), 3063 (w), 3028 (w), 2951 (sh), 2866 (w), 
1650 (s), 1538 (m), 1496 (w), 1476 (w), 1453 (sh), 1394 (w), 1364 (m), 
1327 (w), 1264 (m), 1205 (w), 1079 (w), 1028 (sh), 928 (w), 744 (m). 
 
8.2.48 Preparation of (S)-2-amino-N-benzyl-4,4,N-trimethyl-pentanamide 
141 
 
[SMU-VI-76] 
 
N
H
N
O
Me
Ph O
O
 
 N
O
Me
Ph
NH2
 
135  141 
   
  
135 141 
 
TFA 
 
CH2Cl2, RT, 1 h 
 
 
The same procedure as before (see section 8.2.42 on page 171) was followed on a 2.50 mmol scale 
to obtain a pale yellow oil (670 mg, >99 %). This was used in the following step (see section 8.2.55 
on page 183) without further purification. 
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141 
 
C15H24N2O (248.36 g/mol) 
 
1
2
3 4
5
N
O
Me
NH2
  
Yield 
 
 
670 mg (2.70 mmol, >99 %) 
 
141 
 
 
1H-NMR (300 MHz, CDCl3): δ = 0.88, 0.95 (2s; 9H, H-5), 1.31-1.38, 1.61-1.67 (2m; 
4H, H-3, NH2), 2.90, 2.93 (2s; 3H, NCH3), 3.69-3.80 (m; 1H, H-2), 
4.40-4.68 (m; 2H, PhCH2), 7.13-7.35 (m; 5H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 30.0, 30.1, 30.5, 30.6, 34.2, 34.5, 38.5, 48.8, 48.9, 
49.2, 51.2, 52.7, 126.2, 127.3, 128.0, 128.5, 128.9, 136.6, 137.1, 176.3, 
176.9. 
Two sets of signals were obtained because of dynamic NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3359 (br), 2949 (s), 2863 (w), 1640 (s), 1494 (m), 
1475 (m), 1451 (m), 1411 (w), 1363 (m), 1251 (m), 1202 (w), 1094 (w), 
1028 (w), 943 (w), 916 (w), 848 (w), 816 (w), 731 (m). 
 
8.2.49 Preparation of (S)-N,N-dimethyl-2-isothiocyanato-3,3-dimethyl-
butanamide 142 
 
[SMU-VIII-20] 
 
NH2
Me2N
O  
 NCS
Me2N
O  
136  142 
   
  
136 142 
 
CSCl2, sat. NaHCO3/CH2Cl2 
 
0 °C, 20 min 
 
 
Saturated aqueous sodium bicarbonate solution (10 mL) was added to an ice-cold solution of 
(S)-2-amino-N,N-dimetheyl-3,3-dimethyl-butyramide 136 (275 mg, 1.74 mmol, 1.00 eq) in 10 mL 
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of DCM and the mixture was stirred for 5 minutes. The stirring was stopped and thiophosgene (150 
µL, 1.91 mmol, 1.10 eq) was added to the organic (lower) phase by a syringe. The resulting orange 
mixture was vigorously stirred at 0 °C for 20 mins. The reaction mixture was then diluted with 
DCM (20 mL) and the organic phase was separated. The aqueous phase was extracted with DCM (2 
× 20 mL). The combined organic layers were dried over anh. Na2SO4 and concentrated in vacuo to 
obtain a pale yellow oil which became crystalline solid (337 mg, 1.68 mmol,  97 %) on standing in 
the refrigerator. This was used immediately for the thiourea formation (see section 8.2.56 on page 
184) without further purification and characterization. 
 
8.2.50 Preparation of (S)-N,N-diethyl-2-isothiocyanato-3,3-dimethyl-
butanamide 143 
 
[SMU-V-78] 
 
NH2
Et2N
O  
 NCS
Et2N
O  
137  143 
   
  
137 143 
 
CSCl2, sat.NaHCO3/CH2Cl2 
0 °C, 20 min 
 
 
The same procedure as before (see section 8.2.49 on page 179) was followed on a 2.11 mmol scale 
to obtain a pale yellow oil which became crystalline solid (440 mg, 1.93 mmol, 92 %) on standing 
in the refrigerator. This was used immediately for the thiourea formation (see section 8.2.57 on 
page 186) without any purification or characterization. 
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8.2.51 Preparation of (S)-N,N-diisobutyl-2-isothiocyanato-3,3-dimethyl-
butanamide 144 
 
[SMU-VI-33] 
 
NH2
i-Bu2N
O  
 NCS
i-Bu2N
O  
138  144 
   
  
138 144 
 
CSCl2, sat.NaHCO3/CH2Cl2 
 
0 °C, 20 min 
 
 
The same procedure as before (see section 8.2.49 on page 179) was followed on a 2.17 mmol scale 
to obtain a pale yellow crystalline solid (598 mg, 2.10 mmol, 97 %). This was used immediately for 
the thiourea formation (see section 8.2.58 on page 188) without any purification or characterization. 
 
8.2.52 Preparation of (S)-N-benzyl-2-isothiocyanato-3,3,N-trimethyl-
butanamide 145 
 
[SMU-VI-02] 
 
NH2
N
O
Me
Ph
 
 NCS
N
O
Me
Ph
 
139  145 
   
  
139 145 
 
CSCl2, sat.NaHCO3/CH2Cl2 
 
0 °C, 20 min 
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The same procedure as before (see section 8.2.49 on page 179) was followed on a 1.62 mmol scale 
to obtain a thick oil (430 mg, 1.56 mmol, 96 %). This was used immediately for the thiourea 
formation (see section 8.2.59 on page 190) without any purification or characterization. 
 
8.2.53 Preparation of (R)-N-benzyl-2-isothiocyanato-3,3,N-trimethyl-
butanamide ent-145 
 
[SMU-VI-29] 
 
NH2
N
O
Me
Ph
 
 NCS
N
O
Me
Ph
 
ent-139  ent-145 
   
  
ent-139 ent-145 
 
CSCl2, sat.NaHCO3/CH2Cl2 
 
0 °C, 20 min 
 
 
The same procedure as before (see section 8.2.49 on page 179) was followed on a 2.10 mmol scale 
to obtain a yellow oil (552 mg, 2.00 mmol, 95 %). This was used immediately for the thiourea 
formation (see section 8.2.60 on page 192) without any purification or characterization. 
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8.2.54 Preparation of (S)-N-benzyl-2-isothiocyanato-3,3-dimethyl-
butanamide 146 
 
[SMU-VIII-42] 
 
NH2
H
N
O
Ph
 
 NCS
H
N
O
Ph
 
140  146 
   
  
140 146 
 
CSCl2, sat.NaHCO3/CH2Cl2 
 
0 °C, 20 min 
 
 
The same procedure as before (see section 8.2.49 on page 179) was followed on a 1.66 mmol scale 
to obtain a thick yellow oil (430 mg, 1.64 mmol, 99 %). This was used immediately for the thiourea 
formation (see section 8.2.61 on page 193) without any purification or characterization. 
 
8.2.55 Preparation of (S)-N-benzyl-2-isothiocyanato-4,4,N-trimethyl-
pentanamide 147 
 
[SMU-VI-82] 
 
N
O
Me
Ph
NH2
 
 N
O
Me
Ph
NCS
 
141  147 
   
  
141 147 
 
CSCl2, sat.NaHCO3/CH2Cl2 
 
0 °C, 20 min 
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The same procedure as before (see section 8.2.49 on page 179) was followed on a 2.68 mmol scale 
to obtain a yellowish oil (747 mg, 2.57 mmol, 96 %). This was used immediately for the thiourea 
formation (see section 8.2.62 on page 195) without any purification or characterization. 
 
8.2.56 Preparation of 1-{(S)-1-(dimethylcarbamoyl)-2,2-dimethyl-propyl}-
3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea 15 
 
[SMU-VIII-22] 
 
NH2
NMe2  
 NCS
Me2N
O  
 
NMe2
N
H
N
H
S
Me2N
O
101  142  15 
     
    
101 + 142 15 
   
abs. CH2Cl2 
 
RT, 16 h 
  
 
A solution of (S)-N,N-dimethyl-2-isothiocyanato-3,3-dimethyl-butyramide 142 (337 mg, 1.68 
mmol, 1.00 eq) in 3 mL abs. DCM was added to a solution of (1R,2R)-N,N-dimethyl-1,2-
diaminocyclohexane 101 (275 mg, 1.93 mmol, 1.15 eq) in DCM (1 mL). The resulting mixture was 
stirred at room temperature under argon for 16 hours. The reaction mixture was then concentrated 
in vacuo and the residue was purified by column chromatography on silicagel (CH2Cl2/MeOH/TEA 
= 100:5:1 as the eluant) to afford a colorless foam (350 mg, 61 %). 
 
 
15 
 
 
C17H34N4OS (342.54 g/mol) 
 
 
N
H NMe2
N
H
S
N
O
Me
Me 12
3
4
61'
2'
3'
4'
1''
5
  
Yield 
 
 
350 mg (1.02 mmol, 61 %) 
 
Melting Point 146 °C 
15 
 
 
 
Specific Rotation 
 
[ ]20589α = +7.3°, [ ]20546α = +8.9°, [ ]20405α = +10.6°, [ ]20365α = -2.9° (c =0.71, CHCl3) 
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TLC Rf = 0.22 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.93 (s; 9H, H-4′), 1.02-1.12 (m; 4H, H-3, H-4, H-5, 
H-6), 1.58-1.76 (m; 3H, H-4, H-5, H-6), 2.13 (s; 6H, NCH3), 2.21-2.29 (m; 
2H, H-1, H-3), 2.85 (s; 3H, H-1′′), 3.15 (s; 3H, H-1′′), 3.50 (m; 1H, H-2), 
5.50 (d, J = 8.97 Hz; 1H, H-2′), 6.66 (br s; 1H, C-2-NH), 7.03 (d, 
J = 8.97 Hz; 1H, C-2′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.9 (C-6), 24.5 (C-4 or C-5), 24.9 (C-4 or C-5), 26.6 
(C-4′), 32.9 (C-3), 35.4 (C-1′′), 35.9 (C-3′), 38.4 (C-1′′), 40.1 (NCH3), 55.4 
(C-2), 59.9 (C-2′), 66.5 (C-1), 171.9 (C-1′), 182.3 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3307 (br), 2928 (s), 2857 (sh), 2781 (w), 1624 (s), 
1536 (s), 1477 (w), 1416 (w), 1396 (m), 1364 (m), 1319 (w), 1253 (w), 
1238 (w), 1188 (w), 1139 (m), 1118 (w), 1083 (m), 1062 (w), 1036 (m), 
947 (m), 914 (m), 872 (sh), 825 (w), 730 (s). 
 
HR-ESI-MS 
 
Exact molecular mass for [C17H35N4OS] ([M+H]+): 343.2531 
                                                                       Found: 343.253 
 
Elemental 
Analysis 
 
Anal. Calcd. for C17H34N4OS: C 59.61,  H 10.00,  N 16.36 
                                     Found: C 59.20,  H  9.88,   N 16.19 
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8.2.57 Preparation of 1-{(S)-1-(diethylcarbamoyl)-2,2-dimethyl-propyl}-3-
{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea 16 
 
[SMU-V-80] 
 
NH2
NMe2  
 NCS
Et2N
O  
 
NMe2
N
H
N
H
S
Et2N
O
101  143  16 
     
    
101 + 143 16 
   
abs. CH2Cl2 
 
RT, 17 h 
  
 
The same procedure as before (see section 8.2.56 on page 184) was followed on a 1.93 mmol scale. 
Purification in the same way afforded a colorless foam (515 mg, 72 %). 
 
16 C19H38N4OS (370.6 g/mol) 
 
N
H NMe2
N
H
S
N
O
12
3
4
61'
2'
3'
4'
1''
2''
5
  
Yield 
 
 
515 mg (1.39 mmol, 72 %) 
 
Melting Point 120-121 °C 
16 
 
 
 
Specific Rotation 
 
 
[ ]20589α = -46.4°, [ ]20546α = -55.9°, [ ]20405α = -135.9°, [ ]20365α = -209.7° (c =1.01, 
CHCl3) 
 
TLC 
 
Rf = 0.37 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.94 (s; 9H, H-4′), 1.02 (t, J = 7.13 Hz; 3H, H-2′′), 
1.09-1.12 (m; 4H, H-3, H-4, H-5, H-6), 1.20 (t, J = 7.13 Hz; 3H, H-2′′), 
1.58-1.78 (m; 3H, H-4, H-5, H-6), 2.14 (s; 6H, NCH3), 2.25-2.33 (m; 2H, 
H-1, H-3), 2.91-3.03 (m; 1H, H-1′′), 3.25-3.34 (m; 1H, H-1′′), 3.45-3.49 (m; 
1H, H-2), 3.54-3.67 (m; 2H, H-1′′), 5.44 (d, J = 8.96 Hz; 1H, H-2′), 6.60 (br 
Experimental Part 
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s; 1H, C-2-NH), 6.95 (d, J = 8.96 Hz; 1H, C-2′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 12.7 (C-2′′), 14.5 (C-2′′), 21.8 (C-6), 24.5 (C-4 or 
C-5), 24.8 (C-4 or C-5), 26.7 (C-4′), 32.9 (C-3), 36.1 (C-3′), 39.8 (C-1′′), 
40.0 (NCH3), 42.7 (C-1′′), 55.2 (C-2), 59.7 (C-2′), 66.5 (C-1), 170.6 (C-1′), 
182.2 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(KBr): ν~ [cm-1] = 3320 (br), 2934 (s), 2861 (m), 2788 (w), 1622 (s), 
1540 (s), 1458 (s), 1364 (s), 1321 (m), 1265 (m), 1216 (w), 1187 (w), 
1138 (w), 1084 (w), 1035 (w), 949 (m), 873 (m), 840 (m), 787 (w), 747 (m). 
 
HR-ESI-MS 
 
Exact molecular mass for [C19H39N4OS] ([M+H]+): 371.2839 
                                                                       Found: 371.284 
 
Elemental 
Analysis 
 
Anal. Calcd. for C19H38N4OS: C 61.58,  H 10.34,  N 15.12 
                                     Found: C 61.28,  H 10.30,  N 15.01 
 
For the X-ray structure see Figure 5.6 on page 68 
Colorless needles from acetone 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
C19H38N4OS 
370.59 g/mol 
100(2) K 
0.71073 Å 
monoclinic 
P21 
a = 11.702(1) Å     α = 90° 
b = 13.351(1) Å     β = 100.81(1)° 
c = 14.156(1) Å     γ = 90° 
2172.4(3) Å3 
4 
1.133 g/cm3 
0.163 mm-1 
816 
0.30 × 0.30 × 0.25 mm 
2.08° to 27.00° 
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 Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]:   
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:        
 
-14 ≤ h ≤ 14 
-14 ≤ k ≤ 17 
-12 ≤ l ≤ 18 
10636 
8211 [ Rint = 0.0387] 
6520 
99.9 % 
Full-matrix least-squares on F2 
8211 / 1 / 756 
1.023 
R1 = 0.0439        ωR2 = 0.0887 
R1 = 0.0655        ωR2 = 0.0973 
0.308 and -0.277 e·Å-3   
 
 
8.2.58 Preparation of 1-{(S)-1-(diisobutylcarbamoyl)-2,2-dimethyl-
propyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea 17 
 
[SMU-VI-35] 
 
NH2
NMe2  
 NCS
i-Bu2N
O  
 
NMe2
N
H
N
H
S
i-Bu2N
O  
101  144  17 
     
    
101 + 144 17 
   
abs. CH2Cl2 
RT, 16 h 
  
 
The same procedure as before (see section 8.2.56 on page 184) was followed on a 2.10 mmol scale. 
Purification in the same way afforded a colorless foam (600 mg, 67 %). 
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17 
 
C23H46N4OS (426.7 g/mol) 
 
 
N
H NMe2
N
H
S
N
O
12
3
4
61'
2'
3'
4'
1''
2''
5
3''  
 
Yield 
 
 
600 mg (1.41 mmol, 67 %) 
 17 
 
 
Melting Point 
 
59-61 °C 
 
Specific Rotation 
 
 
[ ]20589α = -34.9°, [ ]20546α = -42.6°, [ ]20405α = -107.3°, [ ]20365α = -174.3° (c = 1.03, 
CHCl3) 
 
TLC 
 
Rf = 0.33 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.80-0.88 (m; 12H, H-3′′), 0.97 (s; 9H, H-4′), 
1.03-1.24 (m; 4H, H-3, H-4, H-5, H-6), 1.59-1.79 (m; 3H, H-4, H-5, H-6), 
1.85-2.05 (m; 2H, H-2′′), 2.13 (s; 6H, NCH3), 2.19-2.35 (m; 2H, H-1, H-3), 
2.58-2.65 (m; 1H, H-1′′), 3.05-3.12 (m; 1H, H-1′′), 3.37-3.65 (m; 3H, H-1′′, 
H-2), 5.53 (br m; 1H, H-2′), 6.43 (s; 1H, C-2-NH), 6.92 (d, J = 8.6 Hz; 1H, 
C-2′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 19.3 (C-3′′), 20.2 (C-3′′), 20.4 (C-3′′), 20.5 (C-3′′), 
21.7 (C-6), 24.5 (C-4 or C-5), 25.0 (C-4 or C-5), 26.5 (C-2′′), 26.9 (C-4′), 
27.9 (C-2′′), 32.9 (C-3), 36.9 (C-3′), 39.9 (NCH3), 53.5 (C-1′′), 55.3 (C-2′′), 
56.2 (C-1′′), 59.8 (C-2′), 66.6 (C-1), 172.2 (C-1′), 182.1 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3315 (br), 3054 (br), 2954 (s), 2928 (s), 2865 (m), 
2825 (w), 2782 (w), 1617 (s), 1527 (s), 1465 (s), 1445 (s), 1385 (m), 
1363 (s), 1338 (w), 1320 (w), 1301 (w), 1268 (w), 1238 (m), 1207 (m), 
1188 (w), 1140 (m), 1119 (w), 1096 (m), 1085 (m), 1062 (w), 1035 (m), 
946 (sh), 900 (w), 872 (sh), 848 (w), 821 (m), 753 (sh). 
 
HR-EI-MS 
 
Exact molecular mass for [C23H46N4OS] ([M]+): 426.3392 
                                                                  Found: 426.339 
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Elemental 
Analysis 
Anal. Calcd. for C23H46N4OS: C 64.74,  H 10.87,  N 13.13 
                                     Found: C 64.34,  H 10.84,  N 13.09 
  
8.2.59 Preparation of 1-{(S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-
dimethylpropyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea 
18 
 
[SMU-VI-04] 
 
NH2
NMe2  
 NCS
N
O
Me
Ph
 
 
NMe2
N
H
N
H
S
N
O
Me
Ph
101  145  18 
     
    
101 + 145 18 
   
abs. CH2Cl2 
RT, 16 h 
  
 
The same procedure as before (see section 8.2.56 on page 184) was followed on a 1.56 mmol scale. 
Purification in the same way afforded a colorless foam (483 mg, 74 %). 
 
18 
 
C23H38N4OS (418.64 g/mol) 
 
 
N
H NMe2
N
H
S
N
O
Me
12
3
4
61'
2'
3'
4'
5
1''
2''
3''
4''
  
Yield 
 
 
483 mg (1.15 mmol, 73.7 %) 
 18 
 
 
Melting Point 
 
58-59 °C 
 
Specific Rotation 
 
 
 
[ ]20589α = -17.5°, [ ]20546α = -21.8°, [ ]20405α = -60.2°, [ ]20365α = -99.2° (c =1.01, 
CHCl3) 
 
TLC 
 
Rf = 0.33 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
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1H-NMR (500 MHz, CDCl3): δ = 1.06 (s; 9H, H-4′), 1.18-1.32 (m; 4H, H-3, H-4, H-5, 
H-6), 1.69-1.87 (m; 3H, H-4, H-5, H-6), 2.28 (s; 6H, NMe2), 2.36-2.42 (m; 
1H, H-3), 2.56-2.58 (m; 1H, H-1), 3.19 (s; 3H, NCH3), 3,84 (m; 1H, H-2), 
4.50 (d, J = 14.6 Hz; 1H, PhCH2), 4.69 (d, J = 14.6 Hz; 1H, PhCH2), 5.48 (d, 
J = 8.5 Hz; 1H, H-2′), 7.11 (br s; 1H, C-2-NH), 7.20 (br d, J = 8.5 Hz; 1H, 
C-2′-NH), 7.22-7.34 (m; 5H, Har). 
 
13C-NMR 
 
(125 MHz, CDCl3): δ = 21.8 (C-6), 24.5 (C-4 or C-5), 24.8 (C-4 or C-5), 
26.8 (C-4′), 32.9 (C-3), 35.7 (C-3′), 36.0 (NCH3), 39.9 (NMe2), 51.2 
(PhCH2), 55.2 (C-2), 60.3 (C-2′), 66.5 (C-1′), 127.2 (C-4′′), 127.9 (C-2′′ or 
C-3′′), 128.4 (C-2′′ or C-3′′), 136.8 (C-1′′), 172.5 (CO), 182.5 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3308 (br), 3060 (w), 2930 (s), 2857 (m), 2782 (w), 
1626 (s), 1535 (s), 1494 (w), 1477 (w), 1450 (m), 1413 (m), 1364 (m), 
1320 (m), 1267 (w), 1237 (w), 1186 (w), 1081 (m), 1030 (w), 950 (w), 
873 (w), 733 (m), 701 (s). 
 
HR-ESI-MS 
 
Exact molecular mass for [C23H39N4OS] ([M+H]+): 419.2845 
                                                                       Found: 419.284 
 
Elemental 
Analysis 
 
Anal. Calcd. for C23H38N4OS: C 65.99,  H 9.15,  N 13.38 
                                     Found: C 65.60,  H 9.15,  N 13.15 
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8.2.60 Preparation of 1-{(R)-1-(N-benzyl-N-methylcarbamoyl)-2,2-
dimethylpropyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea 
19 
 
[SMU-VI-31] 
 
NH2
NMe2  
 NCS
N
O
Me
Ph
 
 
NMe2
N
H
N
H
S
N
O
Me
Ph
101  ent-145  19 
     
    
101 + ent-145 19 
   
abs. CH2Cl2 
RT, 17 h 
  
 
The same procedure as before (see section 8.2.56 on page 184) was followed on a 2.00 mmol scale. 
Purification in the same way afforded a colorless foam (530 mg, 64 %). 
 
19 
 
C23H38N4OS (418.64 g/mol) 
 
 
N
H NMe2
N
H
S
N
O
Me
12
3
4
61'
2'
3'
4'
5
1''
2''
3''
4''
  Yield 
 
 
530 mg (1.27 mmol, 64 %) 
 19 
 
 
Melting Point 
 
64-65 °C 
 
Specific Rotation 
 
 
[ ]20589α = +47.7°, [ ]20546α = +58.9°, [ ]20405α = +149.1°, [ ]20365α = +216.7° (c = 1.00, 
CHCl3) 
 
TLC 
 
Rf = 0.36 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.02 (s; 9H, H-4′), 1.09-1.26 (m; 4H, H-3, H-4, 
H-5, H-6), 1.64-1.85 (m; 3H, H-4, H-5, H-6), 2.19-2.31 (m; 2H, H-1, H-3), 
2.24 (s; 6H, NMe2), 3.17 (s; 3H, NCH3), 3.48 (br m; 1H, H-2), 4.36 (d, 
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J = 14.6 Hz; 1H, PhCH2), 4.76 (d, J = 14.6 Hz; 1H, PhCH2), 5.60 (d, J = 
9.3 Hz; 1H, H-2′), 6.45 (br s; 1H, C-2-NH), 7.19-7.34 (m; 5H, Har), 8.28 (br 
s; 1H, C-2′-NH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 23.3 (C-6), 24.5 (C-4 or C-5), 24.9 (C-4 or C-5), 
26.8 (C-4′), 33.0 (C-3), 36.1 (C-3′), 36.2 (NCH3), 40.8 (NMe2), 51.1 
(PhCH2), 56.7 (C-2), 60.8 (C-2′), 67.5 (C-1), 127.3 (C-4′′), 128.0 (C-2′′ or 
C-3′′), 128.5 (C-2′′ or C-3′′), 136.9 (C-1′′), 172.1 (C-1′), 183.3 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3324 (br), 3059 (w), 3027 (w), 2929 (s), 2857 (m), 2823 
(w), 2782 (m), 1620 (s), 1530 (s), 1494 (w), 1477 (w), 1448 (m), 1413 (m), 
1363 (m), 1319 (m), 1268 (m), 1253 (w), 1234 (m), 1207 (w), 1189 (w), 
1153 (w), 1108 (w), 1082 (m), 1028 (w), 947 (m), 910 (m), 873 (sh), 849 
(w), 822 (w), 730 (s). 
 
HR-ESI-MS 
 
Exact molecular mass for [C23H39N4OS] ([M+H]+): 419.2845 
                                                                       Found: 419.284 
 
Elemental Analysis 
 
Anal. Calcd. for C23H38N4OS: C 65.99,  H 9.15,  N 13.38 
                                     Found: C 65.55,  H 9.08,  N 13.38 
 
8.2.61 Preparation of 1-{(S)-1-(benzylcarbamoyl)-2,2-dimethyl-propyl}-3-
{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea 20 
 
[SMU-VIII-44] 
 
NH2
NMe2  
 NCS
H
N
O
Ph
 
 
NMe2
N
H
N
H
SH
N
O
Ph
101  146  20 
     
    
101 + 146 20 
   
abs. CH2Cl2 
RT, 16 h 
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The same procedure as before (see section 8.2.56 on page 184) was followed on a 1.64 mmol scale. 
Purification in the same way afforded an off-white foam (490 mg, 74 %). 
 
20 
 
C22H36N4OS (404.61 g/mol) 
 
 
N
H NMe2
N
H
SH
N
O
12
3
4
61'
2'
3'
4'
5
1''
2''
3''
4''
  
Yield 
 
 
490 mg (1.21 mmol, 74 %) 
 20 
 
 
Melting Point 
 
89-91 °C 
 
TLC 
 
Rf = 0.36 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.00 (s; 9H, H-4′), 1.09-1.85 (m; 4H, H-3, H-4, 
H-5, H-6), 1.61-1.76 (m; 3H, H-4, H-5, H-6), 2.16 (s; 6H, NCH3), 
2.22-2.24 (m; 1H, H-3), 2.54 (m; 1H, H-1), 3.98 (m; 1H, H-2), 4.20 (dd, 
J = 5.38, 14.88 Hz; 1H, PhCH2), 4.42 (dd, J = 6.10, 14.88 Hz; 1H, PhCH2), 
4.70 (m; 1H, H-2′), 4.86 (br m; 1H, NH), 7.17-7.24 (m; 7H, Har, 2NHs). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 22.0 (C-6), 24.5 (C-4 or C-5), 24.6 (C-4 or C-5), 
27.0 (C-4′), 32.9 (C-3), 34.4 (C-3′), 39.8 (NCH3), 43.1 (PhCH2), 54.9 (C-2), 
66.5 (C-1, C-2′), 127.0 (C-4′′), 127.6 (C-2′′ or C-3′′), 128.3 (C-2′′ or C-3′′), 
138.1 (C-1′′), 171.3 (C-1′), 182.2 (CS). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3264 (br), 3061 (m), 2933 (s), 2862 (m), 2793 (w), 
1644 (s), 1537 (s), 1474 (w), 1452 (m), 1399 (w), 1359 (m), 1309 (m), 
1232 (w), 1182 (w), 1088 (m), 1028 (sh), 991 (w), 949 (w), 909 (m), 
873 (sh), 851 (w), 824 (w), 728 (s). 
 
HR-ESI-MS 
 
Exact molecular mass for [C22H37N4OS] ([M+H]+): 405.2688 
                                                                       Found: 405.269 
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8.2.62 Preparation of 1-{(S)-1-(N-benzyl-N-methylcarbamoyl)-3,3-di-
methylbutyl}-3-{(1R,2R)-2-(dimethylamino)cyclohexyl}thiourea 21 
 
[SMU-VI-84] 
 
NH2
NMe2  
 N
O
Me
Ph
NCS
 
 
NMe2
N
H
N
H
S
N
O
Me
Ph
101  147  21 
     
    
101 + 147 21 
   
abs. CH2Cl2 
RT, 18 h 
  
 
The same procedure as before (see section 8.2.56 on page 184) was followed on a 2.57 mmol scale. 
Purification in the same way afforded a colorless foam (832 mg, 75 %). 
 
21 C24H40N4OS (432.67 g/mol) 
 
Yield 
 
832 mg (1.92 mmol, 75 %) 
 
12
3
4
5
61'
2'
3' 4'
5'
NMe2
N
H
N
H
S
N
O
Me
1''
2''
3''
4''
 
 
Melting Point 
 
67-68 °C 21 
 
 
TLC 
 
Rf = 0.38 (Silicagel, CH2Cl2/CH3OH/TEA 100:5:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 0.82, 0.99 (2s; 9H, H-5′), 1.06-1.27 (m; 5H), 
1.53-1.77 (m; 5H), 2.24, 2.26 (2s; 6H, NMe2), 2.34-2.41 (m; 2H), 2.92, 
3.11 (2s; 3H, NCH3), 3.64-3.71 (br m; 1H), 4.42 (d, J = 14.84 Hz; 0.7H, 
PhCH2), 4.60 (d, J = 16.50 Hz; 0.3H, PhCH2), 4.68 (d, J = 14.84 Hz; 0.7H, 
PhCH2), 5.06 (d, J = 16.50 Hz; 0.3H, PhCH2), 5.69 (br m; 1H), 6.66 (br m; 
1H), 7.18-7.35 (m; 5H, Har), 7.91 (br s; 1H). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 22.0 (CH2), 22.3 (CH2), 24.5 (CH2), 24.8 (CH2), 
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29.7 (CH3), 30.0 (CH3), 30.7 (Cq), 30.9 (Cq), 33.2 (CH2), 34.4 (CH2), 
35.0 (CH2), 40.2 (CH3), 46.2 (CH2), 46.8 (CH2), 51.3 (CH2), 52.4 (CH), 
53.5 (CH2), 55.1 (CH), 55.3 (CH), 67.0 (CH), 127.1 (Car), 127.4 (Car), 
127.6 (Car), 127.7 (Car), 128.6 (Car), 128.7 (Car), 136.5 (Cqar), 136.7 (Cqar), 
174.2 (CO), 181.7 (CS), 182.0 (CS). 
Two sets of signals were obtained due to dynamic NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3318 (br s), 2931 (s), 2858 (m), 2823 (w), 2779 (m), 
1629 (s), 1543 (s), 1494 (w), 1475 (w), 1450 (m), 1419 (w), 1362 (m), 
1318 (w), 1270 (w), 1253 (w), 1206 (w), 1150 (w), 1084 (m), 1038 (w), 
945 (w), 911 (m), 875 (w), 851 (w), 730 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C24H41N4OS] ([M+H]+): 433.3001 
                                                                       Found: 433.300 
 
8.2.63 Preparation of 1,2-dicyclohexyl-3-{(1R,2R)-2-(dimethylamino)-
cyclohexyl}guanidine 148 
 
[SMU-VIII-33] 
 
NH2
NMe2  
 C NN
 
 
N
H
Me2N
N
H
N
 
101  149  148 
     
    
101 + 149 148 
   
abs. t-BuOH 
100 °C, 24 h 
  
 
To a solution of (1R,2R)-N,N-dimethyl-1,2-diaminocyclohexane 101 (250 mg, 1.76 mmol, 2.00 eq) 
in 4 mL of abs. t-BuOH, was added N,N-dicyclohexyl carbodiimide 149 (182 mg, 880 µmol, 1.00 
eq) and the resulting solution was heated to reflux under argon for 24 hours. The reaction mixture 
was then cooled to ambient temperature and the solvent was removed in vacuo to obtain a highly 
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viscous yellow oil. Purification by bulb-to-bulb distillation (175 °C, <1 mbar) afforded a pale 
yellow oil (230 mg, 75 %). 
 
148 
 
C21H40N4 (348.57 g/mol) 
 
N
H
Me2N
N
H
N
 
 
Yield 
 
 
230 mg (660 µmol, 75 %) 
 148 
 
 
1H-NMR (250 MHz, CDCl3): δ = 1.07-1.31 (m; 15 H), 1.54-1.67 (m; 15 H), 2.16 (s; 
6H, NCH3), 3.03 (br m; 2H). 
The NH protons could not be detected. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3247 (br), 2923 (s), 2849 (s), 2778 (m), 2117 (sh s), 
1637 (s), 1447 (s), 1337 (w), 1267 (w), 1207 (w), 1188 (m), 1150 (m), 
1095 (w), 1042 (m), 951 (w), 889 (sh m), 871 (sh m), 846 (w), 819 (w), 
726 (br m). 
 
HR-EI-MS 
 
Exact molecular mass for [C21H41N4] ([M+H]+): 349.3326 
                                                                  Found: 349.333 
 
8.2.64 Preparation of 1,2-dicyclohexyl-3-{(1R,2R)-2-(dimethylamino)-
cyclohexyl}guanidinidinium trifluoroacetate 150 
 
[SMU-VIII-38] 
 
N
H
Me2N
N
H
N
 
 
N
H
Me2N
N
H
N
CF3CO2 H
 
148  150 
   
  
148 150 
 
CF3CO2H 
abs. DCM, RT, 30 min 
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To a solution of 148 (215 mg, 620 µmol, 1.00 eq) in 3 mL of abs. DCM was added a solution of 
CF3CO2H (48 µL, 620 µmol, 1.00 eq) in 1 mL abs. DCM and the solution was stirred at room 
temperature for 30 minutes. The reaction mixture was then concentrated in vacuo to obtain a pale 
yellow foam (285 mg, 100 %). 
 
150 
 
C23H41F3N4O2 (462.59 g/mol) 
 
N
H
Me2N
N
H
N
CF3CO2 H
 
 
Yield 
 
 
285 mg (620 µmol, 100 %) 
 150 
 
 
1H-NMR 
 
(250 MHz, CDCl3): δ = 1.17-1.43 (m; 15H), 1.60-2.04 (m; 15H), 2.34 (s; 
6H, NCH3), 3.18-3.21 (m; 2H), 8.39 (br s; 1H). 
Two NH protons could not be detected. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3254 (br), 3090 (br), 2929 (s), 2855 (s), 2116 (sh m), 
1685 (s), 1621 (s), 1450 (m), 1365 (w), 1348 (w), 1246 (w), 1198 (s), 
1168 (w), 1124 (s), 1042 (w), 890 (sh), 872 (w), 825 (s), 797 (s), 
717 (sh s). 
 
HR-EI-MS 
 
Exact molecular mass for [C21H41N4] ([M–CF3CO2]+): 349.3326 
                                                                            Found: 349.333 
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8.3 Synthesis of oxazaborolidines and its precursors 
8.3.1 Preparation of N-benzyl-(S)-pyrrolidin-2-carboxylic acid benzyl 
ester 153 
 
[SMU-III-77] 
 
N
H H
OH
O
 
 N H
O
O
Ph
Ph
 
37  153 
   
  
37 153 
 
BnCl, NaHCO3/DMF 
0 °C – reflux, 4 h 
 
 
To an ice-cold suspension of L-proline 37 (10.0 g, 86.9 mmol, 1.00 eq) and NaHCO3 (18.2 g, 217.2 
mmol, 2.50 eq) in 150 mL of absolute DMF, benzyl chloride (24.2 g, 191.1 mmol, 2.20 eq) was 
added dropwise over a period of 40 mins. After complete addition, the resulting mixture was stirred 
for 30 mins at room temperature and then refluxed for 4 hrs under argon atmosphere. The reaction 
mixture was then cooled to room temperature and stirred overnight at that temperature. 150 mL of 
water was added to it and stirred for 5 mins to obtain a homogeneous solution. This was then 
extracted with toluene (3 × 100 mL). The combined organic extract was washed with sat. NaCl 
solution and water (100 mL each) and dried over anh. MgSO4. Solvent was removed in vacuo to 
obtain a pale yellow oil which was dried overnight in vacuo at 60 °C.  This oil (25.4 g, 99 %) was 
used in the following step without further purification. 
 
153 
 
C19H21NO2 (295.38 g/mol) 
 
 
1
5
2
34
N H
O
O
 
 
Yield 
 
 
25.4 g (85.8 mmol, 99 %) 
 153 
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1H-NMR (300 MHz, CDCl3): δ = 1.78-2.21 (m; 4H, H-3, H-4), 2.39-2.48 (m; 1H, 
H-5), 3.02-3.09 (m; 1H, H-5), 3.32-3.37 (m; 1H, H-2), 3.58 (d, J = 12.9 Hz; 
1H, NCH2), 3.95 (d, J = 12.9 Hz; 1H, NCH2), 5.11 (d, J = 12.3 Hz; 1H, 
OCH2), 5.16 (d, J = 12.3 Hz; 1H, OCH2), 7.23-7.41 (m; 10H, Har). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 2956 (m), 2877 (w), 2801 (m), 2360 (s), 2341 (m), 
1729 (s), 1495 (m), 1454 (s), 1371 (w), 1269 (m), 1167 (s), 1028 (w), 
911 (w), 738 (m). 
 
8.3.2 Preparation of N-benzyl-(S)-diphenyl(pyrrolidin-2-yl)methanol 
154a[173] 
 
[SMU-III-11] 
 
N H
O
O
Ph
Ph
 
 N H
OH
Ph
PhPh
 
153  154a 
   
  
153 154a 
 
PhBr, Mg 
THF, reflux, 3 h 
 
 
An oven-dried 250 mL two-necked flask fitted with an argon inlet and a 50 mL pressure-equalized 
addition funnel containing a solution of bromobenzene (3.91 g, 24.9 mmol, 2.80 eq) in 15 mL abs. 
THF was charged with magnesium turnings (606 mg, 24.9 mmol, 2.80 eq; activated with iodine) in 
10 mL of abs. THF. A small portion (2 mL) of the solution of bromobenzene was added with 
stirring at room temperature. After the exothermic reaction started, the reaction flask was cooled 
with a water bath. The remaining bromobenzene was added dropwise over a period of 30 min. After 
the addition was complete, the reaction mixture was stirred at room temperature for 30 min until all 
the magnesium turnings consumed. This solution was then cooled to 0 °C and a solution of 
N-benzyl-(S)-pyrrolidin-2-carboxylic acid benzyl ester 153 (2.63 g, 8.90 mmol, 1.00 eq) in 15 mL 
abs. THF was added dropwise over a period of 1 hr. The resulting mixture was then refluxed for 3 
hrs. The reaction mixture was then cooled to room temperature and an ice-cold saturated NH4Cl-
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solution (12 mL) was added to it followed by 2 mL of 2N hydrochloric acid. 2N KOH solution was 
added to it until pH ~ 7.5. The organic layer was separated and the aqueous layer was extracted 
with ethyl acetate (2 × 200 mL). The combined organic layer was washed with sat. NaCl solution 
(100 mL), dried over anh. Na2CO3 and the solvent was removed in vacuo to obtain a pale yellow 
solid. Recrystallization from ethanol afforded a white crystalline solid (2.45 g, 80 %). 
 
154a 
 
C24H25NO (343.46 g/mol) 
 
 
Yield 
 
 
 
2.45 g (7.13 mmol, 80 %) 
[Lit.[173]: 76 %] 
 
 
1
2
4
5
3
N H
OH
 Melting Point 
 
115 °C (EtOH) 
[Lit[173]: 116 °C (Et2O)] 154a 
 
 
TLC 
 
Rf = 0.65 (Silicagel, n-Hex/EtOAc 5:1) 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.68-1.91 (m; 3H, H-3, H-4), 1.99-2.13 (m; 1H, 
H-3), 2.41-2.50 (m; 1H, H-5), 2.99-3.05 (m; 1H, H-5), 3.13 (d, 
J = 12.63 Hz; 1H, NCH2), 3.33 (d, J = 12.63 Hz; 1H, NCH2), 4.08 (2d, 
J = 4.64 Hz; 1H, H-2), 5.03 (br s; 1H, OH), 7.13-7.42 (m; 11H, Har), 
7.67-7.70 (m; 2H, Har), 7.81-7.84 (m; 2H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 24.2 (C-4), 29.8 (C-3), 55.5 (C-5), 60.6 (NCH2), 
70.6 (C-2), 77.9 (COH), 125.5 (Car), 125.6 (Car), 126.2 (Car), 126.4 (Car), 
126.8 (Car), 128.0 (Car), 128.1 (Car), 128.2 (Car), 128.6 (Car), 139.7 (Cqar), 
146.7 (Cqar), 148.0 (Cqar). 
The NMR data are in agreement with the literature.[173] 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3440 (s), 3052 (m), 1962 (m), 2804 (s), 2357 (m), 
2335 (w), 1604 (s), 1495 (s), 1448 (s), 1375 (s), 1358 (s), 1311 (m), 
1252 (m), 1202 (w), 1162 (w), 1130 (s), 1102 (s), 1040 (s), 866 (m), 
766 (s), 705 (s). 
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8.3.3 Preparation of N-benzyl-(S)-bis(3,5-dimethylphenyl)-pyrrolidin-2- 
methanol 154b[174] 
 
[SMU-III-78] 
 
N H
O
O
Ph
Ph
 
 
N H
OH
Ph
Me
Me
Me
Me
 
153  154b 
   
  
153 154b 
 
m-Xyl-5-Br, Mg 
THF, reflux, 3 h 
 
 
The same procedure as before (see section 8.3.2 on page 200) was followed on a 10.2 mmol scale. 
The crude product was obtained as a yellowish orange oil (4.10 g, >99 %). This was used in the 
subsequent step (see section 8.3.6 on page 207) without further purification. 
 
 
 
154b 
 
 
C28H33NO (399.57 g/mol) 
 
 
N H
OH
Me
Me
Me
Me
1 2
34
5
 
 
Yield 
 
 
4.10 g (10.3 mmol, >99 %) 
 
154b 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.56-1.82 (m; 2H), 1.90-2.03 (m; 1H), 2.24 (s; 6H, 
CH3), 2.29 (s; 6H, CH3), 2.21-2.37 (m; 2H), 2.87-2.93 (m; 1H), 2.99 (d, 
J = 12.62 Hz; 1H, NCH2), 3.15 (d, J = 12.62 Hz; 1H, NCH2), 3.87-3.91 
(m; 1H, H-2), 4.60 (s; 1H, OH), 6.70 (s; 1H, Har), 6.80 (s; 1H, Har), 
7.03-7.05 (m; 2H, Har), 7.17-7.32 (m; 7H, Har). 
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13C-NMR (75 MHz, CDCl3): δ = 21.4 (CH3), 21.5 (CH3), 24.2 (C-4), 29.8 (C-3), 55.6 
(C-5), 60.5 (NCH2), 70.7 (C-2), 78.0 (COH), 123.4 (Car), 126.6 (Car), 
126.8 (Car), 127.4 (Car), 128.4 (Car), 128.5 (Car), 128.9 (Car), 137.17 (Cqar), 
137.23 (Cqar), 139.8 (Cqar), 146.3 (Cqar), 147.7 (Cqar). 
 
8.3.4 Preparation of N-benzyl-(S)-2-(di-β-naphthylhydroxymethyl)-
pyrrolidine 154c[175] 
 
[ILO-I-04] 
 
N H
O
O
Ph
Ph
 
 
N H
OH
Ph  
153  154c 
   
  
153 154c 
 
2-naphthyl-Br, Mg 
THF, reflux, 3 h 
 
 
The same procedure as before (see section 8.3.2 on page 200) was followed on an 8.46 mmol scale. 
The crude product was purified by column chromatography on silica gel (10:1 n-hexane/EtOAc as 
the eluant) to obtain an off-white solid (2.40 g, 64 %). 
 
$nbndnaphproh 
 
C32H29NO  (443.58 g/mol) 
 
1 2
4
5
3
N H
OH
 
 
Yield 
 
 
 
2.40 g (5.41 mmol, 64 %) 
[Lit.[175]: 83 %] 
 154c 
 
 
Melting Point 
 
78 °C [Lit.[175]: 78-79 °C (hexane/tert-butyl methyl ether)] 
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TLC Rf = 0.19 (Silicagel, n-hexane/EtOAc 10:1) 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.62-2.13 (m; 4H, H-3, H-4), 2.37-2.46 (m; 1H, 
H-5), 2.94-3.09 (m; 1H, H-5), 3.06 (d, J = 12.5 Hz; 1H, NCH2), 3.29 (d, 
J = 12.5 Hz; 1H, NCH2), 4.23 (dd, J = 4.8, 9.2 Hz; 1H, H-2), 6.98-7.01 (m; 
2H, Har), 7.11-7.20 (m; 3H, Har), 7.33-7.47 (m; 4H, Har), 7.67-7.88 (m; 8H, 
Har), 8.11 (s; 1H, Har), 8.35 (s; 1H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 24.2 (C-4), 29.9 (C-3), 55.6 (C-5), 60.6 (NCH2), 
70.0 (C-2), 78.3 (C-OH), 123.9 (Car), 124.1 (Car), 124.3 (Car), 124.4 (Car), 
125.6 (Car), 125.7 (Car), 125.9 (Car), 126.0 (Car), 126.8 (Car), 127.38 (Car), 
127.42 (Car), 127.8 (Car), 127.9 (Car), 128.06 (Car), 128.16 (Car), 128.19 
(Car), 128.6 (Car), 132.0 (Cqar), 133.2 (Cqar), 133.3 (Cqar), 139.4 (Cqar), 
143.8 (Cqar), 145.2 (Cqar). 
The NMR data are in agreement with the literature.[175] 
 
8.3.5 Preparation of (S)-α,α-diphenyl-2-pyrrolidin-methanol 97a[174] 
 
[SMU-III-19] 
 
N H
OH
Ph
PhPh
 
 
N
H H
OH
PhPh
 
154a  97a 
   
  
154a 97a 
 
H2, Pd/C 
MeOH, AcOH, 20 h 
 
 
In a 100 mL round bottom flask N-benzyl-(S)-diphenyl(pyrrolidin-2-yl)methanol 154a (1.96 g, 
5.71 mmol, 1.00 eq) and palladium (10 % on charcoal, 60.7 mg, 57 µmol, 0.01 eq) was suspended 
in 35 mL methanol along with 0.5 mL of glacial acetic acid. This suspension was then stirred at 
room temperature under hydrogen atmosphere (p = 1 bar) for 20 hrs. The reaction mixture was then 
filtered through a Celite® pad with suction and concentrated in vacuo to obtain a white crystalline 
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solid (1.78 g) which was dissolved in chloroform (35 mL) and washed with saturated NaHCO3 
solution (40 mL). The aqueous layer was extracted with chloroform (2 × 10 mL) and the combined 
organic layer was washed with sat. NaCl solution (25 mL). The organic layer was dried over anh. 
MgSO4 and the solvent was removed in vacuo to obtain a thick colourless oil. This oil was refluxed 
with n-heptane (15 mL) and cooled to afford a colorless crystalline solid (1.35 g, 93 %). 
 
97a 
 
C17H19NO (253.34 g/mol) 
 
Yield 
 
1.35 g (5.33 mmol, 93 %) 
[Lit.[174]: 95 %] 
 
1 2
4
5
3
N
H H
OH
  
Melting Point 
 
 
76-78 °C (n-heptane) 
[Lit.[174]: 79-79.5 °C] 97a 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.47-1.77 (m; 4H, H-3, H-4), 2.86-3.03 (m; 2H, 
H-5), 4.22 (t, J = 7.5 Hz; 1H, H-2), 7.10-7.16 (m; 2H, Har), 7.21-7.99 (m; 
4H, Har), 7.44-7.48 (m, 2H, Har), 7.52-7.55 (m; 1H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 25.5 (C-4), 26.2 (C-3), 46.7 (C-5), 64.4 (C-2), 77.1 
(COH), 125.5 (Car), 125.8 (Car), 126.3 (Car), 126.4 (Car), 127.9 (Car), 128.2 
(Car), 145.3 (Cqar), 148.1 (Cqar). 
The NMR data are in agreement with the literature.[174] 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3373 (br s), 3061 (w), 2964 (m), 2354 (m), 1606 (s), 
1492 (m), 1452 (m), 1397 (m), 1343 (m), 1189 (m), 1128 (w), 1068 (m), 
993 (m), 754 (s), 708 (s). 
 
For the X-ray structure see Figure 5.9 on page 80 
Colorless needles from n-heptane 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
C17H19NO 
253.34 g/mol 
100(2) K 
0.71073 Å 
orthorhombic 
P212121 
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 Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]:   
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:        
a = 9.0190(2) Å     α = 90° 
b = 9.2900(2) Å     β = 90° 
c = 16.8057(4) Å     γ = 90° 
1408.09(5) Å3 
4 
1.195 g/cm3 
0.074 mm-1 
544 
0.28 × 0.22 × 0.20 mm 
2.56° to 27.00° 
-11 ≤ h ≤ 10 
-11 ≤ k ≤ 11 
-20 ≤ l ≤ 21 
9650 
3070 [Rint = 0.0380] 
2117 
99.7 % 
Full-matrix least-squares on F2 
3070 / 0 / 250 
0.987 
R1 = 0.0419        ωR2 = 0.0952 
R1 = 0.0694        ωR2 = 0.1076 
0.120 and -0.104 e·Å-3   
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8.3.6 Preparation of (S)-α,α-bis(3,5-dimethylphenyl)-pyrrolidin-2-yl-
methanol 97b[174] 
 
[SMU-III-82] 
 
N H
OH
Ph
Me
Me
Me
Me
 
 
N
H H
OH
Me
Me
Me
Me
 
154b  97b 
   
  
154b 97b 
 
H2, Pd/C 
MeOH, AcOH, 24 h 
 
 
The same procedure as before (see section 8.3.5 on page 204) was followed on a 10.3 mmol scale to 
obtain the crude product as a thick oil. This was purified by column chromatography on silica gel 
(n-Hex/EtOAc 5:1 to 1:10 as eluant) to afford a clear oil which was then crystallized from 
n-heptane to obtain colorless crystals (2.49 g, 79 %). 
 
 
97b 
 
C21H27NO (309.45 g/mol) 
 
Yield 
 
2.49 g (8.05 mmol, 79 %) 
[Lit.[174]: 75 %] 
 
N
H H
OH
Me
Me
Me
Me
1 2
34
5
1'
2'
3'
4'
5'
6'
 
Melting Point 
 
 
98 °C (n-heptane) 
[Lit.[174]: 97.5-98 °C] 97b 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.53-1.85 (m; 5H, H-3, H-4, NH), 2.30 (s; 6H, 
CH3), 2.31 (s; 6H, CH3), 2.90-3.07 (m; 2H, H-5), 4.23 (t, J = 7.58 Hz; 1H, 
H-2), 6.82 (s; 2H, H-4′), 7.14 (s; 2H, H-2′), 7.20 (s; 2H, H-6′). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 21.51 (CH3), 21.53 (CH3), 25.4 (C-4), 26.2 (C-3), 
46.7 (C-5), 64.4 (C-2), 76.9 (COH), 123.1 (Car), 123.5 (Car), 127.9 (Car), 
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128.0 (Car), 137.1 (Cqar), 137.4 (Cqar), 145.3 (Cqar), 148.1 (Cqar). 
The NMR data are in agreement with the literature.[174] 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3348 (br), 2943 (s), 2912 (s), 2864 (m), 1602 (s), 
1456 (s), 1394 (m), 1373 (m), 1281 (m), 1151 (s), 1108 (s), 1033 (s), 
981 (w), 941 (w), 919 (w), 901 (m), 847 (s), 795 (w), 740 (s), 689 (w). 
 
8.3.7 Preparation of (S)-2-(di-β-naphthylhydroxymethyl)-pyrrolidine 
97c[175] 
 
[ILO-I-07] 
 
N H
OH
Ph  
 
N
H H
OH
 
154c  97c 
   
  
154c 97c 
 
H2, Pd(OH)2/C 
MeOH, AcOH, 40 h 
 
 
The same procedure as before (see section 8.3.5 on page 204) was followed on a 5.37 mmol scale to 
obtain a clear oil (1.03 g, 54 %). Recrystallization from n-heptane afforded a white amorphous 
solid.  
 
97c 
 
 
C25H23NO (353.46 g/mol) 
 
 
N
H H
OH
1 2
34
5
 
 
Yield 
 
 
1.03 g (2.91 mmol, 54 %) 
[Lit.[175]: 87 %] 97c 
 
 
Melting Point 
 
 
138 °C (n-heptane)  
[Lit.[175]: 137-138 °C (n-hexane/ethyl acetate)] 
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TLC Rf = 0.04 (Silicagel, n-hexane/EtOAc 1:1) 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.56-1.84 (m; 4H, H-3, H-4), 2.95-3.10 (m; 2H, 
H-5), 4.48-4.52 (m; 1H, H-2), 7.37-7.48 (m; 4H, Har), 7.56-7.60 (m; 1H, 
Har), 7.66-7.76 (m; 5H, Har), 7.82-7.87 (m; 2H, Har), 8.10 (s; 2H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 25.6 (C-4), 26.5 (C-3), 46.8 (C-5), 64.0 (C-2), 
77.5 (C-OH), 123.7 (Car), 124.0 (Car), 124.4 (Car), 125.2 (Car), 125.6 (Car), 
125.75 (Car), 125.85 (Car), 126.0 (Car), 127.4 (Car), 127.6 (Car), 128.0 (Car), 
128.17 (Car), 128.23 (Car), 132.19 (Cqar), 132.22 (Cqar), 133.09 (Cqar), 
133.17 (Cqar), 142.6 (Cqar), 145.3 (Cqar). 
The NMR data are in agreement with the literature.[175] 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3349 (br), 3053 (sh), 2965 (m), 2867 (m), 1916 (w), 
1628 (m), 1597 (s), 1504 (sh s), 1457 (w), 1432 (w), 1398 (s), 1268 (s), 
1245 (w), 1156 (s), 1121 (s), 1017 (sh), 998 (m), 946 (w), 892 (m), 857 (s), 
819 (s), 786 (s), 743 (s), 701 (w). 
 
8.3.8 Preparation of 2,4,6-triphenyl-1,3,5-trioxa-2,4,6-triborinane 151a 
 
[SMU-II-54] 
 
B
OH
OH
 
 O
B
O
B
O
B
 
98a  151a 
   
  
98a 151a 
 
toluene 
reflux, 5 h 
 
 
In a 50 mL round-bottomed flask equipped with a magnetic stir-bar and a Dean-Stark apparatus, 
phenylboronic acid 98a (500 mg, 4.1 mmol) was dissolved in 40 mL of freshly dried toluene. 98a 
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was then dehydrated by azeotropic distillation for 5 hrs. The reaction mixture was then cooled to 
ambient temperature and the solvent was removed in vacuo to afford a colorless crystalline solid 
(426 mg, quant.). 
 
151a 
 
C18H15B3O3 (311.74 g/mol) 
 
O
B
O
B
O
B
 
 
Yield 
 
 
426 mg (1.37 mmol, quant.) 
 
151a 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 7.46-7.62 (m; 9H, Har), 8.22-8.25 (m; 6H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 127.9 (CHar), 132.7 (CHar), 135.6 (CHar). 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 1604 (s), 1494 (m), 1444 (s), 1370 (s), 1344 (br s), 
1306 (s), 1261 (s), 1180 (w), 1126 (m), 1088 (s), 1025 (s), 844 (w), 
804 (s), 760 (w), 700 (s). 
 
For X-ray structure see Figure 5.10 on page 81 
Colorless needles from n-hexane/toluene mixture 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
C18H15B3O3 
311.74 g/mol 
293(2) K 
0.71073 Å 
monoclinic 
P21/c 
a = 10.7077(6) Å     α = 90° 
b = 13.6285(7) Å     β = 100.38° 
c = 11.7104(9) Å     γ = 90° 
1680.94(18) Å3 
2 
1.232 mg/m3 
0.079 mm-1 
648 
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 Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]:   
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:        
 
0.20 × 0.20 × 0.30 mm 
1.93° to 26.99° 
-9 ≤ h ≤ 13 
-15 ≤ k ≤ 17 
-14 ≤ l ≤ 14 
7138 
3528 [ Rint = 0.0539] 
1397 
96.0 % 
Full-matrix least-squares on F2 
3528 / 0 / 277 
1.014 
R1 = 0.0617        ωR2 = 0.1446 
R1 = 0.1876        ωR2 = 0.1853 
0.148 and -0.161 e·Å-3 
 
 
8.3.9 Preparation of 2,4,6-tri(o-tolyl)-1,3,5-trioxa-2,4,6-triborinane 
151b[138] 
 
[SMU-II-81] 
 
B
OH
OHMe
 
 O
B
O
B
O
B
Me
Me
Me
 
98b  151b 
   
  
98b 151b 
 
toluene 
reflux, 6 h 
 
 
The same procedure as before (see section 8.3.8 on page 209) was followed on a 3.68 mmol scale to 
obtain a colorless crystalline solid (435 mg, quant.). 
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151b 
 
C21H21B3O3 (353.82 g/mol) 
 
 
Yield 
 
 
435 mg (1.23 mmol, quant.) 
 
O
B
O
B
O
B
Me
Me
Me
 
Melting Point 165 ºC [Lit.[138]: 165-166 °C] 
151b 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 2.80 (s; 9H, CH3), 7.25-7.32 (m; 3H, Har), 
7.44 (app. dt, J = 1.5, 7.5 Hz; 3H, Har), 8.20 (dd, J = 1.5, 7.4 Hz; 3H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 23.1 (CH3), 125.2 (CHar), 130.6 (CHar), 
132.2 (CHar), 137.2 (CHar), 146.3 (Cqar). 
The NMR data are in agreement with the literature.[138] 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 1601 (s), 1486 (m), 1442 (s), 1342 (br s), 1301 (s), 
1200 (m), 1164 (w), 1067 (m), 736 (s). 
 
8.3.10 Preparation of (S)-hexahydro-1,3,3-triphenylpyrrolo[1,2-c][1,3,2]-
oxazaborole 29b[174] 
 
[SMU-II-79] 
 
N
H H
OH
PhPh
 
 O
B
O
B
O
B
Ph
PhPh  
 N
B
O
Ph
PhPhH
 
97a  151a  29b 
     
    
97a + 151a 29b 
   
toluene 
reflux, 6 h 
  
 
A 100 mL oven-dried round bottom flask equipped with a magnetic stirring bar, a dropping funnel 
(filled with 4Å MS) and a reflux condenser was charged with (S)-α,α-diphenyl-2-pyrrolidin 
methanol  97a (200 mg, 0.79 mmol, 1.00 eq) and 2,4,6-triphenyl-1,3,5-trioxa-2,4,6-triborinane 
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151a (81 mg, 0.26 mmol, 0.33 eq). 30 mL of abs. toluene was then added and the resulting solution 
was heated to reflux under positive pressure of argon for 6 hours. The reaction mixture was then 
cooled to ambient temperature under argon, and the dropping funnel and reflux condenser was 
quickly replaced by a short-path distillation set-up. The solvent was then distilled off to a small 
volume under argon atmosphere. The distillation was repeated three times after adding 3 × 5 mL 
toluene. The residual solution was then cooled to room temperature and the distillation head was 
quickly replaced by an argon inlet adapter. It was then concentrated in vacuo to obtain a colourless 
semisolid (263 mg, 99 %). This semisolid was then dissolved in abs. toluene and the solution was 
used for the catalysis experiments. 
 
8.3.11 Preparation of (S)-hexahydro-3,3-bis(3,5-dimethylphenyl)-1-o-
tolylpyrrolo[1,2-c][1,3,2]oxazaborole 29c[138] 
 
[SMU-VII-32] 
 
N
H H
OH
Me
Me
Me
Me
 
 O
B
O
B
O
B
Me
Me
Me
 
 N
B
O
H
Me
Me
Me
MeMe
 
97b  151b  29c 
     
    
97b + 151b 29c 
   
toluene 
 
reflux, 6 h 
  
 
The same procedure as before (see section 8.3.10 on page 212) was followed on a 0.61 mmol scale 
to obtain a colourless semisolid (249 mg, 99 %). This was dissolved in abs. toluene and the solution 
was used in the catalysis experiments. 
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8.4 Asymmetric hydrocyanation of imines 
8.4.1 Preparation of N-benzylidene-1-phenyl-methanamine 27a[36] 
 
[SMU-I-77] 
 
O
H
 
 
H2N
 
 H
N Ph
 
33  155  27a 
     
    
33 + 155 27a 
   
anh. MgSO4 
abs. CH2Cl2, RT, 6 h 
  
 
In a 50 mL oven-dried round bottom flask charged with magnetic stirring bar and anh. MgSO4 (3.0 
g, 24.9 mmol, 1.26 eq) 10 ml of abs. DCM was added. To this suspension benzaldehyde 33 (2.00 
mL, 19.7 mmol, 1.00 eq) was added followed by benzyl amine 155 (2.15 mL, 19.7 mmol, 1.00 eq). 
The resulting mixture was then stirred at room temperature under argon atmosphere for 6 hours. 
MgSO4 was filtered off and the solvent was removed in vacuo to obtain a highly viscous oil (3.83 g, 
99 %). 
 
27a 
 
C14H13N (195.26 g/mol) 
 H
N
  
Yield 
 
3.83 g (19.6 mmol, 99 %) 27a 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 4.87 (s; 2H, CH2), 7.28-7.48 (m; 8H, Har), 
7.82-7.86 (m; 2H, Har), 8.42 (s; 1H, N=CH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 64.9 (CH2), 126.9 (Car), 127.9 (Car), 128.2 (Car), 
128.4 (Car), 128.5 (Car), 130.6 (Car), 136.1 (Cqar), 139.2 (Cqar), 
161.8 (N=CH). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3273 (w), 3085 (w), 3061 (m), 3028 (m), 2871 (m), 
2841 (m), 1959 (w), 1813 (w), 1701 (s), 1643 (s), 1600 (m), 1580 (m), 
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1496 (m), 1452 (s), 1379 (m), 1343 (w), 1311 (w), 1292 (w), 1219 (w), 
1204 (w), 1169 (w), 1157 (w), 1073 (w), 1039 (w), 1026 (m), 1002 (w), 
960 (w), 916 (w), 858 (w), 827 (w), 753 (s), 734 (s), 697 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C14H13N] ([M]+): 195.1048 
                                                            Found: 195.105 
 
HPLC 
 
τR = 8.1 min (Chiralcel OJ, n-hexane/i-PrOH 90:10, 1.0 mL/min) 
 
8.4.2 Preparation of N-benzylidene-1,1-diphenylmethanamine 157[100] 
 
[SMU-I-20] 
 
O
H
 
 
H2N Ph
Ph
 
 
H
N Ph
Ph
 
33  156  157 
     
    
33 + 156 157 
   
anh. MgSO4 
 
abs. CH2Cl2, RT, 24 h 
  
 
The same procedure as before (see section 8.4.1 on page 214) was followed on a 49.2 mmol scale to 
obtain as a colorless solid (12.3 g, 92 %). This was recrystallized from diethylether to obtain 
colorless crystals.  
 
157 
 
C20H17N (271.36 g/mol) 
 
Yield 
 
12.28 g (45.3 mmol, 92 %) 
[Lit.[100]: 93 %] H
N
  
Melting Point 
 
 
100 ºC (Et2O) 
[Lit.[176]: 98-100 ºC (pentane)] 157 
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1H-NMR (300 MHz, CDCl3): δ = 5.60 (s; 1H, CHPh2), 7.20-4.42 (m; 13H, Har), 
7.83-7.86 (m; 2H, Har), 8.42 (s; 1H, N=CH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 77.9 (CHPh2), 127.0 (Car), 127.7 (Car), 128.42 (Car), 
128.46 (Car), 128.51 (Car), 130.8 (Car), 136.3 (Cqar), 143.9 (Cqar), 
160.8 (N=CH). 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3264 (w), 3060 (m), 3032 (m), 3083 (m), 2871 (m), 
2851 (m), 1954 (w), 1896 (w), 1880 (w), 1814 (w), 1700 (w), 1685 (w), 
1639 (s), 1599 (m), 1579 (m), 1540 (w), 1493 (s), 1457 (s), 1450 (s), 
1445 (s), 1380 (s), 1341 (s), 1312 (m), 1285 (s), 1277 (s), 1251 (w), 
1217 (s), 1195 (w), 1178 (w), 1160 (w), 1084 (m), 1076 (m), 1034 (s), 
1025 (s), 1001 (m), 981 (m), 920 (m), 911 (m), 881 (m), 855 (m), 819 (m), 
758 (s), 743 (s), 738 (s), 700 (s). 
 
HPLC 
 
τR = 5.5 min (Chiralpak AD, n-hexane/i-PrOH 90:10, 1.0 mL/min) 
 
8.4.3 Preparation of N-benzylidene-prop-2-en-1-amine 159[177] 
 
[SMU-IV-15] 
 
O
H
 
 H2N   H
N
 
33  158  159 
     
    
33 + 158 159 
   
anh. MgSO4 
 
abs. CH2Cl2, RT, 4 h 
  
 
The same procedure as before (see section 8.4.1 on page 214) was followed on a 29.5 mmol scale. 
The product was obtained as a pale yellow oil (3.90 g, 91 %). 
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159 
 
C10H11N (145.20 g/mol) 
 N
H
H
H
1
2
3
 
 
Yield 
 
 
3.90 g (26.86 mmol, 91 %) 
 159 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 4.23-4.26 (m; 2H, H-1), 5.13-5.14 (m; 0.5 H, H-1), 
5.16-5.18 (m; 0.5 H, H-1), 5.20-5.22 (m; 0.5 H, H-1), 5.26-5.27 (m; 0.5 H, 
H-1), 6.00-6.13 (m; 1H, H-2), 7.38-7.42 (m; 3 H, Har), 7.72-7.77 (m; 2H, 
Har), 8.26 (s; 1H, N=CH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 63.4 (C-1), 115.9 (C-3), 128.0 (Car), 128.4 (Car), 
130.5 (Car), 135.8 (C-2), 136.0 (Cqar), 168.8 (C=N). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3062 (w), 3026 (w), 2981 (w), 2874 (w), 2842 (m), 
2360 (m), 2342 (w), 1960 (w), 1648 (s), 1580 (m), 1490 (w), 1451 (m), 
1375 (w), 1308 (m), 1219 (w), 1025 (m), 993 (m), 920 (s), 846 (w), 
755 (s), 694 (s). 
 
HPLC 
 
τR = 4.5 min (Chiralcel OJ, n-hexane/i-PrOH 90:10, 1.0 mL/min) 
 
8.4.4 Preparation of N-(2-bromobenzylidene)(phenyl)methanamine 27b 
 
[SMU-III-27] 
 
O
H
Br
 
 
H2N
 
 H
N PhBr
 
160  155  27b 
     
    
160 + 155 27b 
   
anh. MgSO4 
 
abs. CH2Cl2, RT, 23 h 
  
 
The same procedure as before (see section 8.4.1 on page 214) was followed on a 17.1 mmol scale to 
obtain a highly viscous oil (4.67 g, >99 %). 
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27b C14H12BrN (274.16 g/mol) 
H
NBr
  
Yield 
 
4.67 g (17.0 mmol, >99 %) 27b 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 4.75 (s; 2H, CH2), 7.11-7.25 (m; 7H, Har), 7.45 
(d, J = 8.1 Hz; 1H, Har), 7.98 (dd, J = 1.8, 7.7 Hz; 1H, Har), 8.67 (s; 1H, 
N=CH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 65.1 (CH2), 125.0 (Cqar), 127.0 (CHar), 127.5 
(CHar), 127.9 (CHar), 128.5 (CHar), 128.9 (CHar), 131.8 (CHar), 132.9 
(CHar), 134.4 (Cqar), 138.9 (Cqar), 160.9 (N=CH). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3085 (w), 3062 (s), 3028 (s), 2888 (s), 2833 (m), 
2360 (w), 2341 (w), 1945 (w), 1697 (s), 1635 (s), 1601 (w), 1588 (s), 
1563 (s), 1495 (s), 1465 (s), 1439 (s), 1373 (s), 1341 (m), 1272 (s), 
1213 (w), 1044 (m), 1028 (s), 959 (w), 754 (s), 734 (s), 697 (s), 682 (m). 
 
HR-EI-MS 
 
Exact molecular mass for [C14H12BrN] ([M]+): 273.0153 
                                                               Found: 273.015 
 
HPLC 
 
τR = 14.1 min (Chiralcel OJ, n-hexane/i-PrOH 90:10, 0.5 mL/min) 
 
8.4.5 Preparation of N-(3-bromobenzylidene)(phenyl)methanamine 27c 
 
[SMU-VII-34] 
 
O
H
Br
 
 
H2N
 
 H
N Ph
Br
 
161  155  27c 
     
    
161 + 155 27c 
   
anh. MgSO4 
abs. CH2Cl2, RT, 23 h 
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The same procedure as before (see section 8.4.1 on page 214) was followed on an 8.58 mmol scale 
to obtain a clear oil (2.35 g, >99 %) which became yellowish white crystalline solid on standing in 
the refrigerator. 
 
27c C14H12BrN (274.16 g/mol) 
H
N
Br
  
Yield 
 
2.35 g (8.57 mmol, >99 %) 27c 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 4.79 (s; 2H, CH2), 7.21-7.64 (m; 6H, Har), 7.51 
(d, J = 7.93 Hz; 1H, Har), 7.63 (d, J = 7.55 Hz; 1H, Har), 7.94 (s; 1H, Har), 
8.28 (s; 1H, N=CH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 64.9 (CH2), 122.9 (Cqar), 127.0 (Car), 127.1 (Car), 
128.0 (Car), 128.5 (Car), 130.1 (Car), 130.8 (Car), 133.6 (Car), 138.1 (Cqar), 
138.9 (Cqar), 160.2 (N=CH). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3060 (sh), 3025 (sh), 2836 (m), 1643 (s), 1563 (s), 
1494 (sh), 1467 (m), 1451 (sh), 1424 (m), 1371 (m), 1340 (m), 1279 (w), 
1262 (w), 1210 (m), 1092 (w), 1064 (sh), 1027 (w), 995 (sh), 956 (w), 
896 (w), 781 (s), 733 (s), 697 (s), 682 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C14H12BrN] ([M]+): 273.0153 
                                                               Found: 273.015 
 
HPLC 
 
τR = 8.9 min (Chiralcel OJ, n-hexane/i-PrOH 95:5, 1.0 mL/min) 
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8.4.6 Preparation of N-{(naphthalene-3-yl)methylene}(phenyl)methan-
amine 27d[153] 
 
[SMU-III-13] 
 
O
H
 
 
H2N
 
 H
N Ph
 
162  155  27d 
     
    
162 + 155 27d 
   
anh. MgSO4 
abs. CH2Cl2, RT, 16 h 
  
 
The same procedure as before (see section 8.4.1 on page 214) was followed on a 6.40 mmol scale to 
obtain a pale yellow solid (1.56 g, >99 %). 
 
27d 
 
C18H15N (245.32 g/mol) 
 H
N
  
Yield 
 
 
1.56 g (6.36 mmol, >99 %) 
 27d 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 4.74 (s; 2H, CH2), 7.09-7.46 (m; 7H, Har), 
7.69-7.76 (m; 3H, Har), 7.89-7.93 (m; 2H, Har), 8.39 (s; 1H, N=CH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 65.1 (CH2), 123.9 (Car), 126.4 (Car), 126.9 (Car), 
127.1 (Car), 127.8 (Car), 128.0 (Car), 128.4 (Car), 128.5 (Car), 128.6 (Car), 
130.1 (Car), 133.0 (Cqar), 133.8 (Cqar), 134.7 (Cqar), 139.2 (Cqar), 
162.0 (N=CH). 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3055 (m), 3030 (w), 2866 (m), 2360 (m), 2355 (w), 
1638 (s), 1604 (s), 1496 (m), 1453 (m), 1422 (w), 1350 (m), 1297 (w), 
1174 (w), 1122 (w), 1047 (m), 992 (w), 956 (m), 903 (m), 867 (s), 833 (s), 
751 (s), 731 (s), 697 (s). 
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HR-EI-MS Exact molecular mass for [C18H15N] ([M]+): 245.1204 
                                                            Found: 245.120 
 
HPLC 
 
τR = 14.2 min (Chiralcel OJ, n-hexane/i-PrOH 80:20, 1.0 mL/min) 
 
8.4.7 Preparation of N-(4-methoxybenzylidene)(phenyl)methanamine 
27e 
 
[SMU-VII-30] 
 
O
H
MeO  
 
H2N
 
 H
N Ph
MeO  
163  155  27e 
     
    
163 + 155 27e 
   
anh. MgSO4 
 
abs. CH2Cl2, RT, 5 h 
  
 
The same procedure as before (see section 8.4.1 on page 214) was followed on an 8.23 mmol scale 
to obtain a highly viscous oil (1.85 g, >99 %). 
 
27e  
 
C15H15NO (225.29 g/mol) 
 H
N
MeO   
Yield 
 
 
1.85 g (8.22 mmol, >99 %) 
 27e 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 3.83 (s; 3H, OCH3), 4.80 (s; 2H, CH2), 6.94 
(d, J = 8.80 Hz; 2H, Har), 7.24-7.37 (m; 5H, Har), 7.75 (d, J = 8.80 Hz; 2H, 
Har), 8.33 (s; 1H, N=CH). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 55.2 (OCH3), 64.9 (CH2), 113.9 (Car), 126.8 (Car), 
127.9 (Car), 128.4 (Car), 129.1 (Cqar), 129.8 (Car), 139.5 (Cqar), 
161.2 (N=CH), 161.6 (Cqar). 
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FT-IR (ATR): ν~ [cm-1] = 3060 (w), 3026 (w), 2834 (m), 1645 (s), 1604 (s), 
1576 (sh), 1510 (s), 1494 (sh), 1451 (sh), 1440 (w), 1420 (sh), 1377 (w), 
1341 (w), 1305 (s), 1249 (s), 1178 (w), 1164 (sh), 1106 (w), 1078 (w), 
1028 (s), 962 (w), 905 (w), 866 (w), 832 (s), 733 (s), 697 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C15H15NO] ([M]+): 225.1154 
                                                              Found: 225.115 
 
HPLC 
 
τR = 22.6 min (Chiralcel OJ, n-hexane/i-PrOH 97:3, 1.0 mL/min) 
 
8.4.8 Preparation of N-(2,2-dimethylpropylidene)(phenyl)methanamine 
27f[37] 
 
[SMU-VII-10] 
 
H
O
 
 
H2N
 
 H
N Ph
 
164  155  27f 
     
    
164 + 155 27f 
   
anh. MgSO4 
 
abs. CH2Cl2, RT, 6 h 
  
 
The same procedure as before (see section 8.4.1 on page 214) was followed on a 13.6 mmol scale to 
obtain a clear oil (2.38 g, >99 %). 
 
27f  
 
C12H17N (175.27 g/mol) 
 
H
N
  
Yield 
 
 
2.38 g (13.6 mmol, >99 %) 
 27f 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.15 (s; 9H, CH3), 4.61 (s; 2H, CH2), 7.23-7.39 
(m; 5H, Har), 7.70 (s; 1H, N=CH). 
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13C-NMR (75 MHz, CDCl3): δ = 26.9 (CH3), 36.2 (Cme3), 64.5 (CH2), 126.7 (Car), 
127.5 (Car), 128.3 (Car), 139.6 (Cqar), 173.3 (N=CH). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3061 (w), 3026 (w), 2958 (s), 1898 (w), 2865 (m), 
2813 (m), 1665 (s), 1603 (w), 1495 (sh), 1474 (m), 1451 (sh), 1393 (w), 
1363 (s), 1340 (w), 1297 (w), 1204 (w), 1051 (m), 1029 (sh), 914 (w), 
818 (w), 776 (w), 731 (s), 696 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C12H17N] ([M]+): 175.1361 
                                                           Found: 175.136 
 
GC 
 
τR = 2.0 min (Chiraldex γ-TA, Isothermal 120 °C, 1.0 mL/min) 
 
8.4.9 General procedure for the preparation of racemic α-amino nitriles 
 
To an ice-cold solution of the imine (1.00 eq) in DCM was added TMSCN (2.00 eq), followed by 
methanol (2.00 eq), and the resulting mixture was stirred at 0 °C for 1 hour and then at room 
temperature. After the imine was consumed completely (the reaction was monitored by HPLC), the 
reaction mixture was concentrated in vacuo to obtain the pure α-amino nitrile. 
 
Analytical data of the racemic α-amino nitriles are given below. 
 
8.4.9.1 2-(Benzylamino)-2-phenylacetonitrile rac-28a 
 
[SMU-I-91] 
 
CN
HN
 
rac-28a 
 
C15H14N2 (222.29 g/mol) 
 
rac-28a 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.89 (s; 1H, NH), 3.95 (d, J = 13.1 Hz; 2H, CH2), 
4.06 (d, J = 13.1 Hz; 2H, CH2), 4.74 (s; 1H, CHCN), 7.27-7.45 (m; 8H, 
Har), 7.52-7.56 (m; 2H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 51.1 (CHCN), 53.3 (CH2), 118.7 (CN), 127.2 (Car), 
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127.5 (Car), 128.3 (Car), 128.5 (Car), 128.8 (Car), 128.9 (Car), 134.7 (Cqar), 
138.0 (Cqar). 
 
HPLC 
 
τR = 16.8 min [(R)-28a], 20.4 min [(S)-28a] (Chiralcel OJ, n-hexane/i-
PrOH 90:10, 1.0 mL/min) 
 
8.4.9.2 2-(Benzhydrylamino)-2-phenylacetonitrile rac-169 
 
[SMU-I-30] 
 
CN
HN
 
rac-169 
 
 
C21H18N2 (298.38 g/mol) 
 
 
rac-169 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 2.08 (s; 1H, NH), 4.54 (s; 1H, CHPh2), 5.18 (s; 
1H, CHCN), 7.14-7.51 (m; 15 H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 52.4 (CHPh2), 65.6 (CHCN), 118.7 (CN), 127.1 
(Car), 127.2 (Car), 127.4 (Car), 127.7 (Car), 127.9 (Car), 128.8 (Car), 129.0 
(Car), 134.9 (Cqar), 141.0 (Cqar), 142.7 (Cqar). 
 
FT-IR 
 
(CsI): ν~ [cm-1] = 3304 (s), 3083 (m), 3061 (m), 3038 (m),  3022 (m), 
2847 (m), 2229 (m), 1596 (m), 1494 (s), 1472 (m), 1456 (s), 1354 (m), 
1343 (w), 1311 (m),  1269 (m), 1199 (m), 1188 (w), 1158 (w), 1098 (s), 
1079 (m), 1029 (m), 918 (s), 910 (m), 887 (w), 836 (w), 771 (s), 745 (s), 
699 (s). 
 
HPLC 
 
τR = 10.6 min [(R)-169], 19.5 min [(S)-169] (Chiralpak AD, n-hexane/i-
PrOH 90:10, 1.00 mL/min) 
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8.4.9.3  2-(Allylamino)-2-phenylacetonitrile rac-170 
 
[SMU-IV-16] 
 
CN
HN H
H
1
2
3
 
rac-170 
 
C11H12N2 (172.23 g/mol) 
 
rac-170 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.70 (NH), 3.36-3.53 (m; 2H, H-1), 4.78 (s; 1H, 
CHCN), 5.16-5.18 (m; 0.5 H, H-3), 5.20-5.21 (m; 0.5 H, H-3), 5.27-5.29 
(m; 0.5 H, H-3), 5.33-5.34 (m; 0.5 H, H-3), 5.82-5.95 (m; 1H, H-2), 
7.33-7.42 (m; 3H, Har), 7.49-7.53 (m; 2H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 49.8 (C-1), 53.4 (CHCN), 117.7 (C-3), 118.7 (CN), 
127.2 (Car), 128.8 (Car), 128.9 (Car), 134.7 (C-2). 
 
FT-IR 
 
(Film): ν~ [cm-1] = 3322 (m), 3066 (m), 2840 (m), 2227 (w), 1644 (s), 
1601 (w), 1494 (s), 1453 (s), 1419 (m), 1305 (w), 1191 (w), 1104 (s), 
1028 (m), 994 (s), 925 (s), 832 (w), 754 (s), 698 (s). 
 
HPLC 
 
τR = 9.3 min [(R)-170], 11.4 min [(S)-170] (Chiralcel OJ, n-hexane/i-
PrOH 90:10, 1.0 mL/min) 
 
8.4.9.4  2-(Benzylamino)-2-(2-bromophenyl)acetonitrile rac-28b 
 
[SMU-III-30] 
 
CN
HNBr
 
rac-28b 
 
C15H13BrN2 (301.18 g/mol) 
 
rac-28b 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.89 (br s; 1H, NH), 3.81 (d, J = 12.7 Hz; 2H, 
CH2), 3.92 (d, J = 12.7 Hz; 2H, CH2), 4.89 (s; 1H, CHCN), 7.07-7.27 (m; 
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7H, Har), 7.46 (dd, J = 1.3, 7.9 Hz; 1H, Har), 7.51 (dd, J = 1.7, 7.8 Hz; 1H, 
Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 51.7 (CH2), 53.5 (CHNH), 118.23 (CN), 123.4 
(Cqar), 127.7 (Car), 128.1 (Car), 128.5 (Car), 128.6 (Car), 129.2 (Car), 130.7 
(Car), 133.6 (Car), 134.2 (Cqar), 137.7 (Cqar). 
 
HPLC 
 
τR = 37.0 min [(R)-28b], 42.8 min [(S)-28b] (Chiralcel OJ, n-hexane/i-
PrOH 90:10, 0.5 mL/min) 
 
8.4.9.5 2-(Benzylamino)-2-(3-bromophenyl)acetonitrile rac-28c 
 
[SMU-VII-35] 
 
CN
HN
Br
 
rac-28c 
 
C15H13BrN2 (301.18 g/mol) 
 
rac-28c 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.92 (s; 1H, NH), 3.90 (d, J = 12.93 Hz; 1H, CH2), 
4.02 (d, J = 12.93 Hz; 1H, CH2), 4.69 (s; 1H, CHCN), 7.12-7.38 (m; 6H, 
Har), 7.44-7.54 (m; 2H, Har), 7.67 (s; 1H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 51.2 (CH2), 52.7 (CHCN), 118.1 (CN), 122.9 
(Cqar), 125.9 (Car), 127.7 (Car), 128.4 (Car), 128.7 (Car), 130.35 (Car), 130.4 
(Car), 132.2 (Car), 136.9 (Cqar), 137.7 (Cqar). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3321 (br), 3061 (w), 3027 (w), 2845 (w), 2226 (w), 
1594 (m), 1570 (s), 1494 (m), 1472 (s), 1452 (s), 1422 (m), 1362 (w), 
1299 (w), 1260 (w), 1185 (s), 1106 (w), 1072 (s), 1027 (w), 997 (w), 
967 (w), 928 (w), 885 (w), 858 (w), 781 (s), 738 (s), 698 (s). 
 
HPLC 
 
τR = 23.7 min [(S)-28c], 28.8 min [(R)-28c] (Chiralcel OJ, n-hexane/i-
PrOH 95:5, 1.0 mL/min) 
 
Experimental Part 
 
 227
8.4.9.6 2-(Benzylamino)-2-(naphthalene-2-yl)acetonitrile rac-28d 
 
[SMU-III-26] 
CN
HN
 
rac-28d 
 
C19H16N2 (272.34 g/mol) 
 
rac-28d 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.93 (br s; 1H, NH), 3.99 (d, J = 13.3 Hz; 2H, 
CH2), 4.08 (d, J = 13.3 Hz; 2H, CH2), 4.9 (s; 1H, CHCN), 7.28-7.44 (m; 
5H, Har), 7.50-7.61 (m; 3H, Har), 7.83-7.89 (m; 3H, Har), 8.03 (s; 1H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 51.2 (CH2), 55.5 (CHNH), 118.7 (CN), 124.7 (Car), 
126.4 (Car), 126.7 (Car), 126,8 (Car), 127.6 (Car), 127.7 (Car), 128.1 (Car), 
128.4 (Car), 128.6 (Car), 128.9 (Car), 131.9 (Cqar), 132.9 (Cqar), 133.3 
(Cqar), 138.0 (Cqar). 
 
HPLC 
 
τR = 31.4 min [(R)-28d], 38.0 min [(S)-28d] (Chiralcel OJ, n-hexane/i-
PrOH 80:20, 1.0 mL/min). 
 
8.4.9.7 2-(Benzylamino)-2-(4-methoxyphenyl)acetonitrile rac-28e 
 
[SMU-VII-79] 
 
CN
HN
MeO  
rac-28e 
 
C16H16N2O (252.31 g/mol) 
 
rac-28e 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.77 (s; 1H, NH), 3.73 (s; 2H, OCH3), 3.85 
(d, J = 12.94 Hz; 1H, PhCH2), 3.96 (d, J = 12.94 Hz; 1H, PhCH2), 4.61 (s; 
1H, CHCN), 6.81-6.86 (m; 2H, Har), 7.17-7.39 (m; 7H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 51.1 (CH2), 52.8 (CHCN), 55.3 (OCH3), 114.2 
(Car), 118.9 (CN), 126.8 (Cqar), 127.5 (Car), 128.3 (Car), 128.5 (Car), 128.6 
(Car), 138.2 (Cqar), 160.0 (Cqar). 
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FT-IR (ATR): ν~ [cm-1] = 3324 (br), 3061 (w), 3027 (w), 3001 (w), 2931 (w), 
2836 (m), 2224 (w), 1719 (w), 1609 (s), 1584 (m), 1510 (s), 1495 (w), 
1453 (s), 1419 (w), 1361 (w), 1305 (m), 1249 (s), 1176 (sh s), 1112 (m), 
1075 (w), 1029 (s), 965 (w), 918 (w), 859 (w), 829 (s), 776 (w), 740 (s), 
698 (s). 
 
HPLC 
 
τR = 56.1 min [(R)-28e], 62.2 min [(S)-28e] (Chiralcel OJ, n-hexane/i-
PrOH 97:3, 1.0 mL/min) 
 
8.4.9.8 2-(Benzylamino)-3,3-dimethyl-butyronitrile rac-28f 
 
[SMU-VII-18] 
 
CN
HN
 
rac-28f 
 
C13H18N2 (202.3 g/mol) 
 
rac-28f 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.06 (s; 9H, CH3), 1.51 (br s; 1H, NH), 3.09 (s; 
1H, CHCN), 3.80 (d, J = 13.2 Hz; 1H, CH2), 4.13 (d, J = 13.2 Hz; 1H, 
CH2), 7.24-7.38 (m; 5H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 26.2 (CH3), 34.2 (Cme3), 52.1 (CH2), 60.3 (CHCN), 
119.6 (CN), 127.4 (Car), 128.3 (Car), 128.4 (Car), 138.5 (Cqar). 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3342 (br), 3026 (w), 2961 (s), 2871 (w), 2222 (w), 
1603 (w), 1495 (w), 1474 (s), 1453 (s), 1397 (m), 1369 (s), 1296 (w), 
1204 (w), 1119 (s), 1028 (sh), 931 (w), 880 (w), 738 (s), 698 (s). 
 
GC 
 
After derivatization with TFAA 
τR = 16.1 min [(S)-28f], 17.3 min [(R)-28f] 
(Chiraldex γ-TA, Isothermal 120 °C, 1.0 mL/min) 
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8.4.10 General procedure for the asymmetric hydrocyanation of imines 
 
Condition A: In a flame-dried Schlenk flask, a solution of the imine (0.51 mmol) in 1.25 mL of abs. 
toluene was cooled to –25 °C under positive argon pressure. To this cold solution was added 
100 µL of a 1M solution of catalyst in toluene (102 µmol, 0.2 equiv.) and stirred for 5 mins. at 
-25 °C. In a separate flask, 1 mL abs. toluene along with 96.0 µL TMSCN (765 µmol, 1.5 equiv.) 
was cooled to 0 °C under argon, and 31 µL methanol (765 µmol, 1.5 equiv.) was added. This 
solution was stirred at 0 °C for 1 hour. and added in one portion to the reaction flask by means of a 
syringe. The resulting mixture was stirred at –25 °C under argon. After 24 hours, a 100 µL of 
sample was withdrawn, diluted with 900 µL DCM and conversion and enantiomeric excess were 
determined immediately by HPLC or GC using a chiral column. 
 
Condition B: In a flame-dried Schlenk flask, a mixture of 50.0 µL of a 1M solution of catalyst in 
toluene (51.0 µmol, 0.1 equiv.) and 300 µL abs. toluene was cooled to –70 °C under positive 
pressure of argon. To this cold solution was then added a 0.2 M solution of triflic acid in toluene 
(250 µL, 51 µmol, 0.1 equiv.) and stirred for 5 mins. A solution of the imine (510 µmol) in 750 µL 
abs. toluene was added and stirred for another 5 mins. An HCN solution (765 µmol, 1.5 equiv.) in 
1 mL toluene was then added by slow syringe addition of over a period of 40 mins. The resulting 
mixture was then stirred at –70 °C under argon. After 1, 2 or 3 hours, the reaction mixture was 
analyzed in the same way as described for condition A. 
 
8.4.11 Crystallographic data for 29b·HCN 
 
[SMU-II-52] 
 
N
B
O
Ph
PhPhH
H
NC  
29b·HCN  
 
 
C24H23BN2O (366.26 g/mol) 
 
 
29b·HCN 
 
 
For X-ray structure see Figure 5.11 on page 84 
Colorless needles from dichloromethane 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
C24H23N2O 
366.26 g/mol 
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 Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]:   
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:        
 
293(2) K 
0.71073 Å 
monoclinic 
P21 
a = 10.588(1) Å     α = 90° 
b = 6.950(1) Å    β = 105.07(1)° 
c = 14.249(2) Å     γ = 90° 
1012.5(2) Å3 
2 
1.201 g/cm3 
0.073 mm-1 
388 
0.18 × 0.12 × 0.08 mm 
1.48° to 29.91° 
-13 ≤ h ≤ 10 
-8 ≤ k ≤ 8 
-15 ≤ l ≤ 17 
5378 
3974 [ Rint = 0.0612] 
1327 
95.0 % 
Full-matrix least-squares on F2 
3974 / 1 / 259 
0.890 
R1 = 0.0674        ωR2 = 0.0890 
R1 = 0.2718        ωR2 = 0.1291 
0.136 and -0.162 e·Å-3 
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8.5 Synthesis of new tridentate ligands 
8.5.1 Preparation of 2,4-di-tert-butyl-6-{(S)-2-(hydroxydiphenylmethyl) 
pyrrolidin-1-yl-methyl}phenol 31a 
 
[SMU-IV-52] 
 
N
H H
OH
PhPh
 
 OH
H
O
t-Bu
t-Bu  
 
N
H
HO
Ph
Ph
OHt-Bu
t-Bu  
97a  100a  31a 
     
    
97a + 100a 31a 
   
NaBH3CN, AcOH 
CH3CN, RT, 18 h 
  
 
A mixture of (S)-α,α-diphenyl-2-pyrrolidin methanol 97a (500 mg, 1.97 mmol, 1.02 eq) and 2,4-di-
tert-butyl-salicylaldehyde 100a (452 mg, 1.93 mmol, 1.00 eq) in absolute CH3CN (22 mL) was 
stirred at room temperature for 1.5 hours. NaBH3CN (364 mg, 5.79 mmol, 3.00 eq) was then added 
followed 15 minutes later by acetic acid (580 mg, 9.65 mmol, 5.00 eq). The resulting mixture was 
stirred at room temperature under argon for 18 hours. The reaction mixture was then diluted with 
DCM (25 mL) and washed with 1N NaOH solution (20 mL). The aqueous layer was extracted with 
DCM (25 mL). The combined organic layer was washed with saturated NaCl solution (20 mL), 
dried over anh. MgSO4 and the solvent was removed in vacuo to obtain a yellowish white foam. 
Recrystallization from ethanol afforded a colorless crystalline solid (422 mg, 46 %). 
 
31a 
 
C32H41NO2 (471.67 g/mol) 
 
 
Yield 
 
422 mg (0.89 mmol, 46 %) 
 
N
H
HO
Ph
Ph
OH
1
2
34
5
61'
2'
3'
4'
5' 6'
2'a
4'a
  
Melting Point 
 
161-162 °C (EtOH) 31a 
 
 
TLC 
 
Rf = 0.49 (Silicagel, n-hexane/EtOAc 11:1) 
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1H-NMR (300 MHz, CDCl3): δ = 1.24 (s; 9H, 4′a-CH3), 1.38 (s; 9H, 2′a-CH3), 
1.59-1.77 (m; 2H, H-3), 1.83-1.93(m; 1H, H-2), 2.00-2.14 (m; 1H, H-2), 
2.38-2.46 (m; 1H, H-4), 2.85-2.92 (m; 1H, H-4), 3.26 (d, J = 12.93 Hz; 
1H, H-5), 3.53 (d, J = 12.93 Hz; 1H, H-5), 3.95-3.99 (2d, J = 4.85 Hz; 1H, 
H-6), 6.68 (d, J = 2.28 Hz; 1H, H-5′), 7.08-7.12 (m; 1H, Har), 7.14 (d, 
J = 2.28 Hz; 1H, H-3′), 7.17-7.34 (m; 5H, Har), 7.54-7.63 (m; 4H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 24.2 (C-3), 29.4 (C-2), 29.5 (C-2′a-CH3), 31.65 
(C-4′a-CH3), 34.0 (C-4′a), 34.8 (C-2′a), 55.2 (C-4), 61.8 (C-5), 72.7 (C-1), 
79.7 (C-6), 122.1 (C-6′), 122.7 (C-3′), 123.2 (C-5′), 125.75 (Car), 125.9 
(Car), 126.7 (Car), 126.9 (Car), 128.2 (Car), 128.4 (Car), 134.9 (C-2′), 140.1 
(C-4′), 145.8 (Cqar), 146.0 (Cqar), 153.4 (C-1′). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3544 (br w), 2951 (s), 2867 (w), 1598 (m), 1478 (sh s), 
1446 (sh s), 1389 (sh), 1359 (s), 1301 (m), 1235 (s), 1201 (m), 1163 (m), 
1124 (m), 1091 (w), 1059 (w), 1031 (sh), 999 (m), 938 (w), 877 (s), 
822 (w), 799 (w), 766 (m), 745 (s), 701 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C32H41NO2] ([M]+): 471.3137 
                                                                Found: 471.315 
 
For X-ray structure see Figure 5.12 on page 89 
Colorless needles from ethanol 
 
Crystallographic 
Data 
Empirical formula: 
Formula weight (M): 
Temperature (T): 
Wavelength (λ): 
Crystal system: 
Space group: 
Unit cell dimension: 
 
 
Unit cell volume: 
Z: 
C32H41NO2 
471.67 g/mol 
100(2) K 
0.71073 Å 
orthorhombic 
P212121 
a = 8.6654(1) Å     α = 90° 
b = 11.4308(2) Å    β = 90° 
c = 28.3519(4) Å     γ = 90° 
2808.33(7) Å3 
4 
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 Calculated density (ρcalcd.): 
Absorption coefficient (µ): 
F(000): 
Crystal size: 
Θ-range for data collection: 
Limiting indices: 
 
 
Reflections collected: 
Unique reflections: 
Reflections observed [I>2σ (I)]:   
Completeness to Θ: 
Refinement method: 
Data / restraints / parameters: 
Goodness-of-fit on F2: 
Final R-indices [I > 2σ(I)]:  
R-indices (all data): 
Largest diff. peak and hole:        
 
1.116 g/cm3 
0.068 mm-1 
1024 
0.32 × 0.28 × 0.26 mm 
1.92° to 27.00° 
-11 ≤ h ≤ 7 
-13 ≤ k ≤ 14 
-33 ≤ l ≤ 36 
16908 
6109 [ Rint = 0.0360] 
5227 
99.8 % 
Full-matrix least-squares on F2 
6109 / 0 / 454 
1.023 
R1 = 0.0407        ωR2 = 0.0922 
R1 = 0.0526        ωR2 = 0.0972 
0.238 and -0.221 e·Å-3 
 
8.5.2 Preparation of 2,4-diiodo-6-{(S)-2-(hydroxydiphenylmethyl) 
pyrrolidin-1-yl-methyl}phenol 31b 
 
[SMU-IV-59] 
 
N
H H
OH
PhPh
 
 OH
H
O
I
I  
 
N
H
HO
Ph
Ph
OHI
I  
97a  100b  31b 
     
    
97a + 100b 31b 
   
NaBH3CN, AcOH 
CH3CN, RT, 24 h 
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The same procedure as before (see section 8.5.1 on page 231) was followed on a 1.97 mmol scale to 
obtain the crude product as an off-white foam. Purification by column chromatography on silica gel 
(2:1 n-hexane/EtOAc as the eluant) afforded an off-white foam (839 mg, 70 %). 
 
31b 
 
C24H23I2NO2 (611.25 g/mol) 
 
 
Yield 
 
839 mg (1.37 mmol, 70 %) 
N
H
HO
Ph
Ph
OH
1
2
34
5
61'
2'
3'
4'
5' 6'
I
I
 
Melting Point 87-89 ºC 
31b 
 
 
TLC 
 
Rf = 0.57 (Silicagel, n-hexane/EtOAc 2:1) 
 
1H-NMR (300 MHz, CDCl3): δ = 1.64-1.77 (m; 2H, H-3), 1.83-1.93 (m; 1H, H-2), 
2.04-2.18 (m; 1H, H-2), 2.29-2.38 (m; 1H, H-4), 2.91-2.98 (m; 1H, H-4), 
3.16 (d, J = 13.8 Hz; 1H, H-5), 3.40 (d, J = 13.8 Hz; 1H, H-5), 3.91-3.95 
(2d, J = 4.9 Hz; 1H, H-1), 7.03-7.04 (m; 1H, H-5′), 7.10-7.35 (m; 6H, Har), 
7.49-7.57 (m; 4H, Har), 7.82-7.83 (m; 1H, H-3′). 
 
13C-NMR (75 MHz, CDCl3): δ = 24.0 (C-3), 29.3 (C-2), 55.6 (C-4), 59.8 (C-5), 71.9 
(C-1), 79.6 (C-6), 80.4 (C-4′), 85.6 (C-2′), 125.3 (C-6′), 125.7 (Car),125.9 
(Car), 127.0 (Car), 127.1 (Car), 128.3 (Car), 128.45 (Car), 136.6 (C-5′), 144.7 
(C-3′), 145.3 (Cqar), 145.9 (Cqar), 156.3 (C-1′). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3550 (br), 3054 (w), 2965 (m), 2876 (w), 2822 (w), 
1580 (w), 1550 (w), 1490 (sh), 1445 (s), 1373 (m), 1349 (m), 1277 (m), 
1259 (m), 1136 (m), 1084 (w), 1061 (w), 1031 (sh), 1000 (m), 942 (w), 
863 (s), 765 (w), 735 (s), 701 (s). 
 
HR-EI-MS 
 
Exact molecular mass for [C24H23I2NO2] ([M]+): 610.9818 
                                                                  Found: 610.978 
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8.5.3 Preparation of 2,4-dibromo-6-{(S)-2-(hydroxydiphenylmethyl) 
pyrrolidin-1-yl-methyl}phenol 31c 
 
[SMU-IV-61] 
 
N
H H
OH
PhPh
 
 OH
H
O
Br
Br  
 
N
H
HO
Ph
Ph
OHBr
Br  
97a  100c  31c 
     
    
97a + 100c 31c 
   
NaBH3CN, AcOH 
CH3CN, RT, 24 h 
  
 
The same procedure as before (see section 8.5.1 on page 231) was followed on a 1.97 mmol scale to 
obtain an off-white foam. Purification by column chromatography on silicagel 
(5:1 n-hexane/EtOAc as the eluant) afforded a pale yellow foam (660 mg, 65 %). 
 
31c 
 
C24H23Br2NO2 (517.25 g/mol) 
 
 
Yield 
 
660 mg (1.28 mmol, 65 %) 
N
H
HO
Ph
Ph
OH
1
2
34
5
61'
2'
3'
4'
5' 6'
Br
Br
 
Melting Point 64-65 °C 
31c 
 
 
TLC 
 
Rf = 0.33 (Silicagel, n-hexane/EtOAc 5:1) 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 1.62-1.78 (m; 2H, H-3), 1.82-1.92 (m; 1H, H-2), 
2.03-2.17 (m; 1H, H-2), 2.29-2.38 (m; 1H, H-4), 2.92-3.24 (m; 1H, H-4), 
3.26 (d, J = 13.8 Hz; 1H, H-5), 3.43 (d, J = 13.8 Hz; 1H, H-5), 3.91-3.96 
(2d, J = 4.85; 1H, H-1), 6.87 (d, J = 2.0 Hz; 1H, H-5′), 7.10-7.35 (m; 6H, 
Har), 7.46 (d, J = 2.0 Hz; 1H, H-3′), 7.49-7.59 (m; 4H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 24.0 (C-3), 29.3 (C-2), 55.6 (C-4), 59.6 (C-5), 
71.8 (C-1), 79.6 (C-6), 110.3 (C-4′), 110.5 (C-2′), 125.7 (Car), 125.8 (C-6′), 
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125.9 (Car), 126.9 (Car), 127.0 (Car), 128.3 (Car), 128.4 (Car), 129.9 (C-5′), 
133.6 (C-3′), 145.4 (Cqar), 146.0 (Cqar), 153.0 (C-1′). 
The assignments were made by 2D-NMR. 
 
FT-IR 
 
(ATR): ν~ [cm-1] = 3565 (br), 3058 (w), 2966 (m), 2875 (w), 2825 (w), 
1595 (m), 1559 (w), 1490 (sh), 1447 (s), 1378 (m), 1350 (w), 1262 (m), 
1214 (w), 1150 (s), 1089 (w), 1061 (w), 1031 (sh), 1000 (m), 943 (w), 
861 (s), 765 (w), 747 (s), 702 (s). 
 
HR-ESI-MS 
 
Exact molecular mass for [C24H24Br2NO2] ([M+H]+): 518.0153 
                                                                          Found: 518.0153 
 
8.6 Application of metal complex of the tridentate ligand 
8.6.1 Preparation of the aluminium complex 32 
 
[SMU-IV-54] 
 
N
H
HO
Ph
Ph
OHt-Bu
t-Bu  
 
O
Al
N
O
Ph
Ph
Cl
H
t-Bu
t-Bu
 
31a  32 
   
  
31a 32 
 
Me2AlCl 
abs. toluene, RT, 2 h 
 
 
To a solution of the tridentate ligand 31a (46 mg, 97.5 µmol, 1.0 eq) in 1 mL of abs. toluene, was 
added a 1M solution of dimethylaluminium chloride in n-hexane (98 µL, 97.5 µmol, 1.0 eq) and the 
resulting solution was stirred at room temperature in the glove box for 2 hours. This solution was 
used immediately for catalysis experiment (see section 8.6.2 on page 237). 
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8.6.2 Asymmetric hydrocyanation of benzaldehyde 33 
 
[SMU-IV-56] 
 
O
H
 
 ∗ CN
OH
 
33  34 
   
  
33 34 
 
HCN, 32 
abs. toluene, –40 °C, 2 h 
 
 
In an oven-dried Schlenk flask, a solution of benzaldehyde 33 (100 µL, 0.98 mmol, 1.0 eq) in 1 mL 
abs. toluene was cooled to –40 °C under positive pressure of argon. To this cold solution was added 
the solution of the aluminium-complex 32 (97.5 µmol, 0.1 eq) in 1mL abs. toluene followed by an 
HCN solution (generated from TMSCN and MeOH) in 1 mL toluene (1.3 eq). The resulting mixture 
was stirred at –40 °C under argon. After 17 hours, 100 µL of the reaction mixture was diluted with 
0.9 mL of DCM and conversion and enantiomeric excess were determined immediately by HPLC 
using chiral column. 
 
CN
OH
 
34  
 
C8H7NO (133.15 g/mol) 
 
34 
 
 
1H-NMR 
 
(300 MHz, CDCl3): δ = 3.83 (s; 1H, OH), 5.46 (s; 1H. CHCN), 7.39-7.49 
(m; 5H, Har). 
 
13C-NMR 
 
(75 MHz, CDCl3): δ = 63.3 (CHCN), 118.9 (CN), 126.6 (Car), 129.1 (Car), 
129.7 (Car), 135.0 (Cqar). 
 
HPLC 
 
τR = 5.6 min (33), 18.9 min (34), 25.3 min (ent-34) 
(Chiralcel OJ, n-hexane/i-PrOH 90:10, 1.0 mL/min) 
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10 Appendix 
 
10.1 Abbreviations 
 
abs. absolute (distilled and dried) 
Ac Acetyl (CH3CO) 
aq. Aqueous  
ATR Attenuated total reflection 
Boc tert.-Butyloxycarbonyl 
Bn Benzyl (PhCH2) 
CPME Cyclopentyl methyl ether 
DCC N,N-Dicyclohexyl carbodiimide 
DCM Dichloromethane (CH2Cl2) 
DKR Dynamic kinetic resolution 
DIPEA Diisopropylethylamine (Hünig base) 
DMAP N,N-Dimethylamino pyridine 
DMF N,N-Dimethyl formamide (Me2NCHO) 
ee enantiomeric excess 
ent Enantiomer 
eq Equivalent 
Et Ethyl (CH3CH2) 
FT-IR Fourier-Transform infrared spectroscopy 
GC Gas chromatography 
h hour 
HBTU O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium hexafluorophosphate 
HPLC High performance liquid chromatography 
HR-MS High resolution mass spectrometry 
Hz Hertz 
i-Bu iso-butyl (Me2CHCH2) 
KR Kinetic resolution 
Me Methyl (CH3) 
min minute 
NMR Nuclear magnetic resonance 
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n.d. Not detected  
PG Protecting group 
Ph Phenyl 
ppm Parts per million 
Rf Retention factor 
RT Room temperature 
sat. Saturated 
t-Bu tertiary butyl (Me3C) 
TEA Triethylamine (Et3N) 
TFA Trifluoroacetic acid (CF3CO2H) 
TFAA Trifluoroacetic anhydride [(CF3CO)2O] 
THF Tetrahydrofuran 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
 
 247
10.2 Structure table 
 
 R1 R2 R3 X  R1 R2 R3 X
 
1 
 
Me 
 
Me 
 
3,5-(CF3)2C6H3 
 
S
 
7 
 
Me 
 
Me 
 
2,4,6-(CH3)3C6H2 
 
O  
2 Me Me 3,5-(CF3)2C6H3 O 8 Me Me 3-pyridyl S
3 Et Et 3,5-(CF3)2C6H3 O 9 Me Me c-hex S
4 -(CH2)4- 3,5-(CF3)2C6H3 O 10 Me Me 1-adamantyl S
5 Me Bn 3,5-(CF3)2C6H3 O 12 Me Me (R)-PhCH(CH3) O
 
 
 
NR1R2
N
H
N
H
X
R3
 
6 Me Me 3,5-(NO2)2C6H3 O 13 Me Me (S)-PhCH(CH3) O
 
 
NH2
NH2  
 
N
H NMe2
N
H
OH
N
H
N
O
Me2N
3
 
 
N
H NMe2
N
H
S
Me2N  
 
 
102 11 14  
 
 
R1 
 
R2 
 
n 
 
15 
 
Me 
 
Me 
 
0 
16 Et Et 0 
17 i-Bu i-Bu 0 
18 Me Bn 0 
20 H Bn 0 
 
 
 
NMe2
N
H
N
H
S
N
O
R2
R1
t-Bu
n
 
21 Me Bn 1 
 
 
NMe2
N
H
N
H
S
N
O
t-BuMe
Ph
 
19 
 
 
N
H
Me2N
N
H
N
 
N
H
Me2N
N
H
N
CF3CO2 H
 
 
 148 150  
 
N
B
O
R
Ar ArH
 
 
N
B
O
R
Ar ArH
H OTf
N
H
HO
Ph
Ph
OHR
R  
29  30 31 
         29a/30a: Ar = Ph, R = Me        31a: R = t-Bu 
         29b/30b: Ar = Ph, R = Ph        31b: R = I 
         29c/30c: Ar = m-Xyl, R = o-Tol 
 
       31c: R = Br 
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10.3 Abstract – Kurzzusammenfassung 
 
In this work, new approaches to enantiomerically pure α- and β-amino acids via resolution and 
asymmetric synthesis were developed. First, a wide array of azlactones derived from both natural 
and unnatural α-amino acids were ring-opened with allyl alcohol under dynamic kinetic resolution 
(DKR) in the presence of a newly identified (thio)urea-based bifunctional organocatalyst to obtain 
N-acyl α-amino acid esters. The results are unprecedented in the chemically catalyzed DKR of 
azlactones in terms of optical purity of the product and substrate scope. Kinetic and NMR-studies 
indicate the formation of a 1:1 substrate-catalyst complex prior to alcoholysis. 
The same bifunctional organocatalyst was then applied to the alcoholytic ring opening of 
oxazinones bearing aromatic as well as aliphatic substituents under kinetic resolution (KR) to afford 
N-acyl β-amino acid esters. This is the first time that oxazinones were subjected to a catalytic ring 
opening reaction. 
Besides the DKR, the catalytic asymmetric hydrocyanation of imines was also revisited using chiral 
oxazaborolidine and oxazaborolidinium cations as the catalysts. Here a rather broad range of imines 
was applied. Although the resulting α-amino nitriles were obtained in low to moderate 
enantioselectivities, the catalyst afforded products with the opposite sense of stereoinduction upon 
protonation. This is the first successful application of neutral and cationic oxazaborolidines for the 
asymmetric hydrocyanation of imines. 
 
Im Rahmen der vorliegenden Arbeit wurden neue Verfahren zur Darstellung von α- und 
β-Aminosäuren durch Racematspaltung bzw. asymmetrische Synthese entwickelt. Eine große 
Anzahl von Azlactonen, abgeleitet von natürlichen und unnatürlichen α-Aminosäuren wurde durch 
alkoholytische Ringöffnung unter dynamisch kinetischer Racemattrennung in Anwesenheit eines 
neuartigen bifunktionalen Organokatalysators zu N-Acyl α-Aminosäureestern umgesetzt, wobei 
sowohl hinsichtlich Selektivität als auch bezüglich der Breite des Substratspektrums herausragende 
Ergebnisse erzielt wurden. Durch kinetische Studien und NMR-Untersuchungen konnten Hinweise 
auf einen 1:1 Substrat-Katalysator-Komplex erhalten werden, der sich vor der Ringöffnung 
ausbildet. 
Der gleiche bifunktionale Katalysator auf (Thio-)harnstoffbasis wurde in der alkoholytischen 
Ringöffnung von Oxazinonen mit aromatischen und aliphatischen Resten eingesetzt. Unter den 
Bedingungen einer kinetischen Racemattrennung konnten so zum ersten Mal enantiomerenreine 
N-Acyl β-Aminosäuren durch eine katalytische Ringöffnungsreaktion dargestellt werden. 
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Weiterhin wurden chirale Oxazaborolidin- und Oxazaborolidinium-Katalysatoren in der 
katalytischen asymmetrischen Hydrocyanierung eines breiten Spektrums von Iminen eingesetzt. 
Obwohl die erhaltenen α-Aminonitrile nur mit niedrigen bis moderaten Enantioselektivitäten 
erhalten wurden, konnten allein durch die Protonierung des Katalysators Produkte mit inverser 
stereochemischer Induktion erhalten werden. Hierbei handelte es sich um die erste Anwendung 
neutraler und kationischer Oxazaborolidine für die asymmetrische Hydrocyanierung. 
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